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Abstract 
DNA ligase I, encoded by the CDC9 gene in Saccharomyces cerevisiae, is an 
essential enzyme that catalyzes the ligation of newly synthesized DNA on the lagging 
strand called Okazaki fragments. In humans, approximately 30 million Okazaki 
fragments are synthesized during every S phase and require further processing prior to 
DNA ligation. An individual harboring DNA ligase I mutations exhibited growth 
retardation, sunlight sensitivity, severe immunosuppression and developed lymphoma, 
indicating a link between defects in Okazaki fragment maturation and cancer 
predisposition. How cells monitor and suppress such accumulation of DNA damage that 
arises due to defective Okazaki fragment processing is unclear. Using S. cerevisiae as a 
model system, we uncovered a novel and conserved ubiquitination pathway that targets 
proliferating cell nuclear antigen (PCNA) at lysine 107 when DNA ligase I activity is 
inhibited. The modification at K107 is catalyzed by the E2 variant Mms2 together with 
Ubc4 and the E3 ubiquitin ligase Rad5. Most importantly, this signal is crucial to activate 
the S phase checkpoint, which promotes cell cycle arrest. In support of this notion, a 
pol30K107 mutation alleviated cell cycle arrest in cdc9 mutants. To determine whether 
PCNA ubiquitination occurred in response to nicks or the lack of PCNA-DNA ligase 
interaction, we complemented cdc9 cells either with wild-type DNA ligase I or Chlorella 
virus ligase, the latter of which fails to interact with PCNA. Both enzymes reversed 
PCNA ubiquitination, arguing that the modification is likely triggered directly by nicks. 
To further understand how cells cope with nicks during replication, we utilized cdc9-1 in 
a genome-wide synthetic lethality screen and identified RAD59 as a strong negative 
  
 
iv 
interactor. cdc9 rad59! mutants did not alter PCNA ubiquitination but enhanced 
phosphorylation of the mediator of the replication checkpoint, Mrc1, indicative of 
increased replication fork stalling. Thus, Rad59 promotes fork progression when Okazaki 
fragment processing is compromised and counteracts PCNA-K107 mediated cell cycle 
arrest.  
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 Eukaryotic cell proliferation is regulated by a highly complex network of 
processes to ensure the preservation of genomic integrity and faithful transmission of 
genetic information during cell divisions.  Error-free DNA replication is the key process 
to guarantee accurate duplication of chromosomes prior to their segregation and 
transmission from a mother to a daughter cell. This is a daunting task because the genome 
is most vulnerable during DNA replication.  Cells must overcome many obstacles during 
DNA replication to prevent accumulation of mutations that arise from endogenous as 
well as exogenous DNA damaging events.  Failure to promote efficient and error-free 
DNA replication can result in DNA double-stranded breaks (DSBs) and ultimately gross 
chromosomal rearrangements (GCR), a hallmark of many cancers [Kolodner et al., 2002; 
Mitelman et al., 2007].  Eukaryotic cells have developed a network of signaling pathways 
known as the DNA damage response (DDR) to monitor the presence of DNA damage 
and coordinate DNA replication with DNA repair, chromosome segregation, and cell 
cycle progression [Ciccia and Elledge, 2010].    Therefore, a better understanding of how 
cells integrate different cellular processes to ensure proper DNA replication and suppress 
genomic instability will provide more insight into how genetic mutations cause cancer 
and other pathological disorders. 
 
Mechanism of DNA replication 
Cell cycle regulation.   
The cell cycle consists of two essential events, DNA replication of the genome 
(Synthesis or S phase) and segregation of the fully duplicated genome into two daughter 
  
 
3 
cells (mitosis or M phase) (Figure 1.1).  To ensure that genome segregation occurs only 
after the completion of DNA synthesis, the two events are separated by a “gap” phase 
called G2.  Similarly, another gap phase, G1, takes place before the start of every S phase 
to ensure that cells have the adequate size and all the necessary components required for 
DNA replication.   
The progression through different phases of the cell cycle in budding yeast 
Sacharomyces cerevisiae is regulated solely by cyclin dependent kinase 1 (Cdk1) 
[Hartwell et al., 1973; Reed et al., 1985].  S. cerevisiae expresses nine cyclins that 
associate with Cdk1 throughout the cell cycle to regulate its kinase activity, three G1 or 
A-type cyclins (Cln1-3) [Reed et al., 1989; Richardson et al., 1989] and six B-type 
cyclins (Clb1-6) (Figure 1.1) [Epstein and Cross, 1992; Fitch et al., 1992; Schwob and 
Nasmyth, 1993; Surana et al., 1991].  Although Cln1-3 have redundant roles primarily in 
the G1-S phase transition [Richardson et al., 1989], their molecular functions are 
different.  Cln3/Cdk1 regulates transcriptional programs, including Cln1 and Cln2 [Cross 
and Tinkelenberg, 1991; Dirick et al., 1995; Dirick and Nasmyth, 1991], whereas 
association of Cdk1 with either Cln1 or Cln2 regulates spindle pole duplication 
[Jaspersen et al., 2004] and bud morphogenesis [Lew and Reed, 1993].  To promote the 
G1-S transition, Cdk1 must dissociate from Cln1-3 and bind to Clb1-6.  In fact, Cln1-3 
are phosphorylated by Cln/Cdk1 and targeted for proteasomal degradation by the SCFGrr1 
(SKP1-CUL1-F-box containing E3 ubiquitin ligase Grr1) complex [Lanker et al., 1996; 
Skowyra et al., 1999; Tyers et al., 1992; Yaglom et al., 1995].  Additionally, Cln/Cdk1 is 
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required to phosphorylate Sic1, an inhibitor of Clb/Cdk1, to promote Sic1 proteolysis 
[Koivomagi et al., 2011; Nash et al., 2001; Schwob et al., 1994; Verma et al., 1997].    
Following Cln1-3 function in G1, the B-type cyclins, Clb1-6, associate with Cdk1 
at different times during S, G2, and M phase (Figure 1.1).  In G1, Clb5 and Clb6 are both 
highly expressed to drive DNA replication [Schwob and Nasmyth, 1993].  Clb5,6/Cdk1, 
also known as S-CDK, is involved in the assembly of initiation factors for DNA 
replication while simultaneously preventing reinitiation events at origins of replication 
that have already “fired” [Dahmann et al., 1995; Piatti et al., 1996; Schwob and 
Nasmyth, 1993; Zou and Stillman, 1998].  Whereas Clb5 is stable until mitosis, Clb6 is 
ubiquitinated by the SCFCDC4 at the G1/S border and is rapidly degraded [Jackson et al., 
2006].  Clb3,4 are expressed in S phase until anaphase and are involved in DNA 
replication, spindle assembly, and G2/M transition [Richardson et al., 1992].  Clb1,2 are 
expressed in G2/M phase to the end of M phase and are involved in mitotic events 
[Seufert et al., 1995].  Clb/Cdk1 activate an E3 ubiquitin ligase called the anaphase 
promoting complex or cyclosome (APC/C), which is important for the progression 
through mitosis, mitotic exit, and in turn reduce Cdk1 kinase activity in M and early G1 
phase [Alexandru et al., 1999; Rahal and Amon, 2008].  The activation of APC/C is 
regulated by the interaction with two different proteins, Cdc20 or Cdh1, contributing to 
cyclin proteolysis [Alexandru et al., 1999; Rahal and Amon, 2008; Shirayama et al., 
1999; Wasch and Cross, 2002].  Lastly, following mitosis, cells need to reset their cell 
cycle program in G1 to proceed through the next round of replication.  This is 
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accomplished by the phosphatase Cdc14 to dephosphorylate Cdk1 targets [Bloom and 
Cross, 2007].   
 
Origin licensing.   
DNA replication initiates at multiple regions along chromosomes that are termed 
origins of replication.  Since the first defined eukaryotic origin of replication in budding 
yeast was identified in 1979 [Stinchcomb et al., 1979], ongoing efforts aim to determine 
the molecular mechanisms by which these sequences direct initiation events.  Replication 
origins in yeast are known as autonomously replicating sequences (ARS), which contain 
an essential and conserved A-element called the ARS consensus sequence (ACS).  The 
origins are recognized by the evolutionarily conserved six-subunit origin recognition 
complex (ORC) that is essential for the stepwise assembly of a replication initiation 
complex [Bell and Dutta, 2002].  Although replication initiation is dependent on ORC in 
metazoa, they do not have a stringent sequence-specific ARS requirement.  Instead, they 
depend on other factors such as chromatin structure and epigenetics [Cadoret and 
Prioleau, 2010; Kuo et al., 2012; Wyrick et al., 2001].   
Detailed molecular mechanisms of replication initiation events have been 
elucidated in budding yeast using cell-free systems.  The initiation of DNA synthesis is a 
multi-step process that can be divided into two distinct temporal events, origin licensing 
(preparation of origins for initiation) and origin activation (initiation of DNA synthesis) 
[Bell and Dutta, 2002].  During origin licensing, ORC binds to origins in an ATP-
dependent manner in late M/G1 phase of the cell cycle when Cdk1 activity is low 
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[Aparicio et al., 1997; Bell and Stillman, 1992; Klemm et al., 1997].  ORC recruits two 
additional replication factors Cdc6 (cell division control protein 6) [Coleman et al., 1996; 
Liang et al., 1995] and Cdt1 (chromatin licensing and DNA replication factor 1) 
[Maiorano et al., 2000; Nishitani et al., 2000; Whittaker et al., 2000].  These factors are 
needed to load the head-to-head double-hexameric, replicative helicases Mcm2-7 
(minichromosome maintenance 2-7) proteins around the dsDNA origin [Evrin et al., 
2009; Gambus et al., 2011; Remus et al., 2009], forming the pre-replicative complex 
(pre-RC) (Figure 1.2, step I) [Bowers et al., 2004; Chen et al., 2007; Diffley et al., 1995; 
Klemm and Bell, 2001; Randell et al., 2006].  The loading of Mcm2-7 helicase to origins 
complete the origin licensing event, however, they remain inactive because S-CDK 
activity is low [Piatti et al., 1996]. 
 
Origin activation.   
As cells transition from G1 to S phase, DNA replication initiation requires a step-wise 
recruitment of multiple factors that are coordinated by two S phase dependent kinases, S-
CDK (Clb5,6/Cdk1) and Dbf4-dependent Cdc7 kinase (DDK) to form a complete 
replisome (Figure 1.2) [Bell and Dutta, 2002].  The activation of the Mcm2-7 helicase at 
pre-RCs requires the association of two helicase cofactors, Cdc45 and GINS (Go, Ichi, 
Nii, and San, 5-1-2-3 referred to number of the subunits in Japanese), forming the Cdc45-
Mcm2-7-GINS (CMG) complex [Moyer et al., 2006], which is also known as the pre-
initiation complex (pre-IC) [Zou and Stillman, 1998].  How DDK and S-CDK regulate 
the pre-IC formation and subsequent initiation of DNA synthesis has been controversial 
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until a recent report dissected their functions using an in vitro replication initiation assay 
[Heller et al., 2011].  The authors demonstrated a two-step mechanism leading to the 
formation of the pre-IC, first by DDK and subsequently by S-CDK.  DDK 
phosphorylates the chromatin-bound Mcm2-7 complex [Francis et al., 2009; Randell et 
al., 2010; Sclafani, 2000; Sheu and Stillman, 2006], promoting the interdependent 
recruitment and stable association of the synthetic lethality with Dpb11 (Sld) 3/Sld7 
complex and Cdc45 to the pre-RC complex [Aparicio et al., 1999; Kanemaki and Labib, 
2006; Masai et al., 2006; Takayama et al., 2003; Tanaka et al., 2011] (Figure 1.2, step 
II).   
Following DDK-dependent activity, S-CDK phosphorylates both Sld2 and Sld3, 
which are essential for replication initiation [Tanaka et al., 2007; Zegerman and Diffley, 
2007].  Because phospho-mimetic mutants of Sld2 and Sld3 can bypass the requirement 
of S-CDK activity, Sld2 and Sld3 phosphorylations are the “minimal set” of S-CDK 
substrates required for replication initiation.  S-CDK phosphorylation of Sld2 and Sld3 
stimulates their association to another essential replication factor, Dpb11 in order to 
recruit GINS to the origins [Kamimura et al., 1998; Tanaka et al., 2007; Zegerman and 
Diffley, 2007].  Dpb11 can simultaneously interact with both phosphorylated Sld2 and 
Sld3 through its C- and N-terminus BRCT (BRCA1 (breast cancer 1) C-terminus) 
domains, respectively [Tak et al., 2006; Tanaka et al., 2007; Zegerman and Diffley, 
2007].  Additionally, S-CDK also stimulates an unstable formation of the preloading 
complex (pre-LC), which consists of Sld2, Dpb11, the replicative polymerase pol-!, and 
GINS [Muramatsu et al., 2010].  This formation of the pre-LC is independent of DDK 
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and DNA binding.  Altogether, Dpb11 bridges the interaction between Sld3 (at the pre-
RC) with Sld2 (in the pre-LC), thereby recruits GINS as well as pol-! to the origins 
(Figure 1.2, step III).  The formation of the CMG complex leads to the activation of the 
helicase and subsequent unwinding of the double-stranded (ds) DNA origin [Moyer et al., 
2006].  Upon unwinding, single-stranded (ss) DNA is coated with replication protein A 
(RPA), allowing for the recruitment of pol-! (Figure 1.2, step IV) [Tanaka and Nasmyth, 
1998; Walter and Newport, 2000; Zou and Stillman, 2000].   Additionally, the stability 
and recruitment of pol-" to origins for de novo DNA synthesis is dependent on Mcm10 
likely through two separate mechanisms, (i) stabilization of ssDNA and (ii) direct binding 
to the catalytic subunit of pol-! [Ricke and Bielinsky, 2004; 2006; Warren et al., 2009; 
Warren et al., 2008].  In higher eukaryotes, MCM10 interacts with CTF4 and recruits 
pol-! to replication origins [Zhu et al., 2007].  In budding yeast, Ctf4 (chromosome 
transmission fidelity 4) is a non-essential gene and thus dispensable.  Depletion of 
Mcm10 in S. cerevisiae results in a reduced recruitment of pol-" and subsequently pol-#, 
but not pol-! to origins [Heller et al., 2011; Ricke and Bielinsky, 2004; 2006].   In 
addition to the CMG complex, additional factors such as Mrc1 (mediator of the 
replication checkpoint 1), Tof1 (topoisomerase 1-interacting factor 1), Csm3 
(chromosome segregation in meiosis 3), Ctf4, components of the histone chaperones 
including FACT, topoisomerase 1 (Top1), and Mcm10 are subsequently recruited to form 
a complete replisome for DNA synthesis [Gambus et al., 2006].  
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Prevention of re-replication.   
In eukaryotic cells, DNA replication occurs once per cell cycle due to a small 
time window when the B-type cyclin-dependent Clb/Cdk1 (S-CDK) activity is low.  The 
activation of Clb/Cdk1 ultimately prevents the reloading of the Mcm2-7 helicase at the 
origins by phosphorylating components of the pre-RC complex, ORC, Cdc6, and Mcm2-
7 [Dahmann et al., 1995; Detweiler and Li, 1998; Piatti et al., 1996].  In budding yeast, 
deregulation of any two or all three components of the pre-RC leads to detectable DNA 
rereplication, contributing to DNA damage and ultimately genome instability [Green et 
al., 2010; Green and Li, 2005; Green et al., 2006; Tanny et al., 2006].  S-CDK inhibits 
ORC function by steric hindrance via two distinct mechanisms, (i) phosphorylation of 
two ORC subunits, Orc2 and Orc6 and (ii) direct interaction with Orc6 [Nguyen et al., 
2001; Wilmes et al., 2004].  The N-terminal regions of both Orc2 and Orc6 facilitate the 
initial recruitment of Cdt1 and Mcm2-7 complex to origins. S-CDK-dependent 
phosphorylation of these regions prevents the interaction between ORC and Cdt1, 
resulting in the complete loss of Mcm2-7 double-hexameric helicase loading [Chen and 
Bell, 2011].  Orc6 also contains an “RXL” motif at the N-terminus that interacts with 
Clb5 throughout S phase into mitosis, but only when origins have already fired [Wilmes 
et al., 2004].  Eliminating the Clb5/Orc6 interaction does not affect origin initiation but 
instead results in DNA rereplication [Wilmes et al., 2004].  Furthermore, Clb5-Orc6-
RXL interaction also stimulates S-CDK phosphorylation of Orc6, suggesting a localized 
role of Clb5 in preventing reinitiation of replicated origins [Chen and Bell, 2011].  
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Another target of Cdk1 that prevents rereplication is Cdc6 [Piatti et al., 1996].  At 
least three layers of regulation exist to ensure that Cdc6’s function is inhibited.  Cdk1 
indirectly inhibits Cdc6 expression by phosphorylating a Cdc6-transcriptional activator 
Whi5, preventing its nuclear import [Moll et al., 1991; Piatti et al., 1995; Zwerschke et 
al., 1994].  Alternatively, Cdc6 is phosphorylated by Cdk1 and subsequently targeted for 
degradation by the SCFCDC4 complex, resulting in reduced Cdc6 expression [Drury et al., 
1997; 2000; Sanchez et al., 1999].  In addition, the association of Cdc6 with Clb2/Cdk1 
also prevents Cdc6 binding to pre-RCs [Mimura et al., 2004].   
Finally, the last component of the pre-RC complex that is targeted by Cdk1 is 
Mcm2-7, where phosphorylation of Mcm2-7 helicase leads to its exclusion from the 
nucleus [Labib et al., 1999; Nguyen et al., 2000].  Under physiological conditions, 
Mcm2-7 enters the nucleus at the end of mitosis and G1 phase and becomes primarily 
cytoplasmic in later stages of the cell cycle.  Expression of a stable Clb2/Cdk1 complex 
in G1 arrested cells is sufficient to exclude Mcm2-7 from the nucleus, suggesting a role 
of Clb2/Cdk1 in regulating Mcm2-7 localization.  Although Cdt1 is constitutively 
expressed throughout the cell cycle, its localization is co-regulated with Mcm2-7 by 
Cdk1 [Tanaka and Diffley, 2002].  Following Mcm2-7 helicase complex loading onto 
chromatin by ORC and Cdt1, Cdt1 is released from pre-RCs and excluded from the 
nucleus [Tanaka and Diffley, 2002].  The prevention of rereplication is slightly different 
in metazoans where hCDKs regulate either hCDT1’s degradation [Liu et al., 2004a; 
Nishitani et al., 2004; Nishitani et al., 2006] or its DNA binding activity [Sugimoto et al., 
2004].  In addition to CDK-dependent phosphorylation in metazoans, geminin, a 
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competitive inhibitor of hCDT1, accumulates from S phase to the metaphase-anaphase 
transition in mitosis, binds directly to hCDT1, and inhibits origin licensing [McGarry and 
Kirschner, 1998; Wohlschlegel et al., 2000].  In fact, overexpression of CDT1 alone or in 
combination with CDC6 in p53-/- human cancer cells is sufficient to induce rereplication 
[Vaziri et al., 2003]. 
 
Activation of the Mcm2-7 helicase.   
DNA unwinding by the activated CMG complex is an essential step for DNA 
replication initiation as well as elongation.  The observation that the replisome consists of 
a single Mcm2-7 helicase [Gambus et al., 2006] suggests that the double-hexameric 
helicase needs to be separated into two individual hexamers during or after its activation.  
It is unclear as to whether the CMG complex translocates along ss or ds DNA.  Fu et al. 
utilized a converging replication fork systems in Xenopus egg extracts where a 
“roadblock” was added specifically to either the leading or lagging strands or both [Fu et 
al., 2011].  The authors demonstrated that “roadblocks” specifically on the leading strand, 
but not the lagging strand, impeded the advancing CMG, suggesting that Mcm2-7 
translocates along ssDNA in 3’-5’ direction.  This result suggests that Mcm2-7 needs to 
extrude the lagging strand from its central core in order to unwind dsDNA.  In a different 
study, using single particle electron microscopy and 3D reconstruction, Costa et. al. 
provides structural information that may explain how the lagging strand is extruded 
[Costa et al., 2011].  Purified Mcm2-7 complex existed in two different conformations, a 
planar, notched-ring and a spiral lock-washer with an opening between Mcm2 and 5 
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[Costa et al., 2011], which has been hypothesized to be required for the loading of the 
helicase onto dsDNA origin [Bochman et al., 2008].  In contrast, the formation of CMG 
exhibited a planar closed state where Cdc45 and GINS closed the gap between the 
Mcm2/Mcm5 interface.  Additionally, the CMG complex constricted the central Mcm2-7 
pore and generated a second, external channel that may interact with the lagging strand 
template DNA.  The sequestration of the lagging strand template is hypothesized to be 
stabilized by ss binding proteins such as RPA, Mcm10, Sld2, or Sld3 [Bruck et al., 2011; 
Kanter and Kaplan, 2011; Warren et al., 2008; Zou and Stillman, 2000].  In line with this 
notion, recent studies suggest a role of Mcm10 in DNA unwinding of the origin prior to 
DNA synthesis, likely stabilizing the ssDNA rather than truly activating the CMG 
helicase [Kanke et al., 2012; van Deursen et al., 2012; Watase et al., 2012].  Besides the 
role of Mcm10 in ssDNA stabilization, it has been shown to travel with the replication 
fork and interact with different components involved in DNA synthesis [Araki et al., 
2003; Chattopadhyay and Bielinsky, 2007; Das-Bradoo et al., 2006; Hart et al., 2002; 
Lee et al., 2010; Merchant et al., 1997; Pacek et al., 2006; Ricke and Bielinsky, 2004; 
2006; Yang et al., 2005].  These properties of Mcm10 indicate its crucial role in 
coordinating DNA unwinding with DNA synthesis.   
 
DNA replication and synthesis.   
Upon origin activation, DNA synthesis proceeds bidirectionally [Prescott and 
Kuempel, 1972].  DNA synthesis depends on three major replicative polymerases, pol-", 
#, and !, all of which synthesize DNA in the 5’-3’ direction (Figure 1.3) [Garg and 
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Burgers, 2005a].  Due to the anti-parallel structure of DNA and the unidirectional 
polymerization activity of the DNA polymerases, synthesis occurs in a semi-
discontinuous manner, generating a continuous leading strand and a discontinuous 
lagging strand also known as Okazaki fragment (Figure 1.3) [Sakabe and Okazaki, 1966].  
Upon DNA unwinding, Mcm10 binds to ssDNA and, together with RPA, recruits the pol-
"/primase complex, which is the only known enzyme that can catalyze de novo DNA 
synthesis on both template strands (Figure 1.2 and 1.3) [Ricke and Bielinsky, 2004; 2006; 
Tanaka and Nasmyth, 1998; Walter and Newport, 2000; Warren et al., 2008; Zou and 
Stillman, 2000]. DNA primase catalyzes a short 8-11 nucleotides (nt) of RNA primer 
[Santocanale et al., 1993], which can then be elongated for another ~20 nt of DNA by 
pol-" activity, thereby generating short RNA/DNA primers [Denis and Bullock, 1993].  
Because pol-" is nonprocessive and lacks proofreading activity, the bulk of the genome 
DNA replication is synthesized by the processive pol-# and -!, which are responsible for 
lagging and leading strand synthesis, respectively [Garg and Burgers, 2005a; Nick 
McElhinny et al., 2008; Pursell et al., 2007]. 
The switch from pol-" to pol-# and -! is thought to be mediated by two additional 
proteins.  After pol-"/primase recruitment to the replication fork by Mcm10, Mcm10 is 
mono-ubiquitinated at two lysine residues (hereforth referred to as di-ubiquitinated 
Mcm10).  Di-ubiquitinated Mcm10 binds the DNA sliding clamp, proliferating cell 
nuclear antigen (PCNA), the processivity factor for pol-# and -! [Das-Bradoo et al., 
2006].  Interestingly, di-ubiquitinated Mcm10 only interacts with PCNA and not with 
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Cdc17, the catalytic subunit of pol-" [Das-Bradoo et al., 2006; Ricke and Bielinsky, 
2004; 2006].  This suggests an attractive model whereby Mcm10 di-ubiquitination 
releases pol-" from chromatin, resulting in Cdc17 degradation [Haworth et al., 2010], 
and simultaneously recruits PCNA, which is loaded onto chromatin by replication factor 
C (RFC) [Lee et al., 1991; Miyata et al., 2004; Tsurimoto and Stillman, 1990; 1991; 
Waga et al., 1994].  As the replication fork progresses to unwind dsDNA, pol-! travels 
with the replisome through the interaction with Mrc1, a component of the replisome, to 
synthesize one continuous leading strand [Lou et al., 2008].  However, lagging strand 
synthesis is more dynamic and requires additional components to join short Okazaki 
fragments together into one continuous strand, a process referred to as Okazaki fragment 
maturation.   
 
Okazaki fragment maturation.  
 In order to ligate Okazaki fragments together, the RNA primers synthesized by 
primase need to be removed and replaced with DNA synthesized by pol-# [Balakrishnan 
and Bambara, 2011].  The removal of the RNA primers involves the coordinated action 
of flap endonuclease 1 (Fen1, encoded by the RAD27 gene in S. cerevisiae) [Garg et al., 
2004; Gary et al., 1999; Liu et al., 2004b; Reagan et al., 1995] and pol-# (Figure 1.3) 
[Burgers, 2009; Garg et al., 2004; Jin et al., 2003].  As pol-# encounters the 5’-end of the 
downstream Okazaki fragment, it continues with synthesis while displacing the RNA 
primer, thereby generating a short 5’-flap [Garg et al., 2004; Jin et al., 2003].  This short 
5’-flap is removed by Fen1 to generate two DNA-DNA ligatable ends [Garg et al., 2004; 
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Jin et al., 2003].  DNA ligase I is recruited by PCNA, encircles the DNA and seals the 
nick [Ellenberger and Tomkinson, 2008; Pascal et al., 2004; Tomkinson et al., 2006].  
Since the homotrimeric PCNA can interact with pol-#, Fen1, and DNA ligase I through a 
highly conserved  PIP (PCNA-interacing protein) box motif, PCNA is thought to 
coordinate the recruitment of necessary factors and processing of lagging strands during 
Okazaki fragment maturation [Dionne et al., 2003].   
Although the short flap removal by Fen1 appears to be essential during Okazaki 
fragment maturation, deletion of Fen1 (rad27!) in S. cerevisiae retains viability, 
suggesting that different pathways for flap removal exist [Reagan et al., 1995; Sommers 
et al., 1995].  Indeed, both genetic and biochemical studies provide support for an 
alternative maturation pathway involving the DNA synthesis defective 2 (Dna2) protein 
[Ayyagari et al., 2003; Bae and Seo, 2000; Budd and Campbell, 1995; 1997].  A 
temperature sensitive allele of DNA2, dna2-1, arrests in S phase, indicating a problem 
during replication [Budd and Campbell, 1995].  Moreover, Dna2 physically and 
genetically interacts with Fen1, suggesting that Fen1 and Dna2 may have complementary 
functions [Budd and Campbell, 1997].  In line with this notion, when Fen1 fails to cleave 
the short flap, excessive strand displacement generating longer 5’-flaps occurs by the 
combined activities of three components: (i) the 3’-exonuclease activity of the catalytic 
subunit of pol-#, (ii) Pol32, a subunit of pol-#, and (iii) the 5’-3’ helicase activity of Pif1 
(petite integration frequency 1) [Budd et al., 2006; Burgers and Gerik, 1998; Jin et al., 
2003; Rossi et al., 2008; Stith et al., 2008].  The longer 30 nt 5’-flap is bound by RPA, 
which subsequently recruits and stimulates Dna2 activity but inhibits Fen1 action in vitro 
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[Bae et al., 2001; Jin et al., 2003; Kao et al., 2004; Maga et al., 2001].  Dna2 cleaves the 
RPA-coated flap, leaving a short 2-6 nt DNA flap that needs to be further processed by 
Fen1 [Bae and Seo, 2000; Kao et al., 2004].  However, in the absence of Fen1, pol-# or 
Exo1 (exonuclease 1) may play a role in generating a proper DNA nick for ligation by 
DNA ligase I [Burgers, 2009; Jin et al., 2003; Tishkoff et al., 1997].  Therefore, Dna2 
can compensate for Fen1-mediated flap removal [Ayyagari et al., 2003], explaining the 
non-essential characteristic of Fen1.  However, an excess of long 5’-flaps can lead to cell 
death [Budd et al., 2011; Budd and Campbell, 1997].  Conversely, suppressing the 
generation of long flaps by deleting PIF1 gene can rescue the loss of viability of dna2! 
mutants [Budd et al., 2006].  In summary, the DNA/RNA primer generated by pol-
"/primase can be removed by two distinct mechanisms, either by Fen1- or Dna2-
mediated short or long flap processing to generate a nick that can be ligated by DNA 
ligase I.  
 
Structure and function of DNA ligase I.   
DNA ligase I belongs to the nucleotidyltransferase (NTase) superfamily, which 
also contains RNA ligases and capping enzymes [Ellenberger and Tomkinson, 2008].  It 
catalyzes the sealing of nicks between adjacent 3’OH and 5’PO4 termini and is crucial for 
DNA replication, repair and recombination.  The DNA ligation mechanism involves three 
nucleotidyl transfer reactions (Figure 1.4) [Ellenberger and Tomkinson, 2008].  In the 
first step of the ligation reaction, DNA ligase reacts with either ATP or NAD+ (in 
prokaryotes) to form a ligase-adenylate intermediate where 5’-adenosine monophosphate 
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(AMP) is linked by a phosphoamide bond with the lysine residue in the active site of the 
enzyme.  In the second step, AMP is transferred to the 5’PO4 terminus of the nick to form 
DNA-adenylate.  Finally, DNA ligase catalyzes the nucleophilic attack of the 3’OH to the 
DNA-adenylate to covalently join the two ends of the DNA strand and release AMP.   
The NTase and oligonucleotide/oligosaccharide binding fold (OB-fold) domains, 
containing both the DNA binding and active site residues, together form a minimal 
catalytic core that is conserved in all known NTase enzyme superfamily members (Figure 
1.5) [Ellenberger and Tomkinson, 2008].  DNA ligase from Chlorella virus, the smallest 
known ATP-dependent DNA ligase I that contains only the NTase and OB-fold domains, 
can rescue the viability and DNA repair functions of DNA ligase I in both budding yeast 
and humans [Ho et al., 1997; Simsek et al., 2011; Sriskanda et al., 1999].  This 
observation illustrates the high degree of conservation among this class of DNA ligases.  
Eukaryotic DNA ligases have additional N- and C-terminal domains that are crucial for 
their biological activities, either for protein-protein and/or protein-DNA interactions 
(Figure 1.5) [Ellenberger and Tomkinson, 2008].  For example, an additional DNA 
binding domain (DBD) in mammalian DNA ligase I is crucial for efficient ligation 
activity [Pascal et al., 2004].   
Molecular insights of human DNA ligase I (hLIG1) action can be extrapolated 
from the structural studies of the enzyme with DNA and PCNA from different species.  
Structural studies demonstrate that the DBD, OB-Fold, and NTase domains of hLIG1 are 
important to circularize and stabilize the nicked DNA substrate [Pascal et al., 2004].  
Another co-crystal structure of PCNA and DNA ligase from Sulfolobus solfataricus 
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further suggests that DNA ligase undergoes a dynamic conformational change, from an 
elongated form (in the absence of DNA) to a circularized form (in the presence of nicked 
DNA) [Pascal et al., 2006].  Since DNA ligase I contains a PIP box motif, it is thought 
that PCNA may direct DNA ligase I to the nicked substrates [Refsland and Livingston, 
2005; Subramanian et al., 2005].   To better understand how DNA ligase I PIP-box motif 
interacts with PCNA, a structural study was carried out using the S. cerevisiae Cdc9 
(homolog of hLIG1) PIP-box peptide crystallized with budding yeast PCNA 
[Vijayakumar et al., 2007].  The authors demonstrated that Cdc9 PIP-box peptide 
interacted with both the inter-domain connector loop (IDCL), which connects the N- and 
C-terminus of each monomeric PCNA, and the hydrophobic pocket in the C-terminus of 
PCNA [Vijayakumar et al., 2007].  In summary, DNA ligase I interacts with PCNA 
through its PIP-box and remains in an elongated conformation in the absence of DNA.  
When the nicked substrate is generated during Okazaki fragment maturation, DNA ligase 
I circularizes around the DNA, likely to make other contacts with PCNA, and ligates the 
two adjacent DNA fragments together.   
   S. cerevisiae encodes two different DNA ligases, Cdc9 and Dln4, which are 
homologs of human DNA ligases I and IV, respectively [Barnes et al., 1990; Johnston 
and Nasmyth, 1978; Schar et al., 1997; Teo and Jackson, 1997; Wei et al., 1995; Wilson 
et al., 1997].  The two proteins have different principal roles in DNA metabolism.  While 
Dln4 functions in DSB repair via non-homologous end joining (NHEJ), Cdc9 participates 
in base excision repair (BER) and nucleotide excision repair (NER) pathways [Johnston 
and Nasmyth, 1978; Montelone et al., 1981; Schar et al., 1997; Teo and Jackson, 1997; 
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Wilson et al., 1997; Wu et al., 1999].  The CDC9 gene also contains two alternative 
translational start sites that encode nuclear and mitrochondrial forms of DNA ligase I 
[Willer et al., 1999].  In addition, Cdc9 is essential for the ligation of Okazaki fragments 
during lagging strand synthesis [Johnston and Nasmyth, 1978].   
Different temperature sensitive (ts) alleles of CDC9 were isolated from the 
original screen for cell division cycle (cdc) mutants [Culotti and Hartwell, 1971; Hartwell 
et al., 1973].  At the non-permissive temperature, cdc9 mutants arrest in late S/G2 phase 
of the cell cycle and accumulate small nascent DNA fragments similar to unligated 
Okazaki fragments [Johnston and Nasmyth, 1978; Schiestl et al., 1989].  This suggests 
that cells replicate the whole genome leaving nicks in the DNA behind until G2/M.  
Furthermore, cdc9 mutants are hyper-recombinogenic and synthetically lethal with 
homologous recombination (HR) repair protein genes, such as RAD52 [Ireland et al., 
2000; Montelone et al., 1981].  These phenotypes suggest that the increasing half-life of 
unligated DNA in S phase leads to DNA recombination and depends on HR for survival.  
Human LIG1 was successfully cloned from a cDNA library screen for genes that were 
able to complements cdc9ts alleles in budding yeast [Barnes et al., 1990].  Although 
Cdc9 and hLIG1 share only 37% sequence identity, the three core domains of hLIG1 
were sufficient to rescue cdc9ts cell viability at the non-permissive temperature, again 
emphasizing the conserved nature of DNA ligase I among species. 
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Genomic instability and cancer. 
The preservation of genomic integrity requires a variety of processes to ensure 
proper genome duplication during cell proliferation.  Efficient and error-free DNA 
replication is crucial towards accurate genome duplication to prevent the accumulation of 
mutations.  Such accumulation of mutations can either activate proto-oncogenes or 
inactivate tumor suppressor genes that are required to promote tumorigenesis.  
Fortunately, cells have evolved the DNA damage response (DDR) system to protect its 
DNA from damage induced by either exogenous environmental agents or endogenous 
DNA alterations during the cell’s normal metabolic processes [Ciccia and Elledge, 2010].  
DDR has the ability to sense and trigger appropriate cellular responses to counteract 
DNA damage.  Not surprisingly, defects in genes involved in DDR have been linked to 
different human cancer susceptibility syndromes [Ciccia and Elledge, 2010].  Better 
understanding of the molecular mechanisms through which the DDR operates will 
provide therapeutic opportunities for many human diseases.  
 
Sources of DNA damage.   
Endogenous DNA damage is induced by spontaneous hydrolytic reactions of 
DNA bases, the cell’s own metabolic processes, and DNA replication errors.  First, 
during spontaneous hydrolytic reactions, DNA bases can either be deaminated or 
completely lost, which leaves an abasic site.  Under physiological conditions, it is 
estimated that 2,000 - 10,000 DNA bases are hydrolyzed in a human cell a day owing to 
hydrolytic depurination [Lindahl, 1993; Lindahl and Nyberg, 1972].  If an 
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apurinic/apyrimidinic (AP) site is left unpaired, it can block replicative polymerases 
during DNA replication, forcing cells to depend on the function of the error-prone 
translesion synthesis (TLS) polymerases [Haracska et al., 2001].  In the same vein, 
deamination of cytosine, adenine, guanine, or 5-methylcytosine, which converts these 
bases to uracil, hypoxanthine, xanthine, and thymine, respectively, are also highly 
mutagenic [Lindahl, 1993; Meira et al., 2005].  The increase of mutations is due to the 
misincorporation of nucleotides opposite of the deaminated bases during DNA 
replication, resulting in permanent mutations in the genome in the next round of 
replication.  Another type of endogenous DNA damage is caused by the exposure of 
DNA to reactive oxygen species (ROS) such as hydroxyl radicals [Lindahl, 1993; Meira 
et al., 2005].  One of the most common DNA lesions caused by ROS is the highly 
mutagenic 8-oxo-7,8-dihydroguanine (8-oxoG), which can mismatch with an adenine, 
resulting in a G:C to A:T transition mutation [Cheng et al., 1992].  Altogether, 
spontaneous hydrolysis of DNA bases causes approximately 20,000 potentially 
mutagenic lesions that arise in a human cell per day [Preston et al., 2010]. 
Besides spontaneous nucleotide hydrolysis, mutations can be inserted in the 
genome naturally by the cell’s own replicative pol-" and pol-# [Preston et al., 2010].  
Although pol-# and pol-! have intrinsic 3’-5’ exonucleolytic proofreading activity, they 
occasionally make errors approximately once every 104 – 105 nt polymerized [Fortune et 
al., 2005; McCulloch and Kunkel, 2008; Shcherbakova et al., 2003].  The majority of the 
errors are either base mismatches or ± 1 slippage events [Fortune et al., 2005; 
Shcherbakova et al., 2003].  Thus, at least 105 – 106 polymerase errors occur for each 
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replicated human cell if left unrepaired [Preston et al., 2010].  These replicative DNA 
polymerases are also capable of incorporating ribonucleotides (rNTPs) into DNA during 
replication in vitro and in vivo since the rNTP pools in cells are significantly higher than 
the dNTP (di-deoxynucleotide) pools [Nick McElhinny et al., 2010a; Nick McElhinny et 
al., 2010b; Nick McElhinny et al., 2010c].  Incorporation of rNTPs into DNA results in 
single-base substitution and 2-5 base deletions [Nick McElhinny et al., 2010b].  Besides 
DNA lesions that give rise to mutations, ROS can also damage DNA by attacking the 
sugar-backbone, generating ss and ds breaks (SSBs and DSBs, respectively) [Caldecott, 
2008; Meira et al., 2005].  Lastly, replication forks can collapse and give rise to DSBs 
either by prolonged stalled replication forks or forks that progress through a SSB that 
leads to the dissociation of replication fork components [Branzei and Foiani, 2008].   
 Besides coping with thousands of endogenous DNA lesions, a cell also needs to 
guard its genome against exogenous DNA damage such as ultraviolet (UV) or ionizing 
irradiation (IR), and other chemical sources [Ciccia and Elledge, 2010; Hoeijmakers, 
2009].  UV-irradiation causes pyrimidine dimers and 6-4 cyclobutane pyrimidine dimers 
(CPD) that can induce up to 105 DNA lesions during a day-long exposure to sunlight 
[Hoeijmakers, 2009].  Ionizing irradiation can cause the combination of oxidative DNA 
bases, SSBs and DSBs [Ciccia and Elledge, 2010].  It has been estimated that mammalian 
cells exposed to 1 Gy (gray) of IR can elicit ~1000 SSBs and ~40 DSBs immediately 
after irradiation [Ciccia and Elledge, 2010].  Many chemical DNA damaging agents used 
in cancer chemotherapy also induce different types of lesions.  For example, methyl 
methansulfonate (MMS) methylates N7-deoxyguanine and N3-deoxyadenine can cause 
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replication blocks and base mispairing [Beranek, 1990].  In conclusion, the combined 
numbers of DNA lesions caused by both endogenous and exogenous DNA damage 
throughout the genome can potentially lead to genomic instability.  However, the fact that 
genome duplication occurs with high fidelity (~10-10 mutations per base pair per cell 
division) [Drake et al., 1998; Preston et al., 2010] indicates that cells have a remarkably 
efficient ability to repair DNA damage.  
 
DNA defense mechanisms.   
To counteract different types of lesions, cells have evolved several distinct repair 
mechanisms that are highly conserved between yeasts and humans (Figure 1.6a) 
[Hoeijmakers, 2001; Ulrich and Walden, 2010].  In BER, spontaneous DNA base 
hydrolysis and small chemical base alterations are excised by DNA glycosylase, 
generating AP sites [Hoeijmakers, 2001; Meira et al., 2005].  The strand at the abasic site 
is excised and repaired by either short- or long patch BER. Second, the removal of 
misincorporated nucleotides caused by pol-# and pol-! relies heavily on the mismatch 
repair (MMR) pathway, which are active during DNA replication [Jiricny, 2006; Preston 
et al., 2010].  Both BER and MMR pathways contribute significantly to the fidelity of 
genome duplication and mutation avoidance.  The repair of intrastrand crosslinks such as 
lesions caused by UV-radiation or other damaging agents depends on NER, a repair 
mechanism in which a stretch of approximately 30 nucleotides encompassing the lesion is 
removed, leaving a ssDNA gap to be resynthesized by DNA polymerases and ligated 
together by DNA ligase [Hoeijmakers, 2001].  If damage is left unrepaired, these bulky 
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adducts can block DNA polymerases during DNA replication.  In this case, however, 
lesions can be bypassed by the TLS polymerases to synthesize across the lesion.  
Alternatively, lesion bypass utilizes a template switch mechanism using newly 
synthesized nascent DNA as the template. These types of repair will be discussed in more 
detail in a separate section (See Postreplicative repair pathways section on page 36). 
Lastly, HR and NHEJ primarily function to repair DSBs (Figure 1.6a) [Heyer et 
al., 2010; Lieber, 2010].  HR is activated in S and G2 phases of the cell cycle where 
undamaged sister chromatids are available as a template to repair broken DNA ends 
[Branzei and Foiani, 2008].  If sister chromatids are not available for HR such as in G1 
phase, NHEJ is the primary mode for DSB repair [Branzei and Foiani, 2008].  Besides 
these conserved repair pathways, there are other repair pathways that are only present in 
higher eukaryotes.  For example, PARP (poly (ADP-ribose) polymerase) proteins, such 
as PARP1 and PARP2, are important for the activation of SSB repair pathway to recruit 
BER components [Caldecott, 2008; Schreiber et al., 2006].  Furthermore, alternative non-
homologous end joining (alt-NHEJ) is also present in mammalian cells where DSB ends 
are resected to expose a short microhomology region for DNA annealing of the ends 
[Lieber, 2010; Symington and Gautier, 2011]. 
 
DNA damage checkpoints.   
To coordinate different repair mechanisms, the DDR network contains DNA 
damage checkpoint genes that regulate appropriate cellular responses to DNA damage.  
These checkpoint genes are important to coordinate DNA repair with other cellular 
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processes such as cell cycle progression, transcription and metabolism to provide 
sufficient time for DNA repair [Ciccia and Elledge, 2010]. Furthermore, they also 
regulate the recruitment and activation of different repair factors at DNA lesions that are 
most efficient for DNA repair [Symington and Gautier, 2011].  In humans, the DNA 
damage checkpoint is primarily mediated by the phosphatidylinositol 3-kinase-like 
protein kinases (PIKKs), ATM, ATR and DNA-PK (Figure 1.6b).  ATM (ataxia-
telangiectasia mutated) and DNA-PK (DNA-dependent protein kinase) are activated in 
response to DSBs such as IR [Ciccia and Elledge, 2010].  Notably, only ATR (ataxia-
telangiectasia mutated- and Rad3-related) is essential for the viability of human and 
mouse cells, whereas ATM and DNA-PK are not [Brown and Baltimore, 2000; de Klein 
et al., 2000; O'Driscoll, 2009; Ruis et al., 2008]. While DNA-PK only phosphorylates 
proteins involved in NHEJ [Symington and Gautier, 2011], ATM regulates hundreds of 
substrates involved in many distinct pathways [Bensimon et al., 2011; Matsuoka et al., 
2007].  Besides DSB recognition, ATM is a direct sensor of ROS in response to oxidative 
stress [Guo et al., 2010a; Guo et al., 2010b].  Moreover, a cytoplasmic fraction of ATM 
can also regulate metabolic processes in response to ROS [Cosentino et al., 2011; Ditch 
and Paull, 2012].   
ATR is activated by ssDNA structures that are generated by different types of 
DNA damage and replication interference such as DNA breaks and inhibition of DNA 
polymerases, respectively [Cimprich and Cortez, 2008].  The length of the ssDNA region 
and at a ssDNA-dsDNA junctions is crucial for effective activation of ATR [Cimprich 
and Cortez, 2008; Flynn and Zou, 2011; Shiotani and Zou, 2009a; b; Zou, 2007].  Upon 
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ATM/ATR activation, they phosphorylate serine or threonine followed by glutamine 
(SQ/TQ) motifs of different target proteins.  For example, over 700 proteins with 
ATM/ATR-dependent SQ/TQ motifs associated with repair, checkpoint, cell cycle, and 
DNA replication processes are phosphorylated in response to IR [Matsuoka et al., 2007].  
How ATM- and ATR-dependent substrate phosphorylation in response to DNA damage 
affects their in vivo functions in still unknown and warrants further investigation in the 
future.   
 
Genetic mutations and human diseases.   
Since the DDR is vital for genome maintenance, defects in DDR result in an 
accumulation of mutations and DNA damage in a cell.  The accumulation of mutations 
can predispose cells to cancer by activating oncogenes or deactivating tumor suppressor 
genes and/or caretaker genes such as ATM.  The activation of oncogenes can promote 
premature entry into S phase, causing replication stress in the form of having too few 
replication forks that can lead to fork stalling and subsequence DNA damage [Bartkova 
et al., 2005].  Such damage activates the ATM/ATR-mediated DDR signaling pathways.  
Consistent with this notion, activated DDR factors were found in early premalignant 
human tumors, likely to inhibit cancer progression [Bartkova et al., 2005].  Therefore, 
DDR is thought to function as an early anti-cancer barrier against tumorigenesis.  
Perhaps, the strongest evidence for the role of the DDR in genome maintenance is that 
mutations in DDR genes were found in many human diseases and genetic disorders such 
as neurodegenerative disorders, immunodeficiencies, infertility, premature ageing and 
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cancer [Ciccia and Elledge, 2010].  Patients with inherited mutations in DDR genes have 
higher risks of cancer development.  Mutations in ATR, ATM, and their downstream 
effector checkpoint kinases 1 and 2 (Chk1 and Chk2, respectively) have been reported in 
malignant human tumors [Meijers-Heijboer et al., 2003; Menoyo et al., 2001; Renwick et 
al., 2006; Tanaka et al., 2012; Wasielewski et al., 2008].  Mutations in ATM are found in 
patients with ataxia telangiectasia (AT) syndrome, which exhibits immunodeficiency, 
hypersensitivity to x-rays, and most importantly, predisposes individuals to cancer [Biton 
et al., 2008].   
In addition to mutations in checkpoint genes, mutations in different DNA repair 
pathways have also been indicated in cancers [Ciccia and Elledge, 2010].  For example, 
mutations in BRCA1 and BRCA2 genes, which are involved in HR result in predisposition 
to breast cancer [Roy et al., 2012].  Second, defects in DNA ligase IV, a component of 
NHEJ, was found in a patient with leukemia [Riballo et al., 1999].  Third, mutations in 
MSH2 (MutS homolog 2) and MLH1 (MutL homolog 1) genes, which cause defective 
MMR, were found in hereditary nonpolyposis colon cancer (HNPCC) and in Lynch 
syndrome patients [Hoeijmakers, 2001; Jiricny, 2006].  The inability to reduce 
spontaneous mutation rates, repair DSBs, or trigger cell cycle arrest or apoptosis result in 
an increase of genome instability that fuels cancer development.  
If DNA lesions are left unrepaired, cells face a bigger problem when the 
replisome encounters damage that blocks its progression in S phase.  The replisome must 
be stabilized in order to resume replication after the removal of DNA damage or 
replication stress.  Moreover, prolonged stalled replication forks can lead to fork collapse, 
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causing DSBs, and subsequently result in GCR, a hallmark of many cancers [Mitelman et 
al., 2007].  Thus, maintaining fork stability is important for genome maintenance.  In line 
with this notion, ATR is activated during S phase to regulate replication origin initiation, 
repair stalled forks and prevent entry into mitosis [Cimprich and Cortez, 2008], which 
may explain the essential function of ATR in humans and mice [Brown and Baltimore, 
2000; de Klein et al., 2000; O'Driscoll, 2009].  A germline mutation in ATR was recently 
identified in oropharyngeal cancer syndrome, which causes reduced activation of p53, a 
tumor suppressor protein, in response to stalled replication forks after depleting dNTP 
pools using hydroxyurea (HU) [Tanaka et al., 2012].  Moreover, inhibition of DNA 
replication has been shown to induce breakage at specific regions of the chromosome, 
which are called fragile sites [Dereli-Oz et al., 2011; Glover et al., 1984; Hecht and 
Glover, 1984].  Chromosome breaks at fragile sites can lead to the deletion of common 
tumor suppressor genes, which paves the way for cancer progression [Bignell et al., 
2010].     
In addition to mutations in DDR genes that stabilize stalled replication forks, 
impairment of DNA replication genes can also lead to genomic instability, GCR, and 
developmental defects [Aguilera and Gomez-Gonzalez, 2008].  Recently, mutations in 
ORC1 and genes that encode other components of the pre-RC, ORC4, ORC6, CDT1, and 
CDC6, were found in Meier-Gorlin syndrome [Bicknell et al., 2011a; Bicknell et al., 
2011b].  However, patients with Meier-Gorlin syndrome have yet to display either 
genomic instability or cancer predisposition.  In contrast to Meier-Gorlin syndrome, 
Bloom’s syndrome (BS) patients, who carry mutations in the BLM (Bloom) gene, display 
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developmental defects, premature aging and cancer predisposition [Ellis and German, 
1996; Ellis et al., 1995].  Although BLM is not a bona fide replication protein per se, BS 
cells exhibit slow rate in chain elongation, accumulate abnormal replication intermediates 
and may be impaired in the restart of stalled forks [Davies et al., 2007; Hand and 
German, 1975; Lonn et al., 1990].  Furthermore, a forward genetic screen searching for 
genes involved in maintaining genome stability identified a mutation in MCM4 
(MCM4chaos3/chaos3) in mice that reduces MCM2-7 helicase stability on chromatin and 
results in abnormal chromosome segregation in mitosis with lagging chromosomes and 
acentric DNA fragments due to incomplete DNA synthesis, illustrating a direct link 
between defects in DNA replication and genomic instability [Kawabata et al., 2011; 
Shima et al., 2007].  Mutations in FEN1, an enzyme that is involved in the removal of 
RNA primers from Okazaki fragments, were identified in several different human tumors 
[Zheng et al., 2007].  Additionally, mice harboring mutations in FEN1 that abrogated its 
flap endonuclease activity developed cancers, suggesting that FEN1 is a tumor suppressor 
in mice [Larsen et al., 2008; Zheng et al., 2007].  Lastly, mutations in DNA ligase I, the 
only ligase that joins Okazaki fragments during lagging strand synthesis, were identified 
in a single individual, who developed lymphoma and died at a young age of pneumonia 
[Barnes et al., 1992; Webster et al., 1992].  In conclusion, knowledge gained from 
exploring the relationship between DNA replication and pathways that suppress genome 
instability to ensure proper genome duplication will be crucial to understand the 
mechanisms by which cancer and other pathological disorders arise.  
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DNA ligase I deficiency and human disease.   
Only one individual, who was initially diagnosed with recurrent infections, has 
been identified with mutations in the LIG1 gene (Figure 1.5) [Barnes et al., 1992; 
Webster et al., 1992].  The female patient exhibited sensitivity to sunlight, growth 
retardation, immunodeficiency, delays in development, lymphoma and died at the age of 
19 from pneumonia [Webster et al., 1992].  She carried an inherited maternal allele in 
which a conserved arginine residue in the OB-fold at position 771 was mutated to 
tryptophan (R771W) [Barnes et al., 1992].  The inherited mutation was present in the 
mother and two brothers of the patient [Webster et al., 1992].  However, all three 
heterozygotes were clinically normal.  Although the R771W mutation caused 
accumulation of adenylated DNA intermediates in the second step of the ligation 
reaction, LIG1 R771W cells retained about 5-10% DNA ligase I activity [Barnes et al., 
1992; Prigent et al., 1994].  A second, spontaneous mutation in the paternal allele 
affected the highly conserved glutamic acid residue at position 566 and replaced it with a 
lysine (E566K).  E566 is two residues away from the active site lysine that catalyzes the 
first step of the ligation reaction [Barnes et al., 1992; Ellenberger and Tomkinson, 2008].  
The E566K mutation resulted in complete inactivation of LIG1 activity [Barnes et al., 
1992].   
Because the CDC9 gene in S. cerevisiae is essential for viability, it was presumed 
that inactivation of LIG1 in human cells would result in cell lethality.  In agreement with 
this hypothesis, homozygous deletion of LIG1 gene in mouse embryonic stem cells was 
only viable when ectopic expression of LIG1 was introduced in these cells, suggesting 
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that DNA ligase I also is essential in human cells [Petrini et al., 1995].  However, two 
different mouse embryos harboring a truncation at the 3’ end of the LIG1 gene developed 
normally until midgestation [Bentley et al., 1996; Bentley et al., 2002].  Although LIG1 
protein levels were below detectable limits, it is possible that LIG1 function was not 
completely ablated in these embryos, thus resulting in normal embryo development at 
least in the early stages.  Nevertheless, these presumed LIG1-/- mouse embryonic 
fibroblast (MEF) cell lines established from both of these animal models display defects 
in Okazaki fragment ligation and increased genome instability, suggesting a link between 
defects in Okazaki fragment maturation and cancer predisposition [Bentley et al., 1996; 
Bentley et al., 2002].  The link between DNA replication defects and cancer development 
was further supported by another LIG1 defective mouse model, harboring homozygous 
R771W human mutation [Harrison et al., 2002].  Similar to the human patient, the LIG1 
R771W mice displayed a delayed growth phenotype.  Notably, these mutant mice 
exhibited an increase in both genomic instability and incidence of spontaneous tumor 
formations.  Therefore, the defective LIG1 function in Okazaki fragment maturation in 
mammals accumulates replication intermediates that promote genomic instability and 
increased incidence of cancer development.   
 
S phase DNA damage response in S. cerevisiae  
During S phase, cells rely on the S phase checkpoint to overcome many obstacles 
that arise during DNA replication.  Failure to promote error-free DNA replication can 
result in the accumulation of DNA damage such as DSBs leading to the formation of 
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GCRs, which are commonly found in cancer cells [Kolodner et al., 2002; Mitelman et al., 
2007].  In S. cerevisiae, mutations in the S phase checkpoint genes exhibited an increase 
in GCRs, suggesting that cells rely on the S phase checkpoint to suppress spontaneous 
genome rearrangements that arise from replication errors [Myung et al., 2001; Myung 
and Kolodner, 2002].   
As mentioned above, cdc9ts (DNA ligase I) mutants arrest in late S/G2 and delay 
the entry into mitosis at the non-permissive temperature, suggesting that cells have 
surveillance mechanisms to ensure the completion of DNA replication and removal of 
any remaining DNA damage before mitosis [Johnston and Nasmyth, 1978; Schiestl et al., 
1989].  This delay in G2 phase was later reported to be dependent on S. cerevisiae RAD9 
gene [Schiestl et al., 1989; Weinert and Hartwell, 1989].  The loss of RAD9 in cdc9ts 
mutants allows cells to enter mitosis and continue a couple of rounds of replication before 
losing viability.  The Rad9-dependent checkpoint is also activated in response to X- and 
UV-irradiation [Weinert and Hartwell, 1989; Weinert and Hartwell, 1990].  These studies 
suggest that cells have different mechanisms to activate a “checkpoint” pathway that 
delays mitotic entry in response to DNA damage or defects in DNA synthesis [Weinert 
and Hartwell, 1989].  Over the past 20 years, identifying genes involved in these 
checkpoint pathways to understand how the cell recognizes different DNA structures and 
activates a checkpoint response have been the focus of many laboratories.  Today, it is 
well appreciated that besides its role in regulating cell-cycle progression, the checkpoint 
pathway also plays a crucial role in response to replication stress during S phase.   In 
particular, maintaining the stability of stalled forks is crucial to prevent them from 
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collapse, thereby facilitating fork restart after the stress is removed [Branzei and Foiani, 
2010].   
 
The activation of the S phase checkpoint.   
A central response to replication stress is the activation of the checkpoint kinase, 
mitotic entry checkpoint 1 (Mec1, homolog of the human ATR) and its downstream 
effector, checkpoint kinase Rad53 (homolog of the human Chk2, but functions similar to 
human Chk1) (Figure 1.7) [Alcasabas et al., 2001; Sanchez et al., 1996; Sun et al., 1996].  
Evidence from different model organisms converge to a centralized theme that ssDNA, 
generated by inhibition of DNA polymerases, is the key structure that activates Mec1 
[Cimprich and Cortez, 2008; Flynn and Zou, 2011].  Uncoupling of DNA synthesis and 
DNA unwinding caused by MMS- or UV-induced stalling of DNA polymerases on either 
strand leads to the accumulation of ssDNA at stalled forks.  RPA binds to exposed 
ssDNA regions, and the ssDNA-RPA complex is critical for the recruitment of the 
Mec1/Ddc2 (DNA damage checkpoint 2) complex to stalled replication forks [Zou and 
Elledge, 2003].  Activation of Mec1 ultimately phosphorylates its downstream 
checkpoint kinase Rad53 through a mediator protein Mrc1, a component of the replisome 
[Alcasabas et al., 2001].  Mrc1 plays a role during both unperturbed replication and 
replication stress.  During normal replication, Mrc1 travels with the replisome and 
promotes efficient replication, but when the machinery encounters a replication block, 
Mrc1-Tof1-Csm3 form a stable pausing complex at the stalled fork [Katou et al., 2003].  
In addition, Mrc1 is phopshorylated in a Mec1- and Rad53-dependent manner [Alcasabas 
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et al., 2001].  Seventeen SQ and TQ consensus Mec1-dependent phosphorylation sites of 
Mrc1 were identified [Osborn and Elledge, 2003].  A recent study illustrates that 
phosphorylation of Mrc1 by Mec1, but not Rad53, is necessary to stabilize Mec1 and the 
replisome at stalled forks, establishing a positive feedback loop [Naylor et al., 2009].  
Cells carrying mutations of all 17 S/T-Q sites on Mrc1 (Mrc1AQ) retain normal 
replication function but inhibit Mec1-dependent Rad53 phosphorylation as well as 
decrease Mec1 stability at stalled forks [Naylor et al., 2009; Osborn and Elledge, 2003].   
 Although Rad9 functions as a mediator, similar to Mrc1, for Rad53 
phosphorylation by Mec1 and Tel1 (telomere maintenance 1, homolog of human ATM) 
in response to DNA damage, it plays no role in response to replication stress in wild-type 
cells (Figure 1.7) [Alcasabas et al., 2001; Emili, 1998; Gilbert et al., 2001; Vialard et al., 
1998].  However, mrc1! mutants exhibit a delay in Rad53 phosphorylation when 
replication is blocked, suggesting that replication stress causes DNA damage in the 
absence of Mrc1 [Alcasabas et al., 2001].  Thus, cells then activate Rad53 
phosphorylation via a Rad9-dependent pathway.  Phosphorylated Rad9 interacts with 
Rad53 and changes its conformation to activate autophosphorylation [Gilbert et al., 2001; 
Sweeney et al., 2005; Vialard et al., 1998].  Consistent with this notion, mrc1! rad9! 
double mutants are synthetically lethal, underscoring the importance of Rad53 activation 
by these two independent branches of the S phase checkpoint [Alcasabas et al., 2001; 
Kim and Weinert, 1997].  
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Role of the S phase checkpoint.   
Although Rad53 is activated in response to replication stress, little is known about 
how its activation regulates replication and DNA damage checkpoint function.  To date, 
only a couple of downstream targets of Rad53 have been identified and the functions of 
these targets range from affecting transcriptional regulation of repair genes and the pools 
of dNTPs, regulating late firing origins, and promoting fork stabilization (Figure 1.7) 
[Branzei and Foiani, 2006; Zegerman and Diffley, 2009].  Following replication stress, 
the level of dNTPs increase by 6-8 fold in budding yeast due to the upregulation of 
ribonucleotide reductase enzyme (RNR) [Chabes et al., 2003].  This upregulation is 
controlled by the damaged-induced kinase Dun1 (DNA damage uninducible 1) [Zhao and 
Rothstein, 2002].  Dun1 phosphorylates Sml1 (suppressor of Mec1 lethality 1), which 
normally binds and inhibits RNR to limit the available dNTP pools during replication.  
Phosphorylation of Sml1 results in its degradation.  This leads to RNR activation and 
ultimately increases dNTP pools that are necessary for efficient replication when cells are 
under replication stress.  In line with this notion, deletion of SML1 gene, similar to RNR 
upregulation, in rad53! and mec1! rescues their lethality even though these mutants are 
still sensitive to DNA damage [Zhao and Rothstein, 2002].  Another function of the S 
phase checkpoint is the Rad53-dependent suppression of late firing origins [Santocanale 
and Diffley, 1998].  Recent studies demonstrate that the replication initiation protein, 
Sld3, and Dbf4 subunit of DDK are the “minimal” targets of Rad53 activity to inhibit late 
firing origins [Lopez-Mosqueda et al., 2010; Zegerman and Diffley, 2010].  Inhibition of 
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late firing origins by Rad53-mediated phosphorylation of Sld3 and Dbf4 allows S-CDK 
to remain active to prevent rereplication during S phase.   
Perhaps the most crucial role of the S phase checkpoint in response to replication 
stress is the stabilization of replication forks.  The notion that preserving replication fork 
stability, rather than inhibition of late firing origins, is more favorable for survival arises 
from a study comparing two different mec1 mutants, mec1! and mec1-100 [Tercero et 
al., 2003].  The authors demonstrated that while both mutants failed to suppress late 
firing origins when treated with MMS, mec1! mutants are more sensitive to DNA 
damaging agents than mec1-100 [Tercero et al., 2003].  The hypersensitivity to DNA 
damaging agents in mec1! mutants is likely due to much higher rate of replication fork 
collapse than in mec1-100 cells.  Replication checkpoint-deficient cells, such as mec1 or 
rad53 mutants, are also unable to resume replication after the removal of replication 
stress or complete DNA replication in the presence of MMS, suggesting that the 
replisome dissociates from stalled forks [Lopes et al., 2001; Tercero et al., 2003].  These 
data provide strong evidence that stabilization of replication forks by the S phase 
checkpoint is more beneficial for cell survival rather than regulating late firing origins. 
   
Postreplicative repair pathways.   
During replication of damaged DNA caused by UV-irradiation, large amounts of 
internal gaps and ssDNA at stalled forks are observed in NER-deficient cells by EM 
[Lopes et al., 2006; Rupp and Howard-Flanders, 1968; Rupp et al., 1971; Sogo et al., 
2002].  Internal gaps are most likely generated by repriming events downstream of the 
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lesions on both leading and lagging strands to bypass the damage [Heller and Marians, 
2006].  These gaps can be filled-in by two different mechanisms, error-prone and error-
free repair pathways, which together are known as postreplicative repair (PRR) (Figure 
1.8) [Branzei and Foiani, 2010].  The error-prone repair pathway relies on RAD6 and 
RAD18 to recruit specialized low-fidelity polymerases that are capable of synthesizing 
across damaged template DNA known as translesion synthesis (TLS) (Figure 1.8) 
[Lehmann et al., 2007; Prakash et al., 2005].  In yeast, three TLS polymerases exist, pol 
$ (pol-eta encoded by RAD30), Rev1, and pol $ (pol-zeta encoded by REV3 and REV7) 
[Ohmori et al., 2001; Shcherbakova and Fijalkowska, 2006].  Because TLS polymerases 
lack proofreading activity and contain larger active sites to accommodate bulky lesions, 
TLS-mediated synthesis is generally mutagenic [Shcherbakova and Fijalkowska, 2006].  
Alternatively, cells activate the error-free repair pathway that relies on the template 
switch mechanism, using nascent DNA from undamaged sister chromatid as a template 
for lesion bypass (Figure 1.8).  Genetic evidence indicates that the template switch 
mechanism can be further categorized into two pathways, mediated either by 
RAD51/RAD52 family or RAD5/MMS2/UBC13-mediated PRR [Gangavarapu et al., 
2007; Prakash, 1981; Torres-Ramos et al., 2002; Zhang and Lawrence, 2005].    Whereas 
both RAD5/MMS2/UBC13-mediated template switch and TLS activities are dependent on 
RAD6 and RAD18, RAD51/RAD52-mediated template switch is RAD6/RAD18-
independent [Schiestl et al., 1990; Torres-Ramos et al., 2002].  This model is supported 
by the synergistic genetic interaction between rad6 and rad52 mutants, where the double 
mutants are much more sensitive to DNA damage than either single mutant [Schiestl et 
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al., 1990].  Altogether, DNA damage tolerance consists of three independent pathways, 
TLS (RAD6, RAD18), RAD5-mediated template switch (RAD6/RAD18/RAD5/MMS2/ 
UBC13), and RAD51/RAD52-mediated template switch.   
 
Linking postreplicative repair pathways to PCNA ubiquitination.   
Although accumulating genetic evidence had shown the requirement of the RAD6 
pathway in DNA repair for almost 20 years, it was not until 2002 that PRR was linked to 
the ubiquitination of PCNA in a RAD6-dependent manner (Figure 1.9) [Hoege et al., 
2002].  Ubiquitination involves a chain reaction whereby an 8 kDa (kilodalton) ubiquitin 
peptide is transferred from an ubiquitin activating (E1) enzyme to an ubiquitin 
conjugating (E2) enzyme, then to an ubiquitin ligase (E3) and finally to a lysine (K) 
residue on the target protein [Hershko and Ciechanover, 1998].  This process can be 
repeated to form a chain of ubiquitin (poly-ubiquitin) linked through K residues of 
ubiquitin.  While a poly-ubiquitin chain linked through K48 is known for its function in 
protein degradation, other ubiquitin chain linkages are not well characterized 
[Hochstrasser, 1996].  In yeast, all ubiquitination pathways occur through the E1 Uba1 
enzyme [McGrath et al., 1991].  Rad6, which is an E2 enzyme, interacts with the E3 
ubiquitin ligase Rad18 to catalyze mono-ubiquitination at a highly conserved K164 of 
PCNA (Figure 1.9) [Bailly et al., 1997a; Bailly et al., 1997b; Hoege et al., 2002].  The 
mono-ubiquitinated PCNA is extended to a poly-ubiquitin chain linked through an 
unconventional, non-proteolytic K63 linkage by another E2-E3 complex, Mms2/Ubc13 
dimer and Rad5 [Hoege et al., 2002; Hofmann and Pickart, 1999; Spence et al., 1995]. 
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This step-wise PCNA mono- and poly-ubiquitination chain elongation by the two distinct 
complexes was recently confirmed by in vitro reconstitution experiments [Parker and 
Ulrich, 2009].    
Although Rad5/Mms2/Ubc13-mediated PCNA poly-ubiquitination promotes 
error-free template switching, the molecular mechanism is still unclear [Hoege et al., 
2002; Papouli et al., 2005; Pfander et al., 2005].  The Rad6/Rad18-mediated PCNA 
mono-ubiquitination is much better understood.  Specifically, PCNA mono-ubiquitination 
enhances the binding or activity to TLS polymerases to PCNA, suggesting a model 
whereby PCNA mono-ubiquitination promotes the switch between replicative and TLS 
polymerases for lesion bypass by the error-prone repair pathway [Acharya et al., 2007; 
Acharya et al., 2008; Garg and Burgers, 2005b; Haracska et al., 2006; Stelter and Ulrich, 
2003; Zhuang et al., 2008].  This is consistent with the genetic requirement for 
Rad6/Rad18-mediated TLS.  As mentioned earlier, EM studies of cells exposed to UV-
irradiation revealed the presence of ssDNA gaps behind replication forks, suggesting that 
DNA damage tolerance mechanisms can be active during S and G2/M phases of the cell 
cycle [Lopes et al., 2006; Rupp and Howard-Flanders, 1968; Rupp et al., 1971; Sogo et 
al., 2002].   The molecular mechanisms of how PRR repairs lesions in G2/M were 
recently demonstrated by expressing genes involved in Rad6-mediated PCNA 
ubiquitination solely in G2.  Induction of PCNA ubiquitination in G2 is still capable of 
activating lesion bypass mechanisms for cell survival [Daigaku et al., 2010; Karras and 
Jentsch, 2010].  Furthermore, deletion of the POL32 gene, a subunit of pol-#, results in 
accumulation of ssDNA on the lagging strand and triggers PCNA ubiquitination in G2, 
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even in the absence of exogenous DNA damage [Karras and Jentsch, 2010].  These data 
suggest that DNA damage tolerance mechanisms can be active at stalled forks and at 
internal ss gaps behind replication forks in G2/M phase [Daigaku et al., 2010; Karras and 
Jentsch, 2010; Vanoli et al., 2010].   
 The activation of DNA damage tolerance pathways requires ssDNA-RPA regions.  
Biochemical studies showed that such ssDNA-RPA regions facilitate the recruitment of 
the Rad6/Rad18 complex, where Rad18 interacts directly with two RPA subunits, Rfa1 
and Rfa2 [Davies et al., 2008].  However, PPR activation requires only ssDNA-RPA 
structures that arise at stalled replication forks and internal ss gaps, but not at resected 
DSBs.  Consistent with this notion, DNA damaging agents that stall replication fork 
progression induce PCNA ubiquitination, whereas DSB-induced damaging agents do not 
[Davies et al., 2008].  Moreover, although the RPA-ssDNA structure is also crucial for 
the recruitment and activation of the S phase checkpoint kinase Mec1 [Zou and Elledge, 
2003], an RPA mutant that is defective in checkpoint activation is still sufficient to 
trigger PCNA ubiquitination [Davies et al., 2008].  This suggests that PCNA 
ubiquitination and the S phase checkpoint are independent pathways in S. cerevisiae 
[Davies et al., 2008]. 
Besides ubiquitination, PCNA is also modified by the ubiquitin-like protein 
SUMO (small ubiquitin-like modifier) [Hoege et al., 2002].  However, this modification 
is limited to S phase during which PCNA is sumoylated at K164 and to a lesser extent, at 
K127 (Figure 1.9) [Hoege et al., 2002].  PCNA sumoylation recruits to the anti-
recombinogenic helicase Srs2 (suppressor of rad six 2) to the fork during unperturbed 
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replication [Pfander et al., 2005; Stelter and Ulrich, 2003].  Srs2 contains a PIP-like and a 
SUMO-interacting motif (SIM) that interacts specifically with sumoylated PCNA and is 
capable of dissociating Rad51 filaments on ssDNA [Armstrong et al., 2012; Krejci et al., 
2003; Pfander et al., 2005].  Thus, Srs2 helicase is thought to inhibit unscheduled 
homologous recombination events during normal replication.  Importantly, a recent report 
demonstrates that PCNA sumoylation also facilitates the Rad5/Mms2/Ubc13-mediated 
template switch mechanism where PCNA is simultaneously sumoylated and 
ubiquitinated [Branzei et al., 2008].  While sumoylated PCNA recruits Srs2 to inhibit 
template switch by a Rad51/Rad52-dependent pathway, poly-ubiquitin promotes 
Rad5/Mms2/Ubc13-mediated template switch [Branzei et al., 2008].  Only in the absence 
of PCNA sumoylation or Srs2, undesired Rad51/Rad52-mediated HR becomes more 
active during S phase [Papouli et al., 2005; Pfander et al., 2005; Schiestl et al., 1990].  A 
recent report of sumoylation in human cells suggests that these mechanims are 
evolutionarily conserved [Moldovan et al., 2012]. 
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Rationale 
 Induction of replication stress by DNA damaging agents such as MMS or UV-
irradiation ultimately disrupts the coordination between DNA unwinding and DNA 
synthesis by inhibiting the progression of DNA polymerases during S phase.  Such 
damage generates ssDNA-RPA structures that are crucial for both checkpoint activation 
and PCNA ubiquitination pathways [Cimprich and Cortez, 2008; Flynn and Zou, 2011].  
However, extended ssDNA regions are likely not the only structures that are generated 
during S phase when replication goes awry and may cause genomic instability.  In fact, 
mutations in genes involved in lagging strand synthesis such as FEN1 and LIG1 have 
been identified in cancer patients, suggesting that flapped and nicked DNA structures 
arise from defects in Okazaki fragment maturation processes also cause DNA damage 
that can lead to genomic instability [Barnes et al., 1992; Webster et al., 1992; Zheng et 
al., 2007].  In humans, half of the replicated genome is dependent on the synthesis and 
maturation of 30,000,000 Okazaki fragments during every S phase.  Furthermore, 
because normal cells can replicate their genomes efficiently and with high fidelity, this 
argues for the presence of DDR pathways to monitor and repair DNA damage that arises 
from Okazaki fragment processing defects.   
The goal of the thesis presented here was to investigate whether cells could sense 
DNA damage that arose from deficient lagging strand synthesis.  More specifically, we 
were curious as to whether cells can recognize damage “behind” the fork that does not 
disturb the replisome progression by inhibiting the replicative polymerases.  Taking 
advantage of the fact that neither Fen1 nor DNA ligase I are stable parts of the replisome, 
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depletion of either protein should not disrupt the progression of DNA synthesis, leaving 
DNA damage “behind” the moving fork.  Defects in DNA ligase I should result in the 
accumulation of nicked DNA intermediates, since Cdc9 is the only DNA ligase that 
functions in Okazaki fragment maturation [Johnston and Nasmyth, 1978].  Therefore, this 
thesis focuses on determining how cells sense and repair the accumulation of nicks 
behind the fork in the absence of Cdc9 and ssDNA.  Human cells have PARP1 (poly 
(ADP-ribose) polymerase) that functions as a nick sensor and activates SSB repair 
pathway to cope with the accumulation of nicks [Menissier-de Murcia et al., 1989].  
However, no known homologue of PARP1 has been identified in S. cerevisiae, arguing 
for the presence of PARP1-independent repair pathways that may be conserved in 
humans.  The greater goal was to gain a better understanding of how eukaryotic cells deal 
with nicks during DNA replication.  This should not only lead to more insight into the 
DDR network, but may ultimately help in devising novel cancer diagnostics and 
treatments.   
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Figure 1.1 
 
 
Figure 1.1  Cell cycle regulation by cyclins.   
The cell cycle consists of four different phases, G1, S, G2, and M.  The duration 
of individual cell cycle phases differs in various organisms and is not drawn to scale.  
Progression through the cell cycle is regulated by the activation of the cyclin dependent 
kinase 1, Cdk1 in S. cerevisiae with different cyclins.  There are three G1 or A-type 
cyclins (Cln1-3) and six B-type cyclins (Clb1-6).  Colored lines indicate expression 
levels of different cyclins at different phases of the cell cycle.  Expression of all cyclins is 
low at the end of M phase and G1, resulting in low Cdk1 activity during origin licensing.  
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Figure 1.2 
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Figure 1.2  Mechanism of DNA initiation.   
Eukaryotic DNA initiation involves multiple, coordinated steps that ultimately 
lead to DNA unwinding and synthesis.  The formation of the pre-replicative complex, 
pre-RC, involves the loading of the double-hexameric Mcm2-7 complex onto origins of 
replication.  This is dependent on ORC, Cdc6, and Cdt1 (Step I).  Replication initiation is 
activated by two S phase dependent kinases, first by DDK (Step II) and then by S-CDK 
(Step III).  DDK phosphorylates the chromatin-bound Mcm2-7 helicase, which is a 
prerequisite for the loading of Sld3 and Cdc45 (Step II).  Following DDK-dependent 
complex formation, S-CDK phosphorylates Sld2 and Sld3 to form a pre-initiation 
complex or pre-IC with Dpb11, GINS and pol-! (Step III).  Finally, Mcm10, together 
with RPA, recruits pol-" to origins to catalyze de novo DNA synthesis (Step IV).     
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Figure 1.3 
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Figure 1.3  Eukaryotic DNA replication mechanism.   
DNA replication occurs in an anti-parallel manner, synthesizing one continuous 
strand (leading strand) and multiple short DNA fragments (lagging strand or Okazaki 
fragments).  First, Mcm10 recruits pol-" to synthesize de novo RNA/DNA primer on 
both leading and lagging strands.  These structures serve as a substrate for PCNA 
(proliferating cell nuclear antigen) loading.  PCNA increases the processivity of pol-! and 
pol-#.  While pol-! can synthesize continuously along the leading strand template, 
lagging strand synthesis requires additional steps.  First, pol-# synthesizes DNA and 
displaces the preceding RNA/DNA primer, generating a short 5’-flap that can be cleaved 
by the flap endonuclease, Fen1.  In the absence of Fen1, the short flap extends in length 
and becomes a substrate for Dna2.  Both Fen1 and Dna2 ultimately generate a DNA nick 
that can be sealed by DNA ligase I.  
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Figure 1.4 
 
 
Figure 1.4  DNA ligation mechanism of DNA ligase I.   
DNA ligation by DNA ligase I involves three nucleotidyl transfer reactions.  First, 
DNA ligase reacts with ATP to form a ligase-adenylate intermediate, where the 5’AMP is 
covalently bound to a lysine in the DNA ligase I active site (Step 1).  AMP is then 
transferred to the 5’-phosphate terminus of the nick, forming a DNA-adenylate 
intermediate (Step 2).  Finally, DNA ligase catalyzes the nucleophillic attack of the 3’OH 
to the DNA-adenylate to join the ends of the DNA strands and release AMP.  The figure 
is adapted from [Ellenberger and Tomkinson, 2008].   
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Figure 1.5 
 
Figure 1.5  Domains of DNA ligase I.   
DNA ligase I from S. cerevisiae (Cdc9) and humans (hLIG1) has a DNA binding 
domain (DBD, green), a nucleotidyltransferase (NTase) domain, which contains a lysine 
in the active site, and an oligonucleotide/oligosaccharide binding fold (OB-fold, red).  A 
PCNA-interacting protein motif (PIP box) is located in the N-terminus of both Cdc9 and 
LIG1.  Mutations in the hLIG1 gene, Glu556Lys and Arg771Trp, were identified in a 
human patient [Webster et al., 1992].  Whereas the Glu556Lys mutation inactivates LIG1 
on one allele, the Arg771Trp carrying allele retains approximately 5-10% of hLIG1 
activity.  The figure is adapted from [Ellenberger and Tomkinson, 2008]. 
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Figure 1.6 
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Figure 1.6  DNA damage response to different types of DNA damage.   
(a) DNA damage that causes a damaged base or nucleotide in the genome can 
either be removed by base excision repair (BER) or mismatch repair (MMR).  In 
nucleotide excision repair (NER), which removes pyrimidine dimers, a stretch of ~30 
nucleotides flanking the lesion is removed, leaving a single-stranded DNA gap.  This gap 
is filled-in by DNA polymerases and ligated together by DNA ligase I.  When DNA 
damage induces a double-strand break (DSB), this can be repaired either by non-
homologous end joining (NHEJ) or homologous recombination (HR).  Whereas NHEJ is 
error-prone, HR is an error-free repair pathway because cells utilize undamaged sister 
chromatid as a template to resynthesize the missing DNA bases.  (b) In higher 
eukaryotes, cells have two DNA checkpoint proteins that are activated depending on the 
type of lesions.  ATM is activated primarily in response to double-stranded ends (left).  
When the DSB is resected and ssDNA is coated with RPA, ATR is recruited (middle).  In 
addition, RPA-ssDNA structures are also generated at stalled replication forks and are 
responsible for recruiting ATR (right). This figure is adapted from [Ulrich and Walden, 
2010]. 
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Figure 1.7 
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Figure 1.7  The S phase checkpoint signaling pathway in S. cerevisiae.   
The S phase checkpoint kinase, Rad53, is activated in response to replication 
stress and physical DNA damage such as double-stranded breaks, DSBs.  In response to 
replication stress (left), Mec1 (yeast homolog of ATR), together with Ddc2 (yeast 
homolog of ATRIP), phosphorylates Rad53, which is mediated through Mrc1.  Rad53 
phosphorylation regulates several different pathways ranging from upregulation of 
dNTPs pools, inhibition of late firing origins, and most importantly, stabilization of 
replication forks to prevent fork collapse.  If fork stabilization cannot be established, 
replication forks can give rise to DSBs (right).  In response to DSBs, Rad53 is activated 
through a second pathway. Either the Mec1 or Tel1 (yeast homologue of ATM) 
checkpoint kinase phosphorylates Rad53, which is mediated through “the Rad53-
adaptor” Rad9 [Sweeney et al., 2005].    
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Figure 1.8 
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Figure 1.8  Postreplicative repair pathways.   
Lesions on the template DNA such as bulky adducts caused by UV-irradiation 
inhibit the progression of the replicative polymerases.  The lesion depicted here is on the 
leading strand, but such lesions can also occur on the lagging strand.  Cells can re-initiate 
DNA synthesis by repriming downstream of the lesion, which leaves a small single-
stranded DNA (ssDNA) gap.  The lesion can be repaired by either error-prone or error-
free repair pathways.  In error-prone repair pathway, which is mediated by RAD6 and 
RAD18, cells recruit special translesion polymerases to synthesize across the lesion.  
Alternatively, cells promote error-free repair by a template switch mechanism using the 
nascent, undamaged sister chromatid as a template to bypass the lesion.  Template switch 
mechanisms are mediated through two distinct pathways, one by 
RAD6/RAD18/RAD5/MMS2/UBC13 and the other by RAD51/RAD52.  This figure was 
adapted from [Branzei and Foiani, 2007]. 
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Figure 1.9 
 
Ub
Ub
Ub
Ub
Ub
Ub
S
S
S
S
PCNA
Rev1, pol!, pol!
Translesion 
synthesis
Template switch
(dependent on Rad6 epitasis 
group & components of 
Rad51/Rad52-epistasis group
Template switch
(dependent only on 
Rad51/Rad52-epistasis group)
Ub ubiquitin
SUMOS
Rad6
Rad18
Rad5
Mms2/Ubc13
Ubc9
Siz1
K63
Srs2
K164
K127 or K164
  
 
58 
Figure 1.9  Functions of PCNA modification by ubiquitin and SUMO.   
The trimeric PCNA clamp can be modified by both ubiquitin and SUMO at lysine 
(K) 164 (sumoylation can occur at K127 to a lesser extent).  For simplicity, modification 
is illustrated only on one subunit, but all modifications can theoretically occur on all three 
subunits of PCNA simultaneously or in any combination.  PCNA mono-ubiquitination at 
K164 is catalyzed by Rad6 and Rad18, whereas SUMO is conjugated by Ubc9 (the 
SUMO E2) and Siz1 (the SUMO E3).  Mono-ubiquitination facilitates the recruitment of 
Y-family polymerases (Rev1, pol$, and pol$) to promote translesion synthesis.  
Alternatively, mono-ubiquitin on PCNA can be extended to a poly-ubiquitin chain linked 
through lysine (K) 63.  This is catalyzed by the E2/E3 complex Mms2/Ubc13/Rad5 and 
promotes template switching by an unknown mechanism.  Sumoylation of PCNA at 
K164, and to a lesser extent at K127, recruits the antirecombinogenic helicase Srs2 to 
displace Rad51 from single-stranded DNA and prevent template switch mediated by the 
Rad51/Rad52-epistasis group.  A recent study demonstrates that disassembling Rad51 
filaments by sumoylated PCNA is crucial to promote Mms2/Ubc13/Rad5-mediated 
template switch by PCNA ubiquitination of the same trimeric PCNA molecule.  The 
figure is adapted from [Sale, 2012]. 
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CHAPTER 2 
Defects in DNA ligase I trigger PCNA ubiquitination 
at lys 107 
 
(The work in this chapter was published Das-Bradoo*, S., Nguyen, H.D.*, Wood, J.L.*, 
Ricke, R.M., Haworth, J.C., Bielinsky, A.K. (2010) Nat. Cell Biol. 12(1):74-9.  
* indicates co-authors) 
 
Authors contributions:  
S.D.-B and H.D.N conducted all PCNA ubiquitination experiments in yeast, helped with 
data analysis and helped write the manuscript. J.L.W conducted all experiments with 
human cells (Figure 2.16), helped with data analysis and helped write the manuscript. 
R.M.R conducted cell-cycle arrest and RIP mapping experiments (Figures 2.1-2.4), and 
helped with data analysis. J.C.H helped with the construction of yeast mutants. A.-K.B 
planned and supervised the project, and wrote the manuscript.  
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In all eukaryotes, the ligation of newly synthesized DNA, also known as Okazaki 
fragments, is catalyzed by DNA ligase I [Ellenberger and Tomkinson, 2008]. An 
individual with a DNA ligase I deficiency exhibited growth retardation, sunlight 
sensitivity and severe immunosuppression [Webster et al., 1992], likely due to 
accumulation of DNA damage.  Surprisingly, not much is known about the DNA damage 
response (DDR) in DNA ligase I-deficient cells.  Because DNA replication and DDR 
pathways are highly conserved in eukaryotes, we utilized Saccharomyces cerevisiae as a 
model system to address this question.  We uncovered a novel pathway, which facilitates 
ubiquitination of lysine 107 of proliferating cell nuclear antigen (PCNA).  Unlike 
ubiquitination at lysine 164 of PCNA in response to UV irradiation, which triggers 
translesion synthesis [Hoege et al., 2002], modification of lysine 107 is not dependent on 
the ubiquitin conjugating enzyme (E2) Rad6 [Jentsch et al., 1987] nor the ubiquitin ligase 
(E3) Rad18 [Bailly et al., 1997a], but requires the E2 variant Mms2 [Broomfield et al., 
1998] in conjunction with Ubc4 [Seufert and Jentsch, 1990] and the E3 Rad5 [Torres-
Ramos et al., 2002; Ulrich and Jentsch, 2000].  Surprisingly, DNA ligase I-deficient 
cdc9-1 cells that carry a PCNAK107R mutation are inviable, because they cannot activate a 
robust DDR.  Furthermore, we show that ubiquitination of PCNA in response to DNA 
ligase I-deficiency is conserved in humans, yet the lysine that mediates this modification 
remains to be determined.  We propose that PCNA ubiquitination provides a "DNA 
damage code" that allows cells to categorize different types of defects that arise during 
DNA replication.  
  
  
 
61 
Materials and methods 
Strains and plasmids.   
All strains are isogenic derivatives of W303-1a or SSL204.  A complete list of 
strains can be found in Table 2.1.  The W303-1a strain carries the rad5-535 mutation 
(http://wiki.yeastgenome.org/index.php/CommunityW303.html), whereas SSL204 
derivatives (CDC9, cdc9-1, cdc9-2) harbor wild type RAD5, which was confirmed by 
sequencing.  SSL204 exhibits severe temperature sensitivity at 37°C and therefore the 
temperature shift experiments were performed at 35°C.  To construct the cdc9-td strain, 
the first 510 base pairs of CDC9 were inserted into pPW66R (a gift from J. F. X. Diffley) 
using HindIII restriction sites [Dohmen et al., 1994]. The resulting pPW66R-CDC9 
plasmid was linearized with BclI and transformed into YKL83, which contains UBR1 
under the control of the GAL1 promoter at the endogenous UBR1 locus [Labib et al., 
2000]. To delete various genes (MRC1, RAD9, UBC4, UBC5, RAD6, RAD18, MMS2, 
UBC13, RAD5) in SSL204 and SSL612, standard one-step PCR gene replacement was 
used [Lorenz et al., 1995] and correct integration was confirmed by sequencing.  Two 
independent colonies of each strain were isolated.  
The UCB4-NES-3HA fragment containing a nuclear export sequence (NES) 
[Wen et al., 1995] and three hemagglutinin (HA) tags was generated by PCR. This was 
inserted into the pRS404 plasmid (a gift from D. Koepp, University of Minnesota) using 
KpnI and SacI restriction sites.  The resulting integration plasmid was linearized using 
BglII and transformed into two independent cdc9-1 ubc5!strains. Correct integration was 
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confirmed by sequencing and immunoblotting with an anti-HA (16B12, Covance) 
antibody.  
For the MRC1 complementation experiments, pAO138 and pMRC1 (gifts from S. 
J. Elledge, Harvard University) were transformed into ABy287 (CDC9 mrc1!) and 
ABy293 (cdc9-1 mrc1!).  pAO138 contains wild-type MRC1 expressed from its 
endogenous promoter and pMRC1 expresses a mrc1 mutant that has 17 putative SQ or 
TQ phosphorylation sites switched to AQ (mrc1AQ mutant) and is also expressed from its 
endogenous promoter [Osborn and Elledge, 2003].  pRS316 served as the empty vector 
control.   
mrc1! rad9! cells were derived from a strain containing a high copy number 
plasmid expressing RNR1 from its endogenous promoter (a gift from D. J. Clarke, 
University of Minnesota) to maintain cell viability.   
PCNA lysine mutants were generated using plasmid YCplac22-POL30 (a gift 
from S. Jentsch) [Hoege et al., 2002].  YCplac22-POL30 expresses full length PCNA 
from its endogenous promoter.  Lysine to arginine substitutions in PCNA were 
introduced at positions 107, 108, 117, 168, 183, 253 by QuikChange mutagenesis 
(Stratagene). Four other lysine to arginine mutations (K127R, K164R, K127/164R, 
K242R) used in this study were a gift from the Jentsch laboratory [Hoege et al., 2002].  
As described previously [Lorenz et al., 1995], the endogenous POL30 gene was 
subsequently deleted by replacement with either a URA3 or LEU2 marker in SSL204 and 
YKL83 strains, respectively.   
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To determine the cell viability of the double mutant cdc9-1 pol30-K107R, a 
plasmid expressing POL30 from its endogenous promoter (pRS316-POL30, a gift from 
D. M. Livingston, University of Minnesota) was first transformed into SSL204 (CDC9) 
and cdc9-1.  PCNA lysine K107R mutant was generated using plasmid pCH1572 (a gift 
from L. Prakash, University of Texas Medical Branch, Galveston TX).  The resulting 
Leu2.PCNA-K107R PCR product was subsequently transformed into strains containing 
pRS316-POL30 plasmid.  PCNA-K107R mutation at the endogenous locus was 
confirmed by sequencing. Strains were streaked out onto SC-Ura plate and 5’-FOA (2 
mg/ml) plates. All plates were incubated at 25°C for 2-3 days.  
For immunoprecipitation of ubiquitinated PCNA, YEp105 plasmid, expressing a 
synthetic Myc-tagged ubiquitin gene from a copper-inducible promoter (a gift from M. 
Hochstrasser, Yale University) [Ellison and Hochstrasser, 1991] was transformed into 
SSL204 (CDC9), SSL612 (cdc9-1), SSL613 (cdc9-2).  For the expression of ubiquitin 
mutants carrying lysine to arginine substitutions at positions 6, 11, 27, 29, 33, 48, 63, 
YEp105 was altered by QuikChange mutagenesis.  The C-terminal glycine to arginine 
mutations in ubiquitin at positions 75 and 76 were constructed in YEp105 by 
QuikChange mutagenesis.  
 
Yeast culture conditions.   
Temperature shift experiments were carried out in YPD, unless stated otherwise.  
For a typical temperature shift experiment, cells were grown to mid-log phase (OD600 = 
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0.6) at 25°C and then shifted to the restrictive temperature of 35°C for 3 hours or as 
indicated.  
The degron strain, cdc9-td, was grown overnight at 28°C in YP plus 2% raffinose 
and supplemented with 10 µM CuSO4 to induce CDC9 gene expression.  Copper sulfate 
was omitted when cells were shifted to 37°C.  To increase the efficiency of Cdc9-td 
degradation, Ubr1 was overexpressed from a galactose-inducible promoter in the 
presence of 2% galactose. 
For all experiments in which PCNA or ubiquitin were expressed from a plasmid, 
two independent colonies of each strain were grown in synthetic complete medium 
lacking tryptophan.  In ubiquitin overexpressing strains, ubiquitin was induced over the 
time period of three generations by addition of 0.1 mM CuSO4 at a low cell density 
(OD600 = 0.1) as described earlier [Ellison and Hochstrasser, 1991].   
 
Co-Immunoprecipitation.   
Whole cell extracts from exponentially growing cells were prepared using glass 
beads as described earlier [Ricke and Bielinsky, 2004].  A cocktail of freshly prepared 
protease inhibitors (pepstatin, leupeptin, benzamidine and phenylmethyl sulfonyl 
fluoride) and N-ethylmaleimide were used to preserve ubiquitinated proteins by 
inhibiting deubiquitinating enzymes [Das-Bradoo et al., 2006].  For immunoprecipitation, 
4 µg of anti-Myc antibody (9E11, Thermo scientific) was added to the extract for 2 hours 
at 4°C.  PCNA was detected by Western blotting with an anti-PCNA antibody (clone 
S871, a gift from Z. Zhang) [Zhang et al., 2000]. 
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Protein Preparation and Western Blot Analysis.   
Total protein extracts were prepared from cycling yeast cultures using TCA 
precipitation [Ricke and Bielinsky, 2006] and proteins were detected by Western blot 
analysis.  Cdc9-td-HA was detected with an anti-HA antibody (16B12, Covance), histone 
H3 was detected with an anti-histone H3 antibody (Abcam), endogenous Cdc9 was 
detected with an anti-Cdc9 antibody (gift from A. E. Tomkinson) and endogenous Rad53 
was detected with an anti-Rad53 antibody (gift from J. F. X. Diffley). "-tubulin served as 
a loading control. In some experiments shown in the Supplementary Information, 
Ponceau S staining of the nitrocellulose membrane prior to blotting served as a loading 
control.  
 
Detection of PCNA ubiquitination.   
Unmodified and mono-ubiquitinated PCNA were analyzed by Western blotting 
with an anti-yeast PCNA antibody (clone S871, a gift from Z. Zhang, Mayo Clinic MN) 
[Zhang et al., 2000].  To detect mono-ubiquitination with the polyclonal S871 antibody, 
we diluted WCEs 10-fold.  Poly-ubiquitinated PCNA was detected with the same 
antibody in undiluted, TCA-precipitated whole cell extracts.  Please note that this 
antibody was not able to detect the 76 kDa poly-ubiquitinated form of PCNA in 
immunoprecipitated samples (Figure 2.6b). 
 
 
  
 
66 
 
Cell Synchrony, FACS Analysis, and Microscopy.   
To arrest cells in G1, alpha-factor was added to a final concentration of either 50 
ng/ml (bar1! cells) or 15 µg/ml (BAR1 cells).  Cells were blocked in S phase with the 
addition of 200 mM hydroxyurea (HU).  For G2/M arrest, nocodazole was added to a 
final concentration of 10 µg/ml.  Cell cycle progression was monitored using flow 
cytometry as described earlier [Tanaka and Diffley, 2002].  DNA was stained with 
propidium iodide in case of YKL83 strains, whereas Sytox Green was used for all other 
strains.  All FACS samples were analyzed using a Becton Dickinson FACSCalibur.  
 
MMS sensitivity.   
Cells were grown to mid-log phase (OD600 = 0.5-0.6) at 25°C for cdc9 strains and 
at 28°C for YKL83 derived strains. Cells were then incubated with 0.02% MMS [Hoege 
et al., 2002] at 30°C for cdc9-1 strains and at 37°C for YKL83 strains for the indicated 
time period.  For YKL83 strains, 2% galactose was added for 30 minutes prior to shifting 
the cells to 37°C.  After each time point, sodium thiosulfate (10%) was added to the 
treated cells to inactivate the MMS. Yeast cells were pelleted, washed with distilled water 
and total protein was TCA-precipitated.  
 
Generation of stable shRNA expressing cell lines.   
U2OS cells were maintained in RPMI 1640 supplemented with 10% heat 
inactivated FBS and 1% penicillin/streptomycin at 37°C in 5% CO2 (v/v).  To generate 
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stable DNA ligase I knockdown cell lines, DNA ligase I specific lentiviral shRNA 
plasmids and control shRNA were purchased from Open Biosystems. The sequences are 
shLIG#1 TGCTGTTGACAGTGAGCGCGCTTTCACCTGCGAATACAAATAGTGAA 
GCCACAGATGTATTTGTATTCGCAGGTGAAAGCTTGCCTACTGCCTCGGA; 
shLIG#2 TGCTGTTGACAGTGAGCGACCTGTTTGTACCGGAAGCAAATAGTGA 
AGCCACAGATGTATTTGCTTCCGGTACAAACAGGCTGCCTACTGCCTCGGA. 
We also used a non-silencing control shRNA TGCTGTTGACAGTGAGCGATCTCGC 
TTGGGCGAGAGTAAGTAGTGAAGCCACAGATGTACTTACTCTCGCCCAAGCG
AGAGTGCCTACTGCCTCGGA.  These vectors have been described previously [Silva 
et al., 2005].  Stable cell lines were constructed as described [Hannon and Conklin, 
2004].  Briefly, U2OS cells were transfected with 10 µg of shRNA plasmid (control or 
ligase I) with Fugene (Roche) per manufacturer’s instructions. 48 h later cells were 
trypsinized and plated in media containing 2 µg /ml puromycin at different dilutions for 
colony formation.  12 days later drug-resistant colonies were picked and expanded and 
screened by Western blot for DNA ligase I expression.  
 
Chromatin fractionation for human cells.   
To obtain the chromatin fraction, one 10 cm plate for each cell line was harvested and 
chromatin fractions were prepared exactly as described [Motegi et al., 2008]. Briefly, 
cells were harvested, extracted to release soluble proteins and nuclear (insoluble) proteins 
pelleted.  The nuclear pellet was then sonicated to release chromatin bound proteins.  
Proteins were fractionated on SDS polyacrylamide gels and analyzed by Western blots.  
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Anti-DNA ligase I- (Santa Cruz), anti-histone H3- (Abcam), anti-PCNA- (Labvision), 
anti-ubiquitin- (Millipore), and anti-tubulin antibodies (Sigma) were used in this study.  
 
Mammalian Cell Lysate and Western blotting.   
Cells were lysed with NETN (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 
% Nonidet P-40 plus protease inhibitors) on ice and then rocked for 10 min at 4°C.  
Crude cell lysates were then centrifuged at 14,000 rpm for 10 min and cleared lysates 
were collected.  Samples were boiled in 2X Laemmli buffer and fractionated on SDS-
PAGE. Membranes were blocked in 5% milk-TBST and then probed with antibodies as 
indicated. 
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Table 2.1.  List of yeast strains used in this study. 
Strain 
Name Relevant Genotype Source 
 W303-derived strains  
YKL83 GAL-UBR1 (HIS3) [Labib et al., 2000] 
ABy778 GAL-UBR1 (HIS3) pol30::LEU2 [YCplac22-POL30-K107R] This Study 
ABy010 GAL-UBR1 (HIS3) bar1::LEU2 This Study 
ABy317 GAL-UBR1 (HIS3) cdc9::cdc9-td (URA3) This Study 
ABy780 GAL-UBR1 (HIS3) cdc9::cdc9-td (URA3) pol30::LEU2 
[YCplac22-POL30-K107R] This Study 
ABy008 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td (URA3) This Study 
 SSL204-derived strains  
SSL204 MATa ade2 his3D200 trp1 leu2 ura3-52 [Dornfeld and Livingston, 1991] 
ABy287 mrc1::TRP1 This Study 
ABy296 rad9::TRP1 This Study 
ABy343 mrc1::TRP1 [pRS316] This Study 
ABy344 mrc1::TRP1 [pAO138] This Study 
ABy345 mrc1::TRP1 [pMRC1] This Study 
ABy349 [YEp105] This Study 
ABy352 [pRNR1] This Study 
ABy356 mrc1::TRP1 rad9::URA3 [pRNR1] This Study 
ABy458 bar1::URA3 This Study 
ABy517 pol30::URA3 [YCplac22-POL30] This Study 
ABy669 [pRS316-POL30] This Study 
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Table 2.1.  List of yeast strains used in this study. 
ABy685 pol30::pol30-K107R (LEU2) This Study 
ABy704 pol30::pol30-K107R (LEU2) [pRS316-POL30] This Study 
ABy366 dna2-1 [YEp105] This Study 
ABy365 rad27! [YEp105] This Study 
SSL612 cdc9-1 [Ireland et al., 2000] 
ABy293 cdc9-1 mrc1::TRP1 This Study 
ABy297 cdc9-1 rad9::TRP1 This Study 
ABy346 cdc9-1 mrc1::TRP1 [pRS316] This Study 
ABy347 cdc9-1 mrc1::TRP1 [pAO138] This Study 
ABy348 cdc9-1 mrc1::TRP1 [pMRC1] This Study 
ABy350 cdc9-1 [YEp105] This Study 
ABy353 cdc9-1 [pRNR1] This Study 
ABy357 cdc9-1 mrc1::TRP1 rad9::URA3 [pRNR1] This Study 
ABy375 cdc9-1 mms2::URA3 This Study 
ABy388 cdc9-1 ubc13::URA3 This Study 
ABy392 cdc9-1 rad18::URA3 This Study 
ABy410 cdc9-1 rad5::URA3 This Study 
ABy520 cdc9-1 rad6::URA3 This Study 
ABy538 cdc9-1 ubc4::URA3 This Study 
ABy539 cdc9-1 ubc5::URA3 This Study 
ABy579 cdc9-1 ubc5::URA3 ubc4::UBC4-NES-3HA (TRP1) This Study 
  
 
71 
Table 2.1.  List of yeast strains used in this study. 
ABy439 cdc9-1 pol30::URA3 [YCplac22-POL30] This Study 
ABy440 cdc9-1 pol30::URA3 [YCplac22-POL30-K164R] This Study 
ABy441 cdc9-1 pol30::URA3 [YCplac22-POL30-K127R/164R] This Study 
ABy442 cdc9-1 pol30::URA3 [YCplac22-POL30-K242R] This Study 
ABy459 cdc9-1 pol30::URA3 [YCplac22-POL30-K107R] This Study 
ABy461 cdc9-1 pol30::URA3 [YCplac22-POL30-K108R] This Study 
ABy463 cdc9-1 pol30::URA3 [YCplac22-POL30-K183R] This Study 
ABy465 cdc9-1 POL30::URA3 [YCplac22-POL30-K253R] This Study 
ABy467 cdc9-1 POL30::URA3 [YCplac22-POL30-K117R] This Study 
ABy469 cdc9-1 POL30::URA3 [YCplac22-POL30-K168R] This Study 
ABy471 cdc9-1 POL30::URA3 [YCplac22-POL30-K127R] This Study 
ABy479 cdc9-1 [YEp105-Ub-K48,63R] This Study 
ABy485 cdc9-1 [YEp105-Ub-K29R] This Study 
ABy489 cdc9-1 [YEp105-Ub-KO] This Study 
ABy497 cdc9-1 [YEp105-Ub-G75,76A] This Study 
ABy453 cdc9-1 bar1::URA3 This Study 
ABy712 cdc9-1 [pRS316-POL30] This Study 
ABy777 cdc9-1 pol30::pol30-K107R (LEU2) [pRS316-POL30] This Study 
ABY782 cdc9-1*  pol30::pol30-K107R from tetrad dissection This Study 
SSL613 cdc9-2 [Ireland et al., 2000] 
ABy351 cdc9-2 [YEp105] This Study 
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Results  
Defects in DNA ligase I trigger mid-S phase arrest.   
Previous studies have suggested that DNA ligase I-deficient cdc9 mutants arrest 
in G2 phase after completing DNA synthesis [Schiestl et al., 1989; Weinert and Hartwell, 
1993] because of the accumulation of nicked DNA [Johnston and Nasmyth, 1978].  
These observations implied that S phase proceeds normally despite single-stranded 
breaks in nascent DNA, suggesting that cells may not be able to efficiently sense this type 
of DNA damage during S phase.  To reinvestigate whether DNA ligase I is required for S 
phase progression, we have analyzed three different temperature sensitive alleles of 
CDC9 (Figure 2.1a and b and Figure 2.2 a and b).  One of these alleles is a thermo labile 
degron mutant [Dohmen et al., 1994] (cdc9-td in Figure 2.3a).  To ensure that ligase 
activity was sufficiently inactivated in these cells, we performed replication initiation 
point mapping and did not detect any measurable ligation of Okazaki fragments over the 
yeast origin ARS1 (Figure 2.2c) as previously demonstrated for the cdc9-1 allele 
[Bielinsky and Gerbi, 1999].  Whereas DNA ligase I was not required for entry into S 
phase (Figure 2.3b), we found it to be necessary to release from a hydroxyurea (HU) 
block (Figure 2.3c).  This was also true for two additional temperature sensitive alleles, 
cdc9-1 and cdc9-2 [Ireland et al., 2000] (Figure 2.3d).  This result was surprising as 
earlier reports suggested that DNA ligase I-deficient cells could complete DNA synthesis 
without joining Okazaki fragments to each other [Schiestl et al., 1989; Weinert and 
Hartwell, 1993].  As expected, cell cycle delay in S phase was dependent on the DDR 
gene RAD9 [Schiestl et al., 1989; Weinert and Hartwell, 1993] because cdc9-1 rad9! 
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mutants progressed farther than cdc9-1 cells (Figure 2.4a).  Importantly, however, the 
mediator of the replication checkpoint (Mrc) 1 appeared to contribute equally to Rad9 
(Figure 2.4a and b).   
Mrc1 has been shown to have two roles, one in DNA replication and one in 
activating Rad53 after replication fork stalling, which results in exposure of single-
stranded DNA [Osborn and Elledge, 2003].  Rad53 is a downstream target of the mitotic 
entry checkpoint gene MEC1, a homolog of the ATM/ATR checkpoint kinases in humans 
[Sanchez et al., 1996].  Complementation of cdc9-1 mrc1! double mutants with the S 
phase checkpoint-deficient mrc1AQ allele [Osborn and Elledge, 2003] failed to induce cell 
cycle arrest (Figure 2.4c), suggesting that the S phase checkpoint and not the replication 
function of Mrc1 is important to delay S phase progression.  Furthermore, the finding that 
both Mrc1 and Rad9 are activated in cdc9-1 cells at the non-permissive temperature 
implies that the DNA substrate recognized contains single stranded DNA at stalled 
replication forks as well as physical damage, which may have arisen from the lack of 
Okazaki fragment ligation [Johnston and Nasmyth, 1978].  
 
PCNA is ubiquitinated in S. cerevisiae cdc9 mutants.   
Besides triggering a checkpoint response, certain types of DNA damage at 
replication forks have also been shown to cause ubiquitination of PCNA [Moldovan et 
al., 2007].  PCNA can be either mono-ubiquitinated or poly-ubiquitinated.  Mono-
ubiquitination of PCNA triggers the error-prone repair pathway through translesion 
polymerases, whereas PCNA poly-ubiquitination is needed for error-free repair 
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[Haracska et al., 2004; Hoege et al., 2002; Stelter and Ulrich, 2003].  Mono-
ubiquitination depends on Rad6 and Rad18 and is a pre-requisite for poly-ubiquitination, 
which in turn is mediated by the ubiquitin conjugating complex Ubc13/Mms2 and Rad5 
[Hoege et al., 2002].  Interestingly, ubiquitin is linked through lysine 63 in these poly-
ubiquitin chains [Hoege et al., 2002; Hofmann and Pickart, 1999].   
To explore whether loss of DNA ligase I leads to PCNA ubiquitination, we 
examined the status of PCNA in whole cell extracts.  We utilized an antibody specific for 
yeast PCNA [Zhang et al., 2000], which displays multiple non-specific bands in 
undiluted extracts (Figure 2.5), but produces clean immunoblots with diluted extracts 
(Figure 2.6a).  Both cdc9-1 and cdc9-2 mutants exhibited a modified form of PCNA of 
approximately 39 kDa when shifted to the non-permissive temperature (Figure 2.6a).  Co-
immunoprecipitation (Co-IP) experiments with strains that expressed Myc-tagged 
ubiquitin [Das-Bradoo et al., 2006; Ellison and Hochstrasser, 1991] identified this 39 
kDa band as ubiquitinated PCNA, which we did not observe when we mixed cell extracts 
only with beads (Figure 2.6b).  Curiously, we observed a non-specific band slightly 
above the 49 kDa marker, which was especially obvious in extracts from cdc9-1 cells.  
Unfortunately, our co-IP studies did not allow us to draw any conclusions about the 
nature of this band, although we cannot exclude that it represents poly-ubiquitinated 
PCNA sticking non-specifically to the beads. Therefore, we overexpressed different 
ubiquitin mutants, including a G75,76A double mutant, specifically designed to interfere 
with mono-ubiquitination.  Another mutant carried substitutions in all seven lysines (Ub-
KO) and was thus defective in forming poly-ubiquitin chains.  Analysis of trichloroacetic 
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acid-precipitated whole cell extracts confirmed that the 39 kDa form of PCNA 
represented mono-ubiquitinated protein (Figure 2.6c).  Furthermore, two forms of PCNA 
that represented poly-ubiquitinated protein (at ~52- and 76 kDa), because they 
disappeared in cells overexpressing the Ub-KO mutant, were visible (Figure 2.6d).  A 
distinct ladder of ubiquitinated PCNA with similar molecular weight distribution has also 
been reported by van der Kemp et al. [van der Kemp et al., 2009].  Surprisingly, poly-
ubiquitin chains on PCNA were not linked through K63 [Hofmann and Pickart, 1999], as 
they are in response to other forms of replication stress [Hoege et al., 2002], but rather 
through K29 (Figure 2.6d).   
 
PCNA ubiquitination in cdc9 mutants requires Ubc4, Mms2 and Rad5.   
Based on this result, we predicted that at least some of the genes that are known to 
play a role in K63 linked poly-ubiquitination (namely RAD6, RAD18, MMS2, UBC13, 
RAD5) [Hoege et al., 2002] are dispensable for the ubiquitination of PCNA in cdc9-1 
mutants.  Indeed, whereas MMS2 and RAD5 were required for mono- as well as poly-
ubiquitination, UBC13 and RAD18 were not (Figure 2.7a and b).  Moreover, deletion of 
RAD6 did not have any effect (Figure 2.7c), suggesting that PCNA ubiquitination in 
response to Okazaki fragment ligation defects differs from that triggered by other types 
of DNA damage. Our results also indicated that Mms2 likely cooperates with other 
ubiquitin conjugating enzymes besides Ubc13 [Hofmann and Pickart, 1999].   
To determine Mms2's potential partner in this reaction, we took advantage of the 
fact that lysine 29 linkages are catalyzed by UbcH5A in mammalian cells [Wang and 
  
 
76 
Pickart, 2005].  UbcH5A's homolog in yeast is Ubc4, which is 93% identical to Ubc5 
[Seufert and Jentsch, 1990].  Unlike Ubc4, which is highly expressed in cycling cells, 
steady state levels of Ubc5 are low and are upregulated in stationary phase [Seufert and 
Jentsch, 1990].  Ubc4 and 5 have previously been implicated in the degradation of 
unfolded proteins in yeast [Seufert and Jentsch, 1990], but not in PCNA ubiquitination. 
When we deleted UBC4 from cdc9-1 mutants and performed a temperature shift 
experiment, PCNA ubiquitination was drastically reduced, whereas deletion of UBC5 had 
no effect (Figure 2.8a).  Because we were unable to generate an ubc4!ubc5! double 
mutant in the cdc9-1 background, we attached a nuclear export sequence onto UBC4 in a 
cdc9-1 ubc5! strain.  Again, this resulted in a 95% reduction of PCNA mono-
ubiquitination (Figure 2.8b).  These results suggested to us that the nuclear fraction of 
Ubc4 cooperates with Mms2 and Rad5 to ubiquitinate PCNA in DNA ligase I-deficient 
cells.  
 
Mms2, but not Ubc13, is required for S phase checkpoint activation in cdc9 
mutants.   
To further discern the function of PCNA ubiquitination in DNA ligase I-deficient 
yeast, we monitored cell cycle progression upon release from G1.  Specifically, we 
compared cdc9-1 cells to cdc9-1 mms2! and cdc9-1 ubc13! double mutants.  Consistent 
with our finding that UBC13 is not involved in the ubiquitination of PCNA (Figure 2.7a), 
cdc9-1 ubc13! cells arrested in S phase similar to the cdc9-1 strain (Figure 2.9a).  In 
contrast, cdc9-1 mms2! mutants that fail to ubiquitinate PCNA at the non-permissive 
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temperature (Figure 2.7a), readily progressed through S phase (Figure 2.9a).  The 
observed lack of PCNA ubiquitination and S phase arrest went hand-in-hand with the 
inability to phosphorylate Rad53 (Figure 2.9b).  Importantly, this was not due to a 
general defect in checkpoint activation, as we detected Rad53 phosphorylation in all three 
strains after exposure to MMS (Figure 2.9c).  
 To address whether mono-ubiquitination is sufficient for Rad53 activation, we 
disrupted poly-ubiquitination by overexpressing a ubiquitin mutant in which lysine 29 
was substituted with arginine. This did not significantly affect Rad53 activation (Figure 
2.10a and b).  These results argue that mono- rather than poly-ubiquitination of PCNA is 
a prerequisite for checkpoint activation of DNA ligase I-deficient yeast cells.  
 
PCNA ubiquitination occurs at Lysine 107 and is a prerequisite for Rad53 
activation in cdc9 mutants.   
Next, we set out to determine which lysine in PCNA was ubiquitinated.  PCNA 
has a total of 18 lysines, nine of which are exposed and easily accessible [Pettersen et al., 
2004].  We mutated these nine lysines at positions 107, 108, 117, 127, 164, 168, 183, 242 
and 253.  Wild-type or mutated forms of PCNA were introduced on a plasmid before the 
endogenous copy was deleted.  When we monitored mono-ubiquitination of PCNA in 
cdc9-1 cells after they were shifted to the non-permissive temperature, the only mutant 
that lacked the characteristic 39 kDa band was pol30K107R (Figure 2.11a). However, 
further examination revealed that this particular mutant had a second site suppressor 
mutation, which resulted in elevated DNA ligase I protein levels that were comparable to 
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those in wild-type cells (Figure 2.11b). Moreover, the strain was no longer temperature 
sensitive (Figure 2.11c).  We attempted several times to make the double mutant but 
these efforts remained unsuccessful, suggesting that the mutations were synthetically 
lethal.   
To prove this point, we performed a plasmid shuffle assay. We introduced 
pol30K107R into the chromosomal copy of PCNA in wild-type and cdc9-1 mutants, and 
expressed POL30 from a plasmid.  Cells were forced to abandon the plasmid by re-
streaking them onto 5-fluoroorotic acid-containing medium. Whereas CDC9 pol30K107R 
cells were viable and formed colonies, cdc9-1 pol30K107R mutants did not, indicating 
that K107 of PCNA becomes essential in this background (Figure 2.12).  This was further 
confirmed by tetrad analysis (data not shown), which seemingly yielded viable double 
mutants, but all of these strains had elevated DNA ligase I levels due to a second site 
suppressor mutation (data not shown).  However, we were able to isolate a single double 
mutant in which Cdc9 levels were only slightly increased compared to cdc9-1 cells 
(Figure 2.13a).  We designated this mutant cdc9-1* pol30K107R.  In fact, the double 
mutant retained its temperature sensitivity (Figure 2.13b) and failed to ubiquitinate 
PCNA under non-permissive conditions (Figure 2.14a). Importantly, PCNA 
ubiquitination in response to MMS was still functional (Figure 2.14b).   
At this point, it is worthwhile to point out that we detected ubiquitinated and 
unmodified PCNA at an apparent ratio of approximately 1:1.  However, it is not clear that 
the antibody binds these two forms of PCNA with equal affinity, and therefore it is 
difficult to make quantitative assessments.  In addition, we take the fact that we could 
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readily generate cdc9-1 mms2! and cdc9-1 rad5!, but not cdc9-1 pol30K107R double 
mutants as an indication that a redundant ubiquitination pathway might exist that targets 
K107 with low efficiency, thereby ensuring cell survival.  
 To confirm that K107 is the target of PCNA ubiquitination in DNA ligase I-
deficient cells, we introduced the pol30K107 mutation into cdc9-td cells.  As expected, 
cdc9-td pol30K107R double mutants retained viability, because CDC9 is expressed from 
an inducible copper promoter [Dohmen et al., 1994].  Under non-permissive conditions, 
the ratio of mono-ubiquitinated to unmodified PCNA in cdc9-td pol30K107R cells 
resembled that of the DNA ligase I-proficient control strain, which carries the same 
mutation in POL30 (Figure 2.14c).  The same was true for poly-ubiquitinated PCNA 
(Figure 2.14d). Furthermore, cdc9-td pol30K107R cells failed to exhibit robust Rad53 
phosphorylation in the absence of DNA ligase I, whereas they displayed Rad53 activation 
in response to MMS (Figure 2.14e). From these results we conclude that ubiquitination of 
PCNA at lysine 107 is a prerequisite for checkpoint activation of DNA ligase I-deficient 
yeast cells.  This is in stark contrast to the previously described ubiquitination of PCNA 
at lysine 164 in response to UV irradiation or DNA alkylating agents [Hoege et al., 
2002].  Although exposure to UV light or DNA alkylating agents triggers both Rad53 
phosphorylation and ubiquitination of PCNA at lysine 164, these processes are thought to 
occur independently and belong to separate genetic pathways [Frampton et al., 2006].  
We demonstrate that this cannot be generalized, but that PCNA ubiquitination in 
response to DNA ligase I deficiency must occur before Rad53 can be fully activated.   
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PCNA is ubiquitinated in DNA ligase I-deficient human cells.   
It is worth noting that K107 is conserved in S. pombe and C. elegans, but higher 
eukaryotes have a conserved lysine residue at position 110, raising the possibility that this 
PCNA ubiquitination pathway is not only specific for S.cerevisiae (Figure 2.15).  To test 
whether human cells depleted for DNA ligase I exhibit PCNA modifications, we 
generated several U2OS cell lines expressing short hairpin RNAs (shRNAs) that interfere 
with DNA ligase I expression (Figure 2.16a).  In the chromatin-bound protein fractions of 
these cells, we detected a slower migrating form of PCNA with the same mobility of 
mono-ubiquitinated PCNA induced by UV irradiation [Kannouche et al., 2004] (Figure 
2.16b and c, upper pannel).  In contrast, cells expressing control shRNA behaved like 
untreated U2OS cells (Figure 2.16b).  Importantly, when we analyzed one representative 
DNA ligase I-specific shRNA clone side by side with a PCNA- or an ubiquitin-specific 
antibody, both antibodies recognized bands at the exact same position, consistent with the 
notion that PCNA ubiquitination in response to DNA ligase I-deficiency is conserved in 
humans, although the lysine residue of PCNA that is ubiquitinated in these cells is still 
under investigation (Figure 2.16b, upper and middle panel). 
 
PCNA ubiquitination at Lys107 in cdc9 mutants may be specific to DNA ligase I 
deficiency.    
In the course of our studies, we also explored rad27! and dna2-1 mutants in S. 
cerevisiae, because both Rad27 and Dna2 have been implicated in lagging strand 
synthesis [Kao et al., 2004]. However, these mutants did not ubiquitinate PCNA (Figure 
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2.17).  This suggested that PCNA ubiquitination at K107 might be specific for DNA 
ligase I-deficiency.  In summary, whereas ubiquitination at lysine 164 is responsible for 
activation of translesion synthesis, and is thus a result of DNA damage in the template 
strand, ubiquitination of lysine 107 in DNA ligase I-deficient cells might provide a signal 
for DNA damage residing in freshly synthesized, nascent DNA.  Most importantly, our 
study demonstrates that PCNA provides a DNA damage-specific code via the 
ubiquitination of different lysines. 
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Figure 2.1 
 
 
Figure 2.1  Temperature sensitivity of DNA ligase I alleles.   
 (a) SSL204 (CDC9), SSL612 (cdc9-1) and SSL613 (cdc9-2) cells were spotted in 
ten-fold serial dilutions on YPD plates and incubated at the indicated temperatures for 2 
days.  (b) Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1) and SSL613 
(cdc9-2) were grown at 25°C and shifted to the restrictive temperature of 35°C for 90 or 
180 min.  Total protein was TCA precipitated [Ricke and Bielinsky, 2006].  Cdc9 was 
detected with an anti-Cdc9 antibody.  Ponceau S staining of the membrane prior to 
blotting served as a loading control.  The asterisk denotes a degradation product. 
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Figure 2.2 
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Figure 2.2  cdc9-td cells lack DNA ligase I at elevated temperatures.   
 (a) ABy021 (UBR1 CDC9), ABy010 (GAL-UBR1 CDC9), and ABy008 (GAL-
UBR1 cdc9-td) cells were streaked onto complete medium containing either 2% glucose 
(Glu.) or 2% galactose (Gal.) as the sole carbon source.  The plates were incubated for 
two days at 28°C or 37°C as noted.  (b) Asynchronous cultures of ABy010 (GAL-UBR1 
CDC9) and ABy008 (GAL-UBR1 cdc9-td) were grown overnight at 28°C in YP plus 
raffinose medium supplemented with 10 %M CuSO4.  At OD600 = 0.6, the culture was 
split, centrifuged and resuspended in either YP (Glu.) or YP plus galactose (Gal.) and 
incubated at 37°C.   Samples were collected at 1, 2 or 3 hours.  Cdc9-td-HA and histone 
H3 were detected by immunoblotting with anti-HA (16B12, Covance) and anti-histone 
H3 (Abcam) antibodies, respectively.  Ponceau S staining served as an additional loading 
control.  (c) DNA was isolated from ABy317 cells (GAL-UBR1 cdc9-td) grown 
asynchronously at 28°C.  In parallel, cells were arrested in G1 with alpha-factor.  
Following arrest, cultures were released and shifted to 37°C in the presence of galactose.  
RIP mapping was performed at the replication origin ARS1 using the primer ARS1/630 as 
described previously [Bielinsky and Gerbi, 1999].  The transition point (TP) maps 
between elements B1 and B2.  Okazaki fragment initiation sites visible at 28°C but not at 
37°C (in the absence of DNA ligase I) are indicated by O1, O2 and O3.  Sequencing 
reactions were fractionated adjacent to the primer extension reactions on a 6% denaturing 
polyacrylamide gel.   
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Figure 2.3 
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Figure 2.3   DNA ligase I is required for S phase progression.   
(a) Asynchronous cultures of ABy010 (GAL-UBR1 CDC9) and ABy008 (GAL-
UBR1 cdc9-td) were induced with galactose at 28°C for 30 min and subsequently shifted 
to 37°C.   (b) Strains were arrested in G1 phase at 28°C and shifted to 37°C in 2% 
galactose and "-factor.  After 90 min, cells were released from G1 phase either at 37°C in 
galactose or at 28°C in glucose.  (c)  Strains were arrested in G1 and released into S 
phase at 28°C in the presence of HU.  Once arrested in S phase, cultures were shifted to 
37°C in the presence of 2% galactose and HU. After 90 min, cells were transferred into 
nocodazole either at 37°C or 28°C.  (d) Asynchronous cultures of SSL204 (CDC9), 
SSL612 (cdc9-1), and SSL613 (cdc9-2) were shifted to 35°C.  In a-d, DNA content was 
monitored by flow cytometry and the vertical line indicates a 2C DNA content. 
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Figure 2.4 
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Figure 2.4   Deletion of MRC1 or RAD9 abrogates the S phase arrest in cdc9 
mutants.   
 (a) Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1), ABy296 
(CDC9 rad9!), ABy297 (cdc9-1 rad9!), ABy287 (CDC9 mrc1!) and ABy293 (cdc9-1 
mrc1!) were grown at 25°C and shifted to the restrictive temperature of 35°C for 1.5, 3 
or 4.5 h.  DNA was stained with Sytox Green and monitored using flow cytometry.  (b) 
Asynchronous cultures of ABy352 (CDC9 pRNR1), ABy353 (cdc9-1 pRNR1), ABy356 
(CDC9 mrc1! rad9! pRNR1) and ABy357 (cdc9-1 mrc1! rad9! pRNR1) were grown at 
25°C and shifted to the restrictive temperature of 35°C for the indicated times.  DNA was 
stained with Sytox Green and monitored using flow cytometry.  (c) Asynchronous 
cultures of ABy343 (CDC9 mrc1! +vector), ABy344 (CDC9 mrc1! +mrc1AQ), ABy345 
(CDC9 mrc1! +MRC1), ABy346 (cdc9-1 mrc1! +vector), ABy347 (cdc9-1 
mrc1! +mrc1AQ), and ABy348 (cdc9-1 mrc1! +MRC1) were grown at 25°C and shifted 
to the restrictive temperature of 35°C for 3 h.  DNA was stained with Sytox Green and 
monitored using flow cytometry.  In a-c, the vertical line indicates a 2C DNA content. 
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Figure 2.5 
 
Figure 2.5 Detection of robust PCNA signal in cdc9 mutants using a yeast specific 
PCNA antibody.   
 Asynchronous cultures were grown at 25°C and shifted to 35°C for 3 h. Total 
protein was TCA-precipitated and PCNA was detected using a yeast specific PCNA 
antibody (S871) [Zhang et al., 2000].  "-tubulin served as a loading control.  
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Figure 2.6 
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Figure 2.6 S. cerevisiae PCNA is mono-ubiquitinated in cdc9 mutants.   
(a) Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1), and SSL613 
(cdc9-2) were shifted to 35°C for 3 h.  Total protein was TCA-precipitated, diluted and 
probed with a yeast specific PCNA antibody (S871).  (b) Cells were shifted to 35°C for 3 
h in the presence of copper sulfate to induce expression of Myc-tagged ubiquitin. Whole 
cell extracts were immunoprecipitated with an anti-Myc antibody and PCNA was 
detected with anti-PCNA antibody (S871).  The right panel shows the beads control with 
or without the cell lysate. 5% of the input was loaded.  (c) PCNA is mono-ubiquitinated 
in cdc9 mutants. Wild-type or mutant ubiquitin expression was induced in 
asynchronously growing cultures. Total protein was TCA-precipitated and diluted. 
Unmodified and mono-ubiquitinated PCNA was detected by PCNA antibody (S871).  (d) 
PCNA poly-ubiquitination is linked through lysine 29 in cdc9 mutants.  Undiluted TCA-
precipitated protein samples from c were probed with anti-PCNA antibody (S871) to 
detect poly-ubiquitinated PCNA.  In b, d, asterisks indicate non-specific bands. In d, 
filled circles (right side of the band) indicate poly-ubiquitinated forms of PCNA.  In a, c, 
d, "-tubulin served as a loading control.  
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Figure 2.7 
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Figure 2.7  PCNA ubiquitination in cdc9 mutants is mediated by Mms2, Rad5 and 
Ubc4 but not Ubc13.   
 (a, b) SSL204 (CDC9), SSL612 (cdc9-1), ABy375 (cdc9-1 mms2!), ABy388 
(cdc9-1 ubc13!), ABy410 (cdc9-1 rad5!) were grown asynchronously and shifted to 
non-permissive temperature of 35°C for 3 h.  (c) Asynchronous cultures of SSL612 
(cdc9-1) and ABy520 (cdc9-1 rad6!) were grown overnight at 25°C to a density of 0.6 at 
600 nm.  Cultures were shifted to the non-permissive temperature of 35°C for 3 h.  In a-c, 
total protein was TCA-precipitated.  Samples were fractionated on SDS-PAGE gels with 
either diluted extracts (in a, c) or undiluted extracts (in b).  Unmodified and mono-
ubiquitinated PCNA was detected in a, c whereas poly-ubiquitinated PCNA was detected 
in b using PCNA antibody (S871).  The asterisks indicate nonspecific bands.  "-tubulin 
and Ponceau S served as a loading control. 
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Figure 2.8 
 
Figure 2.8  PCNA mono-ubiquittination in cdc9 mutants is mediated by E2 
ubiquitin conjugating enzyme, Ubc4.   
 (a) Asynchronous cultures of SSL204 (CDC9), SSL612 (cdc9-1), ABy538 (cdc9-
1 ubc4!), and ABy539 (cdc9-1 ubc5!) were shifted to 35°C for 3 h.  (b) Asynchronous 
cultures of SSL204 (CDC9), SSL612 (cdc9-1) and ABy579 (cdc9-1 ubc5! UBC4-NES-
3HA) were grown at 25°C and shifted to 35°C for 3 h. In a and b, total protein was TCA-
precipitated, diluted and PCNA was detected by anti-PCNA antibody (S871) [Zhang et 
al., 2000].  "-tubulin served as a loading control. 
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Figure 2.9 
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Figure 2.9  MMS2 but not UBC13 is required for S phase checkpoint activation in 
cdc9 mutants.   
(a) Cells were arrested in G1 phase at 25°C and released at 35°C for 3 h.  DNA 
content was monitored by flow cytometry.  The vertical line indicates a 2C DNA content.  
(b) Cells were grown asynchronously at 25°C and then shifted to 35°C for the indicated 
time period.  Total protein was TCA-precipitated and Rad53 was detected by an anti-
Rad53 antibody.  (c) Asynchronous cultures were split and shifted to the non-permissive 
temperature of 35°C in the presence of methyl methanesulfonate (MMS) for 90 and 180 
min or left untreated for 180 min.  Rad53 was detected as described in b.  In b-c, "-
tubulin served as a loading control.   
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Figure 2.10 
 
Figure 2.10 Mono-ubiquitination of PCNA in cdc9 mutants is sufficient for Rad53 
activation.   
 (a) Asynchronous cultures of ABy350 (cdc9-1 Cu-Myc-Ub) and ABy485 (cdc9-1 
Cu-Myc-Ub-K29R) were grown overnight at 25°C to a density of 0.6 at 600 nm.  Cells 
were shifted to 35°C for 3 h in the presence of copper sulfate to induce expression of 
Myc-tagged ubiquitin.  Samples were taken at the indicated times and total protein was 
TCA-precipitated.  Rad53 was detected by Western blotting using an anti-Rad53 
antibody.  Ponceau S served as a loading control.  (b) Asynchronous cultures of ABy349 
(CDC9 Cu-Myc-Ub), ABy350 (cdc9-1 Cu-Myc-Ub) and ABy485 (cdc9-1 Cu-Myc-Ub-
K29R) were grown as described in a.  Total protein was TCA-precipitated.  Poly-
ubiquitinated PCNA was detected by Western blot with a yeast specific anti-PCNA 
antibody (S871) [Zhang et al., 2000].  The asterisks indicate nonspecific bands.  Ponceau 
S staining served as a loading control. 
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Figure 2.11 
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Figure 2.11  A second site suppressor in ABy459 (cdc9-1 pol30!  ppol30-K107R) 
results in elevated DNA ligase I levels and loss of temperature sensitivity.   
 (a) PCNA lysine mutants in DNA ligase I deficient cells (cdc9-1) were grown 
asynchronously and then shifted to 35°C for 3 h.  TCA-precipitated protein samples were 
diluted and PCNA was detected with anti-PCNA antibody (S871).  (b) Asynchronous 
cultures of SSL204 (CDC9), SSL612 (cdc9-1), ABy459 (cdc9-1 pol30! ppol30-K107R) 
were shifted to 35°C for 90 and 180 min.  DNA ligase I was detected in TCA-precipitated 
protein with an anti-Cdc9 antibody and "-tubulin served as a loading control. The 
asterisk denotes a degradation product. b, Cells were spotted in ten-fold serial dilutions 
on SC-trp plates and incubated at the indicated temperatures for 2 days. 
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Figure 2.12 
 
 
Figure 2.12  A PCNA mutation at K107 in DNA ligase I deficient cells inhibits cell 
proliferation.   
Wild-type (CDC9) and DNA ligase I deficient cells (cdc9-1) either with or 
without pol30-K107R integrated at the endogenous PCNA locus, all expressing POL30 
from a low copy number plasmid, were grown on SC-ura and FOA plates for 2-3 days at 
25°C. Wild-type (CDC9) and DNA ligase I deficient cells (cdc9-1) carrying a URA3 
disruption of the BAR1 gene served as controls. 
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Figure 2.13 
 
Figure 2.13 cdc9-1* pol30-K107R has slightly elevated DNA ligase I levels but still 
retains its temperature sensitivity.   
(a) Cultures of SSL204 (CDC9), SSL612 (cdc9-1) and ABy782 (cdc9-1* pol30-
K107R) were grown asynchronously at 25°C and total protein was TCA-precipitated. 
DNA ligase I was detected using anti-Cdc9 antibody and "-tubulin served as a loading 
control. The asterisk denotes a degradation product. (b) Cultures of SSL204 (CDC9), 
ABy685 (CDC9 pol30-K107R), SSL612 (cdc9-1), ABy782 (cdc9-1* pol30-K107R) were 
spotted in ten-fold serial dilutions on YPD plates and incubated at the indicated 
temperatures for 2-3 days. 
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Figure 2.14 
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Figure 2.14  PCNA mono-ubiquitination occurs at lysine 107 in DNA ligase I 
mutants and is required for Rad53 activation.   
(a) Cultures of SSL204 (CDC9), ABy685 (CDC9 pol30-K107R), SSL612 (cdc9-
1), ABy782 (cdc9-1* pol30-K107R) were grown asynchronously and then shifted to 
30°C for 3 h.  (b) Asynchronous cultures were grown at 25°C and shifted to 30°C in the 
presence of MMS for the indicated time. Cultures not treated with MMS served as 
negative controls.  (c) Cultures were induced with galactose at 28°C for 30 min and 
subsequently shifted to 37°C for 3 h. In a-c, TCA-precipitated protein samples were 
diluted and PCNA was detected with anti-PCNA antibody (S871).  (d) Undiluted TCA-
precipitated samples from c were fractionated on SDS-PAGE and poly-ubiquitinated 
PCNA was detected with anti-PCNA antibody (S871).  (e) Cells were grown 
asynchronously at 28°C and then shifted to 37°C in the presence or absence of MMS for 
3 h.  Rad53 and Cdc9-td-HA were detected with anti-Rad53 and anti-HA antibodies, 
respectively. In a, b, d, e, "-tubulin served as a loading control.  In d, e, the asterisks 
indicate non-specific bands.   
 
A 
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Figure 2.15 
 
Figure 2.15  Evolutionary conservation of lysines 107 and 110 in selected eukaryotes.   
Lysine 107 in PCNA is conserved in S. pombe and C. elegans but higher 
eukaryotes have a conserved lysine at position 110.  
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Figure 2.16 
`  
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Figure 2.16  PCNA mono-ubiquitination is conserved in human DNA ligase I-
deficient cells.   
(a) Generation of LIG1 shRNA stable cell lines. U20S cells stably expressing 
either control or DNA ligase I shRNA were harvested and subjected to Western blot 
analysis with the indicated antibodies.  DNA ligase I expression was determined in whole 
cell extracts, whereas PCNA expression was examined in chromatin-bound protein 
fractions. "-tubulin and histone H3 served as loading controls.  (b) U2OS cells were 
either untreated or treated with 60 J/m2 UV and harvested 2 h later along with control 
shRNA (shCON) and DNA Ligase I shRNA (shLIG1 A) cell lines.  Chromatin fractions 
were prepared, fractionated on SDS-PAGE and analyzed with the indicated antibodies.  
Samples on the PCNA and ubiquitin blots were analyzed side by side.  Unmodified 
PCNA served as a loading control for the PCNA blot and histone H3 served as a loading 
control for the ubiquitin blot. 
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Figure 2.17 
 
Figure 2.17  PCNA ubiquitination does not occur in rad27!  and dna2-1 mutants. 
Asynchronous cultures were grown at 25°C and shifted to the restrictive 
temperature of 35°C for 3 h.  Total protein was TCA-precipitated and PCNA was 
detected by a yeast specific anti-PCNA antibody (S871) [Zhang et al., 2000].  "-tubulin 
served as a loading control. 
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CHAPTER 3 
Damage-specific modification of PCNA 
 
(The work in this chapter was published in Das-Bradoo, S.*, Nguyen, H.D.*, Bielinsky, 
A.K. (2010) Cell Cycle 9(18):3674-9. * indicates co-authors.) 
 
Authors contributions: 
S.D.-B. conducted experiment in Figure 3.2. H.D.N. conducted experiment in Figure 3.1 
and generated Figure 3.3. S.D.-B. and H.D.N. helped with data analysis and write the 
manuscript. A.-K.B. planned and supervised the project, and wrote the manuscript. 
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Okazaki fragment processing is an integral part of DNA replication.  For a long 
time, we assumed that the maturation of these small RNA-primed DNA fragments did not 
necessarily have to occur during S phase, but could be postponed to late in S phase after 
the bulk of DNA synthesis had been completed.  This view was primarily based on the 
arrest phenotype of temperature-sensitive DNA ligase I mutants in yeast, which 
accumulated with an almost fully duplicated set of chromosomes.  However, many 
temperature-sensitive alleles can be leaky, and the re-evaluation of DNA ligase I-
deficient cells has offered new and unexpected insights into how cells keep track of 
lagging strand synthesis.  It turns out that if Okazaki fragment joining goes awry, cells 
have their own alarm system in the form of ubiquitin that is conjugated to the replication 
clamp PCNA.  Although this modification results in mono- and poly-ubiquitination of 
PCNA, it is genetically distinct from the known post-replicative repair mark at lysine 
164.  In this Extra View, we discuss the possibility that eukaryotic cells utilize different 
enzymatic pathways and ubiquitin attachment sites on PCNA to alert the replication 
machinery to the accumulation of single-stranded gaps or nicks behind the fork.  
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Introduction 
In humans, more than 30,000,000 Okazaki fragments (OFs) have to be initiated 
(assuming an average size of ~200 nt/OF), processed and ligated during a single round of 
DNA replication [Hubscher and Seo, 2001].  It is easy to imagine that failure to properly 
join OFs would cause a large number of single-strand breaks (SSBs) – at a frequency that 
would likely overwhelm the SSB repair machinery and thus be lethal.  It is therefore not 
surprising that to date only one individual with a severe defect in DNA ligase I, the 
enzyme that joins OFs during DNA replication, has been identified and described [Barnes 
et al., 1992; Webster et al., 1992].  The individual carried compound heterozygous 
mutations in the gene and retained approximately 5% ligase activity [Mackenney et al., 
1997; Prigent et al., 1994].  Importantly, this reduction caused growth retardation, 
immunodeficiency, UV sensitivity and lymphoma [Barnes et al., 1992; Webster et al., 
1992].  Most of these phenotypes are compatible with the known function of DNA ligase 
I in DNA replication and nucleotide excision repair [Ellenberger and Tomkinson, 2008].  
The only exception is the immunodeficiency, which went hand-in-hand with a profound 
lack of immunoglobulin class switching [Barnes et al., 1992; Webster et al., 1992].  
Although this latter defect was not recapitulated in a mouse model carrying a 
homozygous mutation of the viable missense allele, DNA ligase I deficient animals 
displayed growth retardation, abnormal erythropoiesis and increased genome instability 
[Bentley et al., 2002; Harrison et al., 2002].  Moreover, they developed an unexpectedly 
wide range of spontaneous tumors, such as lymphomas, adeno- and other carcinomas.  
The importance of proper OF maturation is further underscored by the fact that mutations 
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in other enzymes that participate in OF processing, such as the flap endonuclease Fen1 
(e.g., a E160D mutation), which retains partial endonuclease activity [Frank et al., 1998], 
have been directly linked to cancer in humans [Zheng et al., 2007].  Interestingly, recent 
evidence suggests that the E160D Fen1 mutation, similar to the DNA ligase I deficiency, 
causes early-onset lymphoma in mice [Larsen et al., 2008].  This raises the question of 
whether cells harbor a system capable of monitoring perturbations during OF processing.  
In addition, it remains unclear if abnormalities in lagging strand maturation affect 
replication fork progression.    
 
Post-replicative repair and DNA damage induction by Okazaki fragment processing 
defects.   
Today we have a relatively good understanding of the post-replication repair 
(PRR) pathways involved in sensing DNA lesions, like ultraviolet (UV) irradiation-
induced thymine dimers [Setlow et al., 1963], in the leading or lagging strand template 
[Bergink and Jentsch, 2009; Lee and Myung, 2008; Ulrich, 2009].  PRR seemed for many 
years somewhat of a misnomer, as most studies analyzed the pathway in the context of an 
active replication fork [Frampton et al., 2006; Hoege et al., 2002; Kannouche et al., 
2004; Moldovan et al., 2007; Stelter and Ulrich, 2003].  However, recent studies have 
come full circle demonstrating that PRR can occur outside of S phase, after replication 
has been largely completed [Daigaku et al., 2010; Karras and Jentsch, 2010].  The first 
description of PRR dates back to 1968 when Rupp and Howard-Flanders described 
discontinuities in the newly synthesized DNA of nucleotide excision repair (NER) 
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defective E. coli [Rupp and Howard-Flanders, 1968].  Shortly thereafter, the concept was 
extended to mammalian cells [Lehmann, 1972].  During the past 42 years much progress 
has been made toward understanding error-prone and error-free PRR, respectively 
[Bridges and Walker, 2004].  Nevertheless, most studies published to date utilize UV or 
other mutagens like methyl methanesulfonate (MMS) to create large adducts in the DNA 
that prompt collisions with the replicative polymerases, thereby causing transient 
replication fork arrest [Kannouche et al., 2004; Niimi et al., 2008; Stokes and Michael, 
2003; Tercero and Diffley, 2001].  This is usually accompanied by formation of long 
stretches of replication protein A (RPA)-coated, single-stranded (ss) DNA [Zou and 
Elledge, 2003].  These RPA-coated regions facilitate PRR activation by ubiquitination of 
PCNA at lysine 164 [Davies et al., 2008; Hoege et al., 2002] and also trigger the S phase 
checkpoint [Zou and Elledge, 2003].  Both events are genetically separable and are 
thought to occur in parallel [Frampton et al., 2006; Yang and Zou, 2009].  Although the 
above-mentioned experimental approach utilizing UV-irradiation or MMS has provided a 
powerful model to dissect the molecular steps of these pathways, it has obvious 
limitations, because forks that accumulate ssDNA are probably not the only structures 
that arise in replication-defective mutants.  Aberrant Okazaki fragment processing, for 
example, can cause nicks – in a wide range of varieties: “clean” nicks due to ligation 
deficiency, “dirty” nicks that exhibit adenylated 5’ ends if the ligation reaction is aborted 
prematurely or “flapped” nicks in the case of improper removal of RNA primers [Rossi 
and Bambara, 2006; Tomkinson et al., 2006].  This latter reaction requires the 
complicated interplay of multiple activities.  Limited displacement synthesis by DNA 
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polymerase (pol)-# is required to initially create a short flap that is deleted one nucleotide 
at a time by Fen1 [Garg et al., 2004].  Excessive strand displacement is counteracted by 
the intrinsic 3’-exonuclease activity of the catalytic subunit of pol-# and its non-essential 
binding partner, Pol32 [Jin et al., 2005; Stith et al., 2008].  Cells defective in Fen1, 
appear to create larger flaps (in a Pol32-dependent manner) that can be processed by a 
second endonuclease, Dna2 [Ayyagari et al., 2003; Budd et al., 2000; Lee et al., 2000].  
Recent studies have also implicated other enzymes, such as exonuclease 1 and the 
helicase Pif1 in this backup system [Rossi et al., 2008; Stith et al., 2008].  Thus, the first 
two steps (strand displacement and flap removal) of OF processing (OFP) already involve 
an elaborate network of partially redundant pathways to assure proper production of a 
ligatable nick that can be sealed by DNA ligase I.  Importantly, primer removal by Fen1 
and OF ligation by DNA ligase I are coordinated by PCNA [Karanja and Livingston, 
2009].  Both enzymes bind PCNA through a PCNA interacting peptide (PIP) box [Maga 
and Hubscher, 2003; Sakurai et al., 2005; Vijayakumar et al., 2007].  
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Results 
Okazaki fragment processing defects trigger PCNA ubiquitination.   
The fact that multiple OFP pathways exist suggests that cells have the ability to 
actively monitor maturation events during lagging strand synthesis.  To address this 
question, we analyzed DNA ligase I-deficient cells [Bielinsky and Gerbi, 1999].  In 
budding yeast, temperature-sensitive cdc9 mutants were among the first strains identified 
to have a cell cycle progression defect under non-permissive conditions as they arrested 
in late S/G2 phase [Culotti and Hartwell, 1971; Johnston and Nasmyth, 1978].  The arrest 
was dependent on the DNA damage response [Weinert et al., 1994] and cell viability 
required functional homologous recombination [Montelone et al., 1981], indicating that 
the nicks might be – at least partially – converted into double strand breaks (DSBs).  
These early studies suggested that OF ligation was uncoupled from replication fork 
progression and could occur very late in S phase after the bulk of the DNA had been 
replicated.  This was also consistent with observations made much later that PCNA 
remained on chromatin after passage of the replication fork, providing anchor points for 
DNA ligase I on chromatin [Shibahara and Stillman, 1999].  In fact, experiments with 
cdc9-1 cells that had two consecutive shifts, to the non-permissive temperature first and 
then back to the permissive temperature demonstrated that OF synthesis could be 
temporally separated from OF ligation [Bielinsky and Gerbi, 1999].  All of these findings 
were consistent with the notion that DNA ligase I was not required until the end of S 
phase.  However, our recent analysis of the cdc9-1 mutation in a different strain 
background suggested that the cells do not move through S phase with normal kinetics, 
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but rather appeared to accumulate in mid-S phase (Figure 2.3) [Das-Bradoo et al., 
2010b].  Further exploration of a temperature-sensitive degron mutant (cdc9-td) verified 
that DNA replication was extensively delayed in the absence of DNA ligase I (Figure 
3.1).  Although it still remains unclear how this delay was mediated (e.g., through 
reduced fork progression or inhibition of late-firing origins), it was dependent on the 
activation of the S phase checkpoint kinase Rad53 [Branzei and Foiani, 2007].  Rad53 
phosphorylation was not only Rad9- (and thus DNA damage) dependent [Sweeney et al., 
2005], but also required the mediator of the replication checkpoint, Mrc1 [Naylor et al., 
2009; Osborn and Elledge, 2003], the yeast homolog of Claspin [Kumagai and Dunphy, 
2000].  This finding implied that replication fork stalling was occurring [Alcasabas et al., 
2001; Tanaka and Russell, 2001].  How this happened in a scenario in which none of the 
DNA polymerases were actively inhibited was puzzling.  Even more surprising was the 
observation that the phosphorylation of Rad53 was amplified by a novel PRR-related 
pathway that triggered mono- and poly- ubiquitination of PCNA (Figure 2.14) [Das-
Bradoo et al., 2010b].  Mutation of lysine 164 of PCNA in cdc9 mutants had no effect on 
cell viability, arguing that neither error-prone translesion synthesis [Kannouche et al., 
2004; Stelter and Ulrich, 2003; Terai et al., 2010; Watanabe et al., 2004; Zhuang et al., 
2008] nor error-free replication by template switch [Blastyak et al., 2007; Branzei et al., 
2008; Minca and Kowalski, 2010; Torres-Ramos et al., 2002] played a role in this 
process.  Instead, we observed synthetic lethality between cdc9-1 and a mutation in lysine 
107 of PCNA (Figure 2.11-2.13), leading us to propose that ubiquitin is conjugated to 
lysine 107 in DNA ligase I-deficient cells.  One aspect that we did not address in our 
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recent study is whether PCNA is also modified by the ubiquitin-related SUMO peptide, 
which is attached to PCNA during S phase at lysine 164 and to a lesser extent at lysine 
127 [Hoege et al., 2002].  In Figure 3.2, we demonstrate that PCNA is indeed sumoylated 
in wild-type cells and cdc9 mutants.  Because the mutants accumulated in S phase, they 
displayed stronger sumoylation signals.  In addition, we observed higher molecular 
weight forms of sumoylated PCNA.  This is consistent with the finding that PCNA 
carries SUMO chains in the face of profound replication stress [Windecker and Ulrich, 
2008].  Alternatively, it is also possible that a single PCNA monomer is ubiquitinated (at 
lysine 107) and sumoylated (at lysine 164) in cdc9 mutants.  Sumoylation of PCNA is 
thought to repress homologous recombination [Branzei et al., 2006; Haracska et al., 
2004; Papouli et al., 2005] at stalled replication forks.  This raises an interesting point 
because homologous recombination is required for the viability of cdc9 mutants and 
therefore its activity needs to be highly regulated.  Future experiments are needed to 
clarify these issues.   However, regardless of their outcome, it is important to mention 
that ubiquitination of PCNA is conserved in human cells that are depleted for DNA ligase 
I, even though lysine 107 of PCNA is not evolutionarily conserved (Figure 2.16) [Das-
Bradoo et al., 2010b].   This underscores the significance of our findings.    
Consistent with the observation that a DNA ligase I deficiency triggers ubiquitin 
conjugation at a non-canonical lysine residue of PCNA in budding yeast, we have also 
uncovered genetic requirements for this process that clearly distinguish it from the 
classical DNA damage tolerance (DDT) pathways.  For example, whereas DDT is 
dependent on Rad6 and Rad18, both proteins are dispensable for PCNA ubiquitination in 
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cdc9 mutants.  This makes sense in as far as Rad6 and Rad18 mediate predominantly 
translesion synthesis [Daigaku et al., 2010], which would help little in facilitating the 
repair of nicks.  Moreover, the poly-ubiquitin chains observed in cdc9 mutants are linked 
through lysine 29 and not lysine 63 as in PRR [Hoege et al., 2002].  In the light of this 
result, it is not surprising that Ubc13, which together with Mms2 catalyzes lysine 63 
linked ubiquitin chains [Eddins et al., 2006; Hofmann and Pickart, 1999; VanDemark et 
al., 2001], did not appear to play a role in this pathway (Figure 2.7 and 2.9) [Das-Bradoo 
et al., 2010b].  What was puzzling, however, was the genetic requirement for MMS2 and 
UBC4 (Figure 2.8).  The human homolog of Ubc4, UbcH5A, synthesizes lysine 29 linked 
ubiquitin chains in vitro [Mastrandrea et al., 1999].  Although Ubc13 has been reported 
to function independently of Mms2 [Stewart et al., 2009], no other studies have 
demonstrated a genetic function for Mms2 that is separable from Ubc13.  How Mms2 fits 
into the PCNA ubiquitination pathway is not at all clear and will require additional 
genetic validation.  Furthermore, biochemical studies are currently underway to dissect 
whether Mms2, Ubc4 and Rad5 cooperate in one physical complex – possibly together 
with other proteins – or not.  At this point, we have no evidence to suggest a direct 
interaction between Mms2 and Ubc4.  Moreover, we would like to emphasize that our 
data does not dispute nor contradict any of the established rules for the DDT and PRR 
pathways [Ulrich and Walden, 2010].  Rather, we interpret them to mean that both the 
repertoires of damaged DNA structures that cause PCNA ubiquitination as well as the 
pathways catalyzing these reactions are likely larger and more complex than anticipated.  
This is also underscored by recent observations that described the Rad6-independent 
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ubiquitination of PCNA in response to chronic HU and MMS treatment at lysine 164 
[Kats et al., 2009].   Although we are still missing many pieces of the puzzle, it appears 
that different types of DNA damage may trigger different PCNA ubiquitination pathways 
that result in distinct attachment sites and/or differently linked ubiquitin chains (i.e., a 
PCNA “DNA damage code”; Figure 3.3 and Chapter 2) [Das-Bradoo et al., 2010b]. 
Taken together, our results suggest that lagging strand synthesis is actively 
monitored and that persistent nicks in newly replicated DNA (and maybe also those that 
arise during abortive repair or result from oxidative damage) can indeed be detected 
during S phase.  Whether earlier steps in Okazaki fragment processing are surveyed in a 
similar manner remains obscure.  Although we tested rad27 and dna2 mutants, and 
neither displayed PCNA ubiquitination under non-permissive conditions (Figure 2.17) 
[Das-Bradoo et al., 2010b], it is highly likely that the respective enzymes substitute for 
one another in these particular mutants. Therefore, the lack of PCNA ubiquitination does 
not necessarily exclude the possibility that other OFP intermediates are recognized by the 
cell and trigger modification(s) of the PCNA clamp.  Indeed, pol32 mutants cause 
lagging strand defects, which result in ss gaps [Karras and Jentsch, 2010].  Although it is 
not clear that these gaps are generated during OFP (e.g., they might occur during actual 
synthesis), they cause PCNA ubiquitination.  The most burning question for us concerns 
the biological function of ubiquitinated PCNA in cdc9 mutants.  What is the connection 
between the modified clamp, the slow replication dynamics and Rad53 activation?  
Replication fork slowdown would certainly aid in extending the time frame of an 
individual ligation reaction.  In the same vein, modified PCNA may help to retain the 
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enzyme on site until Okazaki fragments have been successfully joined and might 
counteract abortive ligation reactions due to the limited amounts of DNA ligase I present 
in the cell.  The exciting new technical developments in producing ubiquitinated PCNA 
in vitro [Chen et al., 2010; Freudenthal et al., 2010] certainly provide invaluable tools 
toward finding answers to these questions.  
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Figure 3.1 
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Figure 3.1  DNA ligase I is required for S phase progression.   
Asynchronous cultures of ABy010 (GAL-UBR1 CDC9) and ABy008 (GAL-UBR1 
cdc9-td) were grown at 28°C and arrested in G1 with !-factor.  After 2 hours, Ubr1 
expression was induced with 2% galactose for 30 min.  Subsequently, cultures were 
shifted to 37°C in medium containing !-factor and 2% galactose.  After 90 min, cells 
were released from G1 for 12 hours. DNA content at indicated time was monitored by 
flow cytometry and the vertical line indicates a 2C DNA content.  The red arrows mark 
entry into S phase and completion of DNA replication in cdc9-td mutants, respectively. 
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Figure 3.2 
 
Figure 3.2  PCNA is sumoylated in cdc9 mutants.   
Wild-type (CDC9) and cdc9 mutants (cdc9-1 and cdc9-2) expressing PCNA-3HA 
were grown asynchronously at 25°C and shifted to 35°C for 3 hours.   Whole-cell 
extracts were immunoprecipitated with anti-HA conjugated agarose beads (Sigma).  Both 
unmodified and modified PCNA was detected with an anti-HA antibody (Covance, 
16B12).   Sumoylated PCNA was detected with an anti-SUMO antibody (a gift from 
Xiaolan Zhao, Memorial Sloan-Kettering Cancer Center).   The red dots mark prominent 
sumoylated PCNA bands.  IgGH indicates the immunoglobulin heavy chain.  Mono-
ubiquitinated PCNA is visible in darker exposures around 42kDa in cdc9 mutants with 
HA-tagged PCNA (only visible as a faint band in this exposure).  cdc9-1 is a more 
stringent allele than cdc9-2 (Figure 2.1) [Das-Bradoo et al., 2010b], and thus sumoylation 
of PCNA is more prominent in this mutant. 
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Figure 3.3 
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Figure 3.3  Damage-dependent PCNA ubiquitination in budding yeast.   
DNA synthesis occurs in a semi-discontinuous manner. Nascent DNA on the 
leading strand is synthesized by pol !, whereas pol # is required to synthesize Okazaki 
fragments (short arrows) on the lagging strand. In response to UV light-induced damage, 
which causes pyrimidine dimers on the template DNA (red X, left), PCNA is 
ubiquitinated at lysine (K) 164 and the poly-ubiquitin chain is linked through K63. 
Activation of the S phase checkpoint by UV damage is independent of PCNA 
ubiquitination at K164.  In contrast, PCNA is ubiquitinated at K107 and the poly-
ubiquitin chain is linked through K29 in response to DNA ligase I deficiency, which 
accumulates persistent nicks due to unligated Okazaki fragments (red arrows, right).  
PCNA ubiquitination at K107 appears to be a prerequisite for activation of the S phase 
checkpoint, illustrated by hyperphosphorylation of Rad53.  The importance of the K29-
linked poly-ubiquitin chain and how PCNA ubiquitination results in activation of the S 
phase checkpoint is still unknown. The S. cerevisiae homotrimeric PCNA structure (PDB 
ID 2OD8) was generated using Chimera software program [Pettersen et al., 2004].  Ub 
denotes ubiquitin. K164 and K107 on each of the subunits are indicated as yellow and red 
surfaces, respectively.  
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CHAPTER 4 
Accumulation of unligated Okazaki fragments induces PCNA 
ubiquitination and Rad59-dependent replication fork 
progression 
 
(The work in this chapter is manuscript in preparation: Nguyen, H.D., Costanzo, M., 
Koch, E.N., Smith, S., Myung, K, Myers, C.L., Boone, C., and Bielinsky, A.K.) 
 
Authors contribution: 
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out analysis of SGA results for Figure 4.7a, Table 4.2 and Supplementary Table S1. S.S 
and K.M carried out GCR and DNA damage sensitivity in Figures 4.4 and 4.5. H.D.N 
and A.-K.B designed experiments, analyzed data for all experiments except for data 
mentioned above. 
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A deficiency in DNA ligase I/Cdc9, which catalyzes the joining of Okazaki 
fragments, triggers PCNA ubiquitination at lysine 107 in S. cerevisiae. This signal is 
crucial to activate the S phase checkpoint, which promotes cell cycle arrest. We report 
here that a pol30K107 mutation alleviated cell cycle arrest in cdc9 mutants. To determine 
whether PCNA ubiquitination occurred in response to nicks or the lack of a PCNA-DNA 
ligase interaction, we complemented cdc9 cells either with wild-type DNA ligase I or 
Chlorella virus ligase, the latter of which fails to interact with PCNA. Both enzymes 
reversed PCNA ubiquitination, arguing that the modification is likely triggered directly 
by nicks. To further understand how cells cope with nicks during replication, we utilized 
cdc9-1 in a genome-wide synthetic lethality screen and identified RAD59 as a strong 
negative interactor. cdc9 rad59! mutants did not alter PCNA ubiquitination but enhanced 
phosphorylation of the mediator of the replication checkpoint, Mrc1, indicative of 
increased replication fork stalling. Thus, Rad59 promotes fork progression when Okazaki 
fragment processing is compromised and counteracts PCNA-K107 mediated cell cycle 
arrest.  
 
 
Supplementary Table S1. A complete SGA results for all query strains used in this 
study. See Materials and Methods for more description of the SGA screen. Table is 
available online.  
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Introduction 
  Replication fork arrest in response to DNA lesions, such as UV-induced thymine 
dimers that physically block DNA synthesis and lead to exposure of unreplicated, single-
stranded (ss) DNA has been studied extensively in multiple different model organisms 
[Branzei and Foiani, 2007]. However, how cells monitor the integrity of replication 
intermediates that undergo Okazaki fragment processing is less well understood. Given 
that human cells produce on the order of 30 million Okazaki fragments that need to be 
processed and ligated during a single round of replication, a tracking system should be in 
place to account for possible errors that could lead to the accumulation of nicked DNA. 
The importance of such a surveillance system is underscored by mutations impinging on 
proper Okazaki fragment processing that have been identified in human cancer patients 
and whose cancer-causing effect has been recapitulated in animal studies [Barnes et al., 
1992; Larsen et al., 2008; Webster et al., 1992; Zheng et al., 2007]. In particular, a DNA 
ligase I-deficiency causes not only growth retardation similar to other replication-
associated genetic syndromes but lymphoma as well [Barnes et al., 1992; Webster et al., 
1992]. 
DNA ligase I catalyzes the sealing of nicks between adjacent 3’-OH and 5’-PO4 
termini and is crucial for DNA replication, repair and recombination. The DNA ligation 
mechanism involves three nucleotidyl transfer reactions [Ellenberger and Tomkinson, 
2008]. In the first step of the ligation reaction, DNA ligase reacts with either ATP or 
NAD+ (in prokaryotes) to form a ligase-adenylate intermediate where 5’-adenosine 
monophosphate (AMP) is linked by a phosphoamide bond with the lysine residue in the 
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active site. In the second step, AMP is transferred to the 5’-PO4 terminus of the nick to 
form a DNA-adenylate. Finally, DNA ligase catalyzes the nucleophilic attack of the 3’-
OH to the DNA-adenylate to covalently join the two ends of the DNA strands and release 
AMP. 
The budding yeast S. cerevisiae encodes two different DNA ligases, Cdc9 and 
Dln4, which are homologs of human DNA ligases I and IV, respectively [Barnes et al., 
1990; Johnston and Nasmyth, 1978; Schar et al., 1997; Teo and Jackson, 1997; Wei et 
al., 1995; Wilson et al., 1997]. Given their different substrate specificities, the two 
proteins have clearly distinct roles in DNA metabolism. Whereas Dln4 primarily 
functions in DSB repair via NHEJ, Cdc9 participates in BER and NER [Johnston and 
Nasmyth, 1978; Montelone et al., 1981; Schar et al., 1997; Teo and Jackson, 1997; 
Wilson et al., 1997; Wu et al., 1999]. Additionally, Cdc9 is essential for the ligation of 
Okazaki fragments and interacts genetically and physically with many proteins involved 
in Okazaki fragment maturation [Ireland et al., 2000; Karanja and Livingston, 2009; 
Refsland and Livingston, 2005; Vijayakumar et al., 2007]. One such interacting protein is 
PCNA [Montecucco et al., 1998]. The N-terminus of Cdc9 contains a conserved PCNA 
interacting peptide (PIP) box motif, QxxLxxFF, which facilitates its interaction with 
PCNA [Refsland and Livingston, 2005; Subramanian et al., 2005; Vijayakumar et al., 
2007]. However, deletion of the PIP-box in Cdc9 does not affect S. cerevisiae mitotic 
growth, suggesting that the interaction is not essential for Okazaki fragment maturation 
[Sriskanda et al., 1999]. In agreement with these data, the smallest form of Chlorella 
virus DNA ligase, containing only the minimal core domain of DNA ligase but not a PIP-
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box, complements cdc9! cells [Sriskanda et al., 1999], and must therefore have a PCNA-
independent nick-sensing activity [Nair et al., 2007].  
Temperature sensitive (ts) alleles of CDC9 were isolated from the original screen 
for cell division cycle (cdc) mutants [Culotti and Hartwell, 1971; Hartwell et al., 1973]. 
At the restrictive temperature, cdc9 mutants arrest in late S/G2 phase of the cell cycle and 
accumulate unligated Okazaki fragments that are joined upon shifting to permissive 
conditions [Bielinsky and Gerbi, 1999]. This suggested that cells replicate the whole 
genome leaving nicks behind for repair in G2 prior to entry into mitosis [Johnston and 
Nasmyth, 1978; Schiestl et al., 1989]. The G2 arrest of cdc9ts mutants is controlled by 
Rad9-dependent phosphorylation of the S phase checkpoint kinase Rad53, which is 
triggered when nicks are converted to double strand breaks (DSBs) [Emili, 1998; Naiki et 
al., 2004; Schiestl et al., 1989; Scott and Plon, 2003; Sweeney et al., 2005; Weinert and 
Hartwell, 1993]. However, we reported recently that the absence of DNA ligase I in more 
stringent cdc9ts  alleles caused a delay in S phase progression and activation of the S 
phase checkpoint kinase Rad53, which was mediated through both Mrc1, the mediator of 
the replication checkpoint [Alcasabas et al., 2001] and Rad9 (Chapter 2) [Das-Bradoo et 
al., 2010b]. This indicated that not only were DSBs present in cdc9ts mutants, but also 
stalled replication forks [Alcasabas et al., 2001; Emili, 1998; Naylor et al., 2009; Osborn 
and Elledge, 2003]. Importantly, robust activation of Rad53 in cdc9ts mutants required 
PCNA ubiquitination at a novel residue, K107 rather than K164, the well-known 
conserved site, which is ubiquitinated in response to DNA damaging agents such as UV-
irradiation or methyl methansulfonate (MMS) that induce stalled forks (Chapter 2) [Das-
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Bradoo et al., 2010b; Hoege et al., 2002]. We hypothesized that cells can distinguish the 
DNA structures arising from nicked DNA due to cdc9ts versus extended ssDNA regions 
caused by UV-irradiation or MMS exposure (Figure 3.3) [Das-Bradoo et al., 2010a]. 
How cells cope with the accumulation of such putative nicked replication intermediates 
and promote S phase progression is unknown. Several studies demonstrated that the 
inhibition of DNA ligase I activity in both yeasts and humans result in a higher incidence 
of DNA recombination [Barnes et al., 1992; Game et al., 1979; Henderson et al., 1985; 
Prigent et al., 1994]. In budding yeast, this notion is supported by the synthetic lethality 
between a recombination deficient mutant, rad52, and cdc9 mutants [Montelone et al., 
1981]. These results are consistent with the assumption that DSBs are formed in cdc9ts 
mutants that require repair by homologous recombination (HR).  
RAD52 is essential to promote DSB repair by HR, which is divided into two sub-
categories, RAD51-dependent and RAD51-independent pathways [Krogh and Symington, 
2004; Paques and Haber, 1999; Symington, 2002]. RAD51-dependent HR repairs most 
DSBs in mitotic cells by initiating strand invasion of a 3’-ssDNA tail following the 
formation of a Rad51 filament [Benson et al., 1998; Sugawara et al., 2000; Sugawara et 
al., 1995]. The alternative RAD51-independent pathway involves a single strand 
annealing (SSA) step, mediated by RAD52 and RAD59 for DSB repair between direct 
repeat sequences and in break-induced replication [Bai et al., 1999; Bai and Symington, 
1996; Fishman-Lobell and Haber, 1992; Ira and Haber, 2002; Ivanov et al., 1996; 
Jablonovich et al., 1999; Signon et al., 2001; Sugawara et al., 2000]. Additionally, genes 
involved in both the RAD51- and RAD59-pathways can promote recombination between 
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sister chromatids independently of DSBs via a template switching mechanism, which 
bypasses DNA lesions that inhibit the progression of the replicative DNA polymerases 
[Gangavarapu et al., 2007; Mott and Symington, 2011; Vanoli et al., 2010]. While genes 
involved in the RAD51-dependent pathway, but not RAD59, promote template switching 
in response to UV-light and MMS exposure [Gangavarapu et al., 2007; Vanoli et al., 
2010], RAD59 facilitates spontaneous mitotic recombination by template switching 
between inverted repeats [Mott and Symington, 2011]. Furthermore, biochemical studies 
demonstrating that the Rad52/Rad59 complex is distinct from the Rad51/Rad52 complex 
support the role of both RAD51- and RAD59-dependent pathways in DNA recombination 
events [Davis and Symington, 2001; 2003].   
In this study, we report that the accumulation of either “clean” (3’-OH and 5’-PO4 
termini) or “dirty” (DNA-adenylate; 3’-OH and 5’-AMP ends) nicks in cdc9-1 mutants 
triggered PCNA mono- and poly-ubiquitination at K107. Moreover, K107 ubiquitination 
was responsible for causing a severe delay in S phase progression. To identify pathways 
involved in nick resolution, we performed a synthetic genetic array (SGA) screen with 
cdc9-1 mutants and verified results by selected manual tetrad dissections. Besides the 
known requirement for genes involved in DSB repair via RAD51/RAD52-mediated HR, 
we uncovered strong genetic interactions with components of the RAD51-independent 
SSA pathway, comprising RAD59, RAD1, and RAD10. Surprisingly however, deletion of 
SLX4 (synthetically lethal with sgs1), a crucial component of SSA-mediated DSB repair 
[Flott et al., 2007; Toh et al., 2010], did not affect cdc9-1 mitotic growth. These results 
suggested that SSA might be dispensable for DSB repair in cdc9-1 cells. This was further 
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corroborated by the fact that the genetic requirement for RAD59 was much stronger than 
that for RAD1 and RAD10, arguing that the three genes did not necessarily act in the 
same pathway. Targeted analysis of RAD59 revealed that its deletion in cdc9-td mutants 
resulted in enhanced Mrc1 phosphorylation. We concluded that stalled replication forks 
accumulated more frequently in cdc9-td rad59! double mutants than cdc9-td cells. 
Together, these results uncover a role for non-canonical PCNA ubiquitination in 
facilitating S phase delay and for RAD59 in promoting slow fork progression when DNA 
ligase I is limiting.  
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Materials and methods 
Yeast strains.  
Yeast strains used in this study are isogenic derivatives of SSL204, YKL83, or the 
RDKY3615 background.  The genotypes of all the strains used in this study can be found 
in Table 4.1.  Strains were constructed using standard genetic methods [Brachmann et al., 
1998].  PCNA lysine mutants were generated as described in Chapter 2 [Das-Bradoo et 
al., 2010b].  
To construct the N-terminally tagged hemagglutinin (HA) MRC1 (3HA-MRC1) in 
the endogenous locus, two step PCR-mediated integration was performed as described 
elsewhere [Tong and Boone, 2006].  Briefly, two pairs of oligonucleotides were 
synthesized to amplify 3HA-MRC1 and the KanMX4 marker separately.  The 3HA-
MRC1, which includes 39 bp upstream and 288 bp downstream of its start and stop 
codons, respectively, was amplified from pRS405-3HA-MRC1 (a gift from D. Koepp, 
University of Minnesota) using 5’-CGTTATTCGCT TTTGAACT TATCACC-3’ and 5’-
GGGATCCGTCGACCTGCAGCGTACGGCAAGATGCTTTGAATACAGAACTG-3’. 
The resulting PCR product contains a 25 bp overlapping segment with the kanMX4 
cassette at the 5’ end (italicized sequence).  The KanMX4 gene was amplified using 5’-
CGTACGCTGCAGGTCGACGGATCCC-3’ and 5’-AGCTTCTGGAGTTCAATCAAC 
TTCTTCGGAAAAGATAAAAAACCAATCGATGAATTCGAGCTCGTTTTCG-3’ to 
create a fragment that overlapped with 40 bp immediately downstream of the endogenous 
MRC1 locus (underlined sequence).  PCR products were combined, denatured at 94°C for 
3 to 4 min, cooled to room temperature and transformed into the desired yeast strains.    
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Synthetic genetic array (SGA) analysis.  
A genome-wide screen for CDC9 genetic interactions was conducted as described 
[Baryshnikova et al., 2010a]. Briefly, a cdc9-1 mutant strain marked with 
a nourseothricin (NatMX4) resistance cassette and harboring the SGA haploid specific 
markers and reporter [Baryshnikova et al., 2010a] was mated the array of 4000 viable S. 
cerevisiae deletion mutants [Winzeler et al., 1999].  Nourseothricin- and geneticin-
resistant heterozygous diploid mutants were selected and sporulated and MATa cdc9-1 
double mutants were subsequently selected as described [Baryshnikova et al., 2010a].  In 
Figure 4.7a, and Supplementary Table S1, genetic interactions involving the pol32!, 
rad27!, and rad6! mutants were obtained from [Costanzo et al., 2010]. Genetic 
interactions involving all other deletion mutants and temperature-sensitive mutants were 
obtained from the most recent SGA dataset (C. Boone, unpublished data, 2 January 
2012). Both of these sources use SGA technology to compare query mutants to a 
collection of 4000 deletion mutants. PH designates alleles that came from Phil Hieter 
[Ben-Aroya et al., 2008; Ben-Aroya et al., 2010]. All genetic interactions were scored as 
described [Baryshnikova et al., 2010b]. 
To confirm the SGA results, all gene deletions were constructed in SSL204 MATa 
strain and crossed with an isogenic cdc9-1 MAT! strain (a gift from D. M. Livingston, 
University of Minnesota).  Diploid cells were sporulated at 25°C and dissected.  Plates 
were incubated for 3 to 5 days at either 25°C or 30°C.  All spore genotypes were 
determined by temperature sensitivity at 35°C and growth on minimal medium lacking 
leucine (for rad52!) and uracil (for all other deleted mutants). 
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Plasmids.  
 The CDC9 gene with its endogenous promoter was initially cloned into the 
vector pRS313 using the BamHI restriction site (pCDC9, a gift from D. M. Livingston, 
University of Minnesota).  pcdc9-N!60, pcdc9-K419A, and pcdc9-K598A plasmids were 
derived from the plasmid pCDC9 using Quikchange Lightning Site-Directed Mutagenesis 
(Agilent, Santa Clara, CA).  pChVLig-3HA was constructed by cloning two different PCR 
fragments into the vector pRS313.  Between the BamHI-XhoI sites of the pChVLig-3HA 
plasmid is the CDC9 promoter (CDC9pro, 449-bp) driving the expression of the 
Chlorella virus DNA ligase coding sequence (ChVLig, a gift from S. Shuman, Memorial 
Sloan Kettering Institute) that is followed by three HA tags at its C-terminus (BamHI-
CDC9pro-ClaI-ChVLig-3HA-XhoI) [Sriskanda et al., 1999]. To overexpress Chlorella 
virus DNA ligase, the ChVLig-3HA fragment was subcloned from the pChVLig-3HA 
plasmid into the pRS423gal vector (pgal) under the control of the GAL10 promoter using 
ClaI-XhoI sites (pgal-ChVLig-3HA). All constructs were confirmed by DNA sequence 
analysis. 
 
Complementation of cdc9-1 temperature sensitivity.   
 All exogenous Cdc9 plasmids and the pRS313-ChVLig-3HA plasmids were 
transformed into wild type, cdc9-1 and cdc9-1 pol30-K164R strains. 10-fold serial 
dilutions of cells were spotted on appropriate medium.  Plates were incubated for 2 to 3 
days at indicated temperatures. Temperature shift experiments were carried out as 
described (Chapter 2) [Das-Bradoo et al., 2010b].  Briefly, cells were grown overnight to 
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mid-log phase (OD600 = 0.6) at 25°C and shifted to the restrictive temperature of 35°C for 
3 hours.  For degron strains, cells were grown overnight at 28°C in YP plus 2% raffinose 
and supplemented with 10 uM CuSO4 to induce gene expression.  Once cells have grown 
to mid-log phase, cells were switched to YP plus 2% galactose without CuSO4 for an 
addition 30 min at 28°C and subsequently shifted to 37°C.     
 For the overexpression experiments of the ChVLig-3HA, both pgal and pgal-
ChVLIG-3HA plasmids were transformed into either wild type or cdc9-1 strains. 10-fold 
serial dilutions of cells were spotted on minimal medium lacking histidine (Sc-His), but 
containing either 2% glucose or 2% galactose.  Plates were incubated for 4 to 5 days at 
either 25°C or 35°C.  For temperature shift experiments, asynchronous cultures were 
grown overnight to mid-log phase at 25°C in Sc-His medium containing 2% raffinose.  
Cultures were split and shifted to 35°C for 3 hours in the presence of either 2% glucose 
or galactose. 
 
Characterization of GCR and CAN1 forward mutation rates.   
GCR rates and CAN1 forward mutation rates were determined as described [Chen 
et al., 1999; Motegi and Myung, 2007].  Briefly, the GCR or mutation rates from two 
independent isolates were determined by fluctuation analyses twice using the method of 
the median [Lea and Coulson, 1949].  Each experiment was performed using 11 cultures 
and the average value from two different clones is reported. 
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Sensitivity to UV, MMS and !-irradiation.  
Overnight cultures of the indicated strains were serially diluted and spotted onto 
YPD plates or YPD plates containing MMS.  For UV- or &-irradiation, strains were 
spotted onto YPD plates and irradiated as indicated.  Pictures were taken after 2 days 
incubation at 30°C. 
 
Protein preparation and western blot analysis.   
 Total protein extracts were prepared from cycling cells using TCA precipitation 
and protein expression was analyzed by immunoblotting [Ricke and Bielinsky, 2006].  
The endogenous Cdc9 and Rad53 proteins were detected using anti-Cdc9 (1:12000, a gift 
from A. E. Tomkinson, University of New Mexico) and anti-Rad53 (1:1000, a gift from 
J. F. Diffley, Cancer Research UK London Research Institute) antibodies, respectively.  
All HA-tagged proteins were detected using either an anti-HA (1:3000, 16B12, Covance) 
or anti-HA-HRP conjugated (1:250, 3F10, Roche) antibodies, respectively. Both 
unmodified and ubiquitinated forms of PCNA were detected using an anti-yeast PCNA 
antibody as described (1:4000, clone S871, a gift from Z. Zhang, Mayo Clinic MN and B. 
W. Stillman, Cold Spring Harbor Laboratory, NY) (Chapter 2) [Das-Bradoo et al., 
2010b].  For detection of mono-ubiquitinated PCNA, protein extracts were diluted prior 
to fractionating by SDS-PAGE gel electrophoresis as described (Chapter 2) [Das-Bradoo 
et al., 2010b].  a-tubulin served as a loading control.  
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Cell cycle and FACS Analysis.  
Cell cycle progression was monitored using flow cytometry as described  in 
Chapter 2 [Das-Bradoo et al., 2010b]. DNA was stained Sytox Green was used and all 
FACS samples were analyzed using a Becton Dickinson FACS Calibur. 
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Table 4.1  List of yeast strains used in this study. 
 
Strain Name Relevant Genotype Source 
 W303-derived strains  
YKL83 GAL-UBR1 (HIS3) [Labib et al., 
2000] 
ABy010 GAL-UBR1 (HIS3) bar1::LEU2 This Study 
ABy1643 GAL-UBR1 (HIS3) bar1::LEU2 MRC1::3HA-
MRC1(KanMX4) 
This Study 
ABy1596 GAL-UBR1 (HIS3) rad59::TRP1 Cl.1 This Study 
ABy1597 GAL-UBR1 (HIS3) rad59::TRP1 Cl.2 This Study 
ABy1654 GAL-UBR1 (HIS3) bar1::LEU2 MRC1::3HA-
MRC1(KanMX4) rad59::TRP1 
This Study 
ABy008 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td 
(URA3) 
This Study 
ABy1541 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td 
(URA3) MRC1::3HA-MRC1(KanMX4) 
This Study 
ABy1598 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td 
(URA3) rad59::TRP1 Cl.1  
This Study 
ABy1599 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td 
(URA3) rad59::TRP1 Cl.2  
This Study 
ABy1656 GAL-UBR1 (HIS3) bar1::LEU2 cdc9::cdc9-td 
(URA3) MRC1::3HA-MRC1(KanMX4) 
rad59::TRP1  
This Study 
 SSL204-derived strains  
SSL204 MATa ade2 his3!200 trp1 leu2 ura3-52 [Dornfeld and 
Livingston, 
1991] 
ABy1321 rad1::URA3 This study 
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Table 4.1  List of yeast strains used in this study (continued) 
ABy1323 rad10::URA3 This study 
ABy1325 rad14::URA3 This study 
ABy1451 slx4::URA3 This study 
ABy1407 rad59::URA3 This study 
ABy1430 rad51::URA3 This study 
ABy1537 exo1::URA3 Cl.1 This study 
ABy1538 exo1::URA3 Cl.2 This study 
ABy805 hxt13::URA3  This study 
SSL212A rad52! HS::LEU2 [Dornfeld and 
Livingston, 
1991] 
ABy1055 pRS313 This study 
ABy1056 pRS313-CDC9 This study 
ABy1127 pRS313-cdc9-K419A This study 
ABy1177 pRS313-cdc9-K598A This study 
ABy1086 pRS313-cdc9-N!60 This study 
ABy1185 pRS313-ChVLig-3HA This study 
ABy1277 pRS423gal This study 
ABy1278 pRS423gal-ChVLig-3HA This study 
ABy1146 pgal This study 
ABy1146 pgal-rad53-K221A/D339A (KD) This study 
ABy685 pol30::pol30K107R (LEU2) [Das-Bradoo et 
al., 2010b] 
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Table 4.1  List of yeast strains used in this study (continued) 
SSL612! cdc9-1 MAT"  ade2 his3!200 trp1 leu2 ura3-52 [Ireland et al., 
2000] 
 SSL612a (cdc9-1)-derived strains  
SSL612a cdc9-1 MATa  ade2 his3!200 trp1 leu2 ura3-52 [Ireland et al., 
2000] 
ABy1539 exo1::URA3 Cl.1 This study 
ABy1540 exo1::URA3 Cl.2 This study 
ABy807 hxt13::URA3  This study 
ABy1057 cdc9-1, pRS313 This study 
ABy1058 cdc9-1, pRS313-CDC9 This study 
ABy1128 cdc9-1, pRS313-cdc9-K419A This study 
ABy1087 cdc9-1, pRS313-cdc9-K598A This study 
ABy1178 cdc9-1, pRS313- cdc9-N!60 This study 
ABy1186 cdc9-1, pRS313-ChVLig-3HA This study 
ABy1279 cdc9-1, pRS423gal This study 
ABy1280 cdc9-1, pRS423gal-ChVLig-3HA This study 
ABy1148 pgal This study 
ABy1149 pgal-rad53-K221A/D339A (KD) This study 
ABy1439-4a cdc9-1 rad59::URA3 Cl.1 This study 
ABy1439-7c cdc9-1 rad59::URA3 Cl.2 This study 
ABy1439-13a cdc9-1 rad59::URA3 Cl.3 This study 
ABy1605 cdc9-1 pol30::pol30K164R (LEU2), pRS313 This study 
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Table 4.1  List of yeast strains used in this study (continued) 
ABy1606 cdc9-1 pol30::pol30K164R (LEU2), pRS313-CDC9 This study 
ABy1607 cdc9-1 pol30::pol30K164R (LEU2), pRS313-cdc9-
K419A 
This study 
ABy1608 cdc9-1 pol30::pol30K164R (LEU2), pRS313-cdc9-
K598A 
This study 
ABy1609 cdc9-1 pol30::pol30K164R (LEU2),  pRS313- cdc9-
N!60 
This study 
ABy872 cdc9-1* pol30::pol30K107R (LEU2) [Das-Bradoo et 
al., 2010b] 
 RDKY3615-derived strains  
RDKY3615 ura3-52, leu2#1, trp1#63, his3#200, lys2#Bgl, 
hom3-10, ade2#1, ade8, htx13::URA3 
[Chen and 
Kolodner, 1999] 
RDKY3735 sml1::KanMX, mec1::HIS3 [Myung et al., 
2001] 
YKJM5789 pol30::HIS3, YCPlac22-POL30 This study 
YKJM5799 pol30::HIS3, YCPlac22-pol30-K183R This study 
YKJM5985 pol30::HIS3, YCPlac22-pol30-K107R This study 
YKJM5986 pol30::HIS3, YCPlac22-pol30-K117R This study 
YKJM5988 pol30::HIS3, YCPlac22-pol30-K127R This study 
YKJM5989 pol30::HIS3, YCPlac22-pol30-K127/164R This study 
YKJM5991 pol30::HIS3, YCPlac22-pol30-K164R This study 
 
  
 
143 
Results 
Accumulation of nicked DNA due to DNA ligase I deficiency triggers PCNA 
ubiquitination independently of lysine 164. 
The depletion of Cdc9 in S. cerevisiae drastically slows down S phase progression 
(Figure 3.1) [Das-Bradoo et al., 2010a]. Specifically, the loss of DNA ligase I triggers a 
novel ubiquitination pathway that targets PCNA at a lysine residue distinct from K164 
and acts upstream of S phase checkpoint activation (Figure 2.14) [Das-Bradoo et al., 
2010b]. However, it was still unclear what molecular defect caused PCNA ubiquitination 
in cdc9 mutants. We envisioned three possible scenarios that could arise when DNA 
ligase I is limiting. First, cells could  directly sense the accumulation of nicks; second, 
cells might recognize the absence of the PCNA-Cdc9 interaction or third, because cdc9 
mutants are known to be highly mutagenic [Montelone et al., 1981], secondary defects 
unrelated to the generation of nicks could cause the ubiquitination of PCNA.   
To distinguish between these different scenarios, we complemented cdc9-1, and 
cdc9-1 pol30-K164R (PCNA-K164R) cells with plasmids expressing either wild-type or 
mutant Cdc9 under its endogenous promoter. As a control, these plasmids were also 
introduced into wild-type cells (Figure 4.1). As expected, expression of wild-type CDC9 
rescued the temperature sensitivity of cdc9-1 mutants at 35°C (Figure 4.1a). In addition, 
we introduced two plasmids carrying DNA ligase I mutations in the active center of the 
enzyme, pcdc9-K419A and pcdc9-K598A. Cdc9-K419 is critical for the covalent binding 
of AMP in the first step of ligation and mutation of this residue results in the 
accumulation of “clean” nicks, whereas Cdc9-K598 is important for the final DNA de-
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adenylation step, and substitution of this residue with alanine results in the accumulation 
of “dirty” nicks [Sriskanda et al., 1999; Subramanian et al., 2005; Tomkinson et al., 
1991]. Neither of the two catalytically inactive Cdc9 mutants allowed cdc9-1 cells to 
grow at the restrictive temperature (Figure 4.1a). In contrast, deletion of the PIP-box 
motif in Cdc9 (pcdc9-N!60), which abolishes the interaction with PCNA [Subramanian 
et al., 2005], had no effect on the ability to rescue cdc9-1 at 35°C. Lastly, cdc9-1 mutants 
expressing PCNA-K164R (cdc9-1 pol30-K164R), which renders cells sensitive to UV-
irradiation and MMS [Hoege et al., 2002], did not exhibit any additional temperature 
sensitivity as compared to cdc9-1 single mutants (Figure 4.1a). These results indicated 
that the survival of cdc9-1 mutants did not depend on K164 of PCNA, but rather solely 
on the reconstitution of DNA ligase I activity.  
In parallel to testing cell viability, we also monitored DNA ligase I expression 
levels and the status of PCNA modification at 35°C (Figures 4.1b and c). PCNA is 
ubiquitinated, likely at K107, and sumoylated at either K127 or K164 in cdc9-1 mutants 
(Figures 2.14 and 3.2) [Das-Bradoo et al., 2010a; Das-Bradoo et al., 2010b]. Consistent 
with an earlier report (Chapter 2) [Das-Bradoo et al., 2010b], we detected four different 
PCNA species in cdc9-1 cells that carried an empty vector (Figure 4.1b): unmodified 
PCNA (29 kDa), mono-ubiquitinated PCNA (39 kDa), and putatively poly-ubiquitinated 
PCNA (at ~52 and 76 kDa). However, it was possible that a single PCNA monomer 
could be simultaneously sumoylated (at K164) and ubiquitinated (at K107). Indeed, a 
K164R substitution in PCNA diminished the 76 kDa band in cdc9-1 cells (Figure 4.1c, 
compare lanes 2 and 3). Thus, the 76 kDa band most likely represented PCNA that was 
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di-ubiquitinated at K107 and sumoylated at K164 (marked as Ub2/S164-PCNA in Figures 
4.1b and c). In contrast, the 39 kDa and ~52 kDa bands represented solely mono- and di-
ubiquitinated PCNA species, respectively (marked as Ub1-PCNA and Ub2-PCNA in 
Figures 4.1b and c), as reported (Figure 2.6b) [Das-Bradoo et al., 2010b].        
Importantly, when we complemented cdc9-1 cells with wild-type Cdc9 (cdc9-1 + 
pCDC9), both PCNA mono- and poly-ubiquitination were abolished (Figure 4.1b). 
Because PCNA ubiquitination is readily detectable at 25°C (Figure 2.6a) [Das-Bradoo et 
al., 2010b], the disappearance of the ubiquitinated PCNA molecules presented a true 
reversal of the ubiquitination response. This result allowed us to exclude nonspecific, 
secondary effects as a trigger of PCNA ubiquitination. Moreover, expression of the Cdc9 
PIP-box mutant (cdc9-1 + pcdc9-N!60) also reversed PCNA mono- and poly-
ubiquitination, making it highly unlikely that cells recognized the absence of PCNA-
Cdc9 interaction (Figure 4.1b). To further corroborate this notion, we examined the 
ability of Chlorella virus DNA ligase (ChVLig) to complement the DNA ligase I 
deficiency in yeast. ChVLig is the smallest known ATP-dependent ligase [Ho et al., 
1997], containing only a conserved catalytic core that consists of a nucleotidyltransferase 
(NTase) and an oligonucleotide/oligosaccharide binding (OB)-fold domain [Nair et al., 
2007]. Since ChVLig has no additional domains beyond its NTase-OB core, it does not 
interact with PCNA. When we expressed ChVLig-3HA under the control of the CDC9 
promoter, it only partially rescued the temperature sensitivity of cdc9-1 mutants (cdc9-1 
+ pChVLig-3HA) at 33°C, but not at 35°C at which temperature PCNA mono-
ubiquitination remained visible (Figures 4.2a and b). However, upon overexpression of 
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ChVLig-3HA from a galactose-inducible promoter we rescued cdc9-1 temperature 
sensitivity and reversed PCNA mono-ubiquitination (Figures 4.2c and d). Thus, the 
ligation of nicks appeared to eliminate PCNA ubiquitination in the complete absence of a 
PCNA-DNA ligase interaction. This was further substantiated by the observation that 
PCNA ubiquitination remained unchanged in cdc9-1 cells that were complemented with 
either pcdc9-K419A or pcdc9-K598A, encoding two different catalytically inactive forms 
of DNA ligase I, which retain PCNA binding activity (Figure 4.1b). Importantly, similar 
alterations to the ubiquitination pattern of PCNA (Ub1-PCNA and Ub2-PCNA) were 
observed in cdc9-1 pol30-K164R mutants after complementation with different DNA 
ligase I constructs (Figure 4.1c). These data suggest that cells induce PCNA mono- and 
poly-ubiquitination independently of K164 in response to nicked DNA. Because we have 
demonstrated that PCNA ubiquitination disappears in a viable cdc9-1 pol30-K107R 
double mutant (Figure 2.14a) [Das-Bradoo et al., 2010b], we postulate that PCNA 
ubiquitinated at K107 (PCNAK107-Ub) functions as a nick sensor at replication forks in 
budding yeast. 
 
PCNA ubiquitination at K107 is important for the S phase delay in cdc9-1 cells. 
PCNAK107-Ub is a prerequisite to activate the S phase checkpoint kinase Rad53 in 
cdc9ts mutants (Figure 2.14e) [Das-Bradoo et al., 2010b]. Although most cdc9-1 pol30-
K107R double mutants were synthetically lethal after tetrad dissection, we were able to 
isolate a viable double mutant with slightly increased DNA ligase I levels, designated as 
cdc9-1* pol30-K107R (Figures 2.13 and 2.14) [Das-Bradoo et al., 2010b]. Because 
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robust Rad53 activation was drastically reduced in pol30-K107R mutants upon DNA 
ligase I depletion, we predicted that cdc9-1* pol30-K107R mutants would readily 
progress through S phase. Therefore, we monitored cell cycle progression of cdc9-1, 
cdc9-1* pol30-K107R, and their respective parental strains (Figure 4.3a). Because cdc9-
1* pol30-K107R mutants are severely more temperature sensitive than cdc9-1 cells 
(Figure 2.13b) [Das-Bradoo et al., 2010b], we performed the temperature shift 
experiments at 30°C instead of 35°C. Neither CDC9 nor CDC9 pol30-K107R strains 
exhibited any cell cycle defects at 30°C (Figure 4.3a). However, cdc9-1 cells 
accumulated in, and progressed through, S phase very slowly after 1.5 and 3h 
temperature shifts. In contrast, cdc9-1* pol30-K107R mutants did not exhibit a delay in S 
phase and accumulated in G2, likely due to segregation defects (Figure 4.3a). These 
results support the notion that PCNA ubiquitination at K107 facilitates robust activation 
of Rad53, which is responsible for the observed S phase delay. In line with this notion, 
galactose-induced overexpression of a dominant negative Rad53 kinase-dead mutant 
(Rad53-K221A/D339A) [Pellicioli et al., 1999; Szyjka et al., 2008] also completely 
suppressed the accumulation of cdc9-1 cells in S phase (compare galactose on the left vs. 
glucose on the right in Figure 4.3b).   
Because K107 of PCNA appeared to have an important role in S phase checkpoint 
activation in cdc9 mutants, we asked whether a K107R substitution exhibited any effect 
on the growth or DNA damage signaling in DNA ligase I-proficient cells. We tested UV- 
and gamma irradiation as well as MMS, but did not detect any growth sensitivity (Figure 
4.4a). In parallel, we also determined the rate of spontaneous mutations by testing 
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resistance to canavanine. In this assay, the K107R mutant displayed a slightly elevated 
mutation frequency comparable to that of K164R and K183R mutants (Figure 4.4b). 
These results are consistent with the idea that PCNA ubiquitination at K107 is specific to 
nicked replication intermediates that persist during lagging strand synthesis. 
 
Identification of the DNA repair network in cdc9-1 mutants. 
 To elucidate the pathways that are crucial to cope with the accumulation of nicked 
DNA during DNA replication, we conducted a SGA screen using the cdc9-1 mutation as 
the query strain, which was mated with approximately 4000 array strains carrying single 
deletions of non-essential genes [Baryshnikova et al., 2010a]. The fitness of the double 
mutants was scored quantitatively by colony size at the semi-permissive temperature of 
30°C [Baryshnikova et al., 2010b].  We observed synthetic sickness between cdc9-1 and 
rad9! (Table 4.2), in accordance with the documented role of RAD9 in response to DNA 
damage [Das-Bradoo et al., 2010b; Schiestl et al., 1989; Scott and Plon, 2003; Weinert 
and Hartwell, 1993]. Since Rad9 functions primarily in response to DSBs [Naiki et al., 
2004], the synthetic sickness of the cdc9-1 rad9! double mutants indicates that some of 
the nicks in cdc9-1 cells are converted to DSBs. Indeed, the rate for gross chromosomal 
rearrangements (GCRs) in cdc9-1 mutants was 30-fold elevated over wild-type (Figure 
4.5), indicative of the presence of spontaneous DSBs. 
The MRX (Mre11-Rad50-Xrs2) complex is the primary sensor of DSBs and 
crucial to initiate HR [Symington, 2002]. Consistent with the presence of DSBs in cdc9-1 
cells, we also identified synthetic sickness between cdc9-1 and mre11! in our screen 
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(Table 4.2), in line with the reported negative genetic interaction between cdc9 and 
rad50! [Davierwala et al., 2005; Symington, 2002]. Curiously, RAD52, a major HR 
component was not synthetically lethal with the cdc9-1 allele in the SGA screen, 
although cdc9 rad52 double mutants have been reported to be synthetically lethal [Ireland 
et al., 2000; Montelone et al., 1981]. Because cdc9-1 mutants are highly mutagenic 
[Montelone et al., 1981], we postulate that the cdc9-1 rad52! double mutants on the 
array likely accumulated a second site suppressor that allowed these mutants to grow at a 
similar rate as cdc9-1 cells. To ensure that our cdc9-1 strain exhibited the same genetic 
properties as described in the literature, we manually crossed it with rad51! and rad52! 
cells, respectively. As expected, we were not able to isolate any viable cdc9-1 rad51! or 
cdc9-1 rad52! double mutants, indicating that RAD51/RAD52-mediated HR is essential 
for survival (Figures 4.6a, b and g). Because our primary interest was the identification of 
novel factors that facilitate nick resolution and promote replication fork progression in 
cdc9-1 cells, we focused on genes participating in pathways different from HR. 
 
The single strand annealing proteins, Rad59, Rad1, and Rad10 but not Slx4 are 
important for cdc9-1 survival. 
  Besides genes involved in DSB repair, we observed that cdc9-1 has genetic 
interactions with genes involved in the nucleotide excision repair (NER) pathway, RAD1 
and RAD14 (Figures 4.7a and g). Strikingly, deletions of RAD1 and RAD14 showed 
drastically opposite effects (Figures 4.7a and g). Whereas the loss of RAD1 decreased 
viability, the deletion of RAD14 promoted cell growth, suggesting that RAD1 and RAD14 
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have independent roles in cdc9-1 mutants. Rad1 interacts with Rad10 to form a structure-
specific endonuclease, a homolog of the XPF/ERCC1 (for Xeroderma pigmentosum 
group F/Excision repair cross-complementing rodent repair deficiency, complementation 
group 1) complex in humans [Bailly et al., 1992; Sung et al., 1993]. During NER, Rad14 
recruits the Rad1-Rad10 endonuclease to the site of DNA damage to incise 5’ of the 
lesion [Guzder et al., 2006]. Besides NER, the Rad1-Rad10 endonuclease has been 
implicated in the SSA pathway, a form of Rad51-independent repair that acts at DSBs 
and stalled replication forks between small repeat regions [Ivanov and Haber, 1995; Mott 
and Symington, 2011; Schiestl and Prakash, 1988; 1990]. Importantly, the role of Rad1-
Rad10 in SSA is independent of Rad14 [Guzder et al., 2006], which offered an 
explanation for the contrasting interactions with cdc9-1 (Figures 4.7a and g) and 
prompted us to direct our attention to RAD59, another known component of the SSA 
pathway [Ivanov et al., 1996; Jablonovich et al., 1999].  Indeed, we also observed a 
negative genetic interaction between RAD59 and cdc9-1 (Table 4.2). Based on these 
results, we hypothesized that RAD1 and RAD59 could possibly function in the same 
pathway in cdc9-1 mutants and independently of RAD14.   
 To validate the genetic interactions identified in the SGA screen, we constructed 
cdc9-1 rad1!, cdc9-1 rad14 and cdc9-1 rad59! double mutants. Curiously, since RAD1 
interacts genetically and physically with RAD10 in both NER and the SSA pathway 
[Schiestl and Prakash, 1988; 1990; Sung et al., 1993], we were surprised that Rad10 did 
not elicit any genetic interaction in our SGA screen. Thus, we also generated cdc9-1 
rad10! double mutants to perform tetrad analysis. We were able to validate the 
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separation of function between RAD1 and RAD14 in cdc9-1 cells, as we observed 
synthetic sickness in cdc9-1 rad1!  mutants, but improved fitness in cdc9-1 
rad14! mutants at 30°C (Figure 4.7b and d). The two different double mutants grew 
comparably to cdc9-1 cells at 25°C, indicating that the differential growth phenotype at 
30°C was due specifically to the loss of DNA ligase I. Similar to cdc9-1 rad1! double 
mutants, deletion of RAD10 also reduced cdc9-1 viability at 30°C but not at 25°C (Figure 
4.7c), suggesting a role for the Rad1-Rad10 endonuclease in maintaining cell growth in 
cdc9-1 cells. Surprisingly, in a manner more severe than rad1! and rad10!, we did not 
observe any viable cdc9-1 rad59! spores at 30°C, suggesting that RAD59 was crucial for 
the survival of cdc9-1 cells at the semi-permissive temperature (Figure 4.7e). At 25°C, 
however, cdc9-1 rad59! mutants were viable although the spores grew significantly 
slower than cdc9-1 cells (Figure 4.7e). Since RAD1, RAD10 and RAD59 have been 
indicated to function in both DSB repair as well as template switching at stalled 
replication forks [Bai et al., 1999; Bai and Symington, 1996; Fishman-Lobell and Haber, 
1992; Flott et al., 2007; Mott and Symington, 2011], we examined the genetic interaction 
between cdc9-1 and SLX4, an essential gene required for DSB repair by SSA between 
direct repeats [Flott et al., 2007]. We did not observe any differences in the growth 
phenotypes of cdc9-1 single and cdc9-1 slx4! double mutants at 25°C or 30°C (Figure 
4.7f). This accurately reflected the result of our SGA screen in which we did not observe 
a genetic interaction between cdc9-1 and slx4!. Altogether, these newly uncovered 
genetic interactions indicated that RAD59 and RAD1/RAD10 were irrelevant for DSB 
  
 
152 
repair per se in cdc9-1 cells. This was supported by the differential requirement for 
Rad59 and the Rad1-Rad10 complex, which is inconsistent with all three proteins acting 
in concert to perform SSA.  
 
Deletion of RAD59 resulted in an increase of stalled forks in cdc9 mutants. 
 To better understand the role of Rad59 in cdc9 mutants, we deleted RAD59 in a 
cdc9-td strain, which expresses DNA ligase I when copper is added to the medium and 
grows similar to wild-type cells at the permissive temperature. cdc9-td rad59! mutants 
grew similar to wild-type and rad59! mutants on glucose at 28°C (Figure 4.8a). In 
contrast, when cdc9-td rad59! mutants were spotted on 2% galactose, cell growth was 
inhibited, even when additional copper was added to express Cdc9. The phenotype was 
further exacerbated at 37°C, which facilitated degradation of Cdc9-td. The growth 
phenotype of cdc9-td rad59! mutants was thus very similar to that of cdc9-1 rad59! 
cells (Figures 4.7e and 4.8a).   
Besides its well-documented role in break-induced replication [Mizuno et al., 
2009; Paek et al., 2009], Rad59 has recently been implicated to function at stalled 
replication forks to promote spontaneous recombination between inverted repeats [Mott 
and Symington, 2011]. Furthermore, a different study in S. pombe provided evidence that 
Rad52 could associate with stalled replication forks independently of Rad51 [Irmisch et 
al., 2009]. Since Rad52 forms distinct complexes with either Rad51 or Rad59 [Davis and 
Symington, 2001; 2003], we postulated that Rad52/Rad59 might be active at stalled 
replication forks in cdc9 mutants.  Because PCNAK107-Ub likely resides at stalled forks 
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(Chapter 2) [Das-Bradoo et al., 2010b], we first determined whether deletion of RAD59 
had any effect on the status of PCNA ubiquitination. When we shifted both cdc9-1 
rad59! and cdc9-td rad59! to their non-permissive temperatures, PCNAK107-Ub remained 
intact in the double mutants compared to the single mutants (Figure 4.8b). These data 
suggested that RAD59 functions either downstream of PCNAK107-Ub or in a parallel 
pathway. If RAD59 were to function downstream of PCNA ubiquitination to promote 
Rad53 checkpoint activation, we predicted that cdc9-td rad59! double mutants should 
exhibit reduced Rad53 activation. To determine whether Mrc1-mediated activation of 
Rad53 is reduced in these mutants, we examined the phosphorylation status of both Mrc1 
and Rad53 [Alcasabas et al., 2001; Osborn and Elledge, 2003]. To our surprise, we 
observed an increase in Mrc1 and Rad53 hyper-phosphorylation in cdc9-td rad59! as 
compared to cdc9-td cells (Figure 4.9). These findings are consistent with the notion that 
Rad59 plays a role to promote replication fork progression through S phase in the 
absence of DNA ligase I and is required to relieve Rad53 activation.  
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Figure 4.1
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Figure 4.1  Defects in DNA ligase I trigger PCNA mono- and poly-ubiquitination 
independently of lysine 164.  
(a) Successive 10-fold dilutions of ABy1055 (CDC9 + pEV), ABy1056 (CDC9 + 
pCDC9), ABy1127 (CDC9 + pcdc9-K419A), ABy1086 (CDC9 + pcdc9-K598A), 
ABy1177 (CDC9 + pcdc9-N!60), ABy1057 (cdc9-1 + pEV), ABy1058 (cdc9-1 + 
pCDC9), ABy1128 (cdc9-1 + pcdc9-K419A), ABy1087 (cdc9-1 + pcdc9-K598A), 
ABy1178 (cdc9-1 + pcdc9-N!60), ABy1605 (cdc9-1 pol30-K164R + pEV), ABy1606 
(cdc9-1 pol30-K164R + pCDC9), ABy1607 (cdc9-1 pol30-K164R + pcdc9-K419A), 
ABy1608 (cdc9-1 pol30-K164R + pcdc9-K598A), and ABy1609 (cdc9-1 pol30-K164R + 
pcdc9-N!60) were grown on Sc-His plates for 3 days at the indicated temperatures.  (b, 
c) All strains in a were grown asynchronously to mid-log phase at 25°C.  Subsequently, 
cultures were shifted to the restrictive temperature of 35°C for 3 hours.  PCNA and its 
ubiquitinated forms, and Cdc9 were detected with anti-PCNA (S871), anti-Cdc9, 
respectively.  !-tubulin served as a loading control.  Asterisks indicate non-specific 
bands.  Ub, ubiquitin and S164, SUMO at K164. 
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Figure 4.2 
!
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Figure 4.2  Overexpression of Chlorella virus DNA ligase fully complements cdc9-1 
temperature sensitivity and PCNA ubiquitination.   
(a) Successive 10-fold dilutions of ABy1055 (CDC9 + pRS313), ABy1177 
(CDC9 + pcdc9-N!60), ABy1185 (CDC9 + pChVLig-3HA), ABy1057 (cdc9-1 + 
pRS313), ABy1178 (cdc9-1 + pcdc9-N!60), and ABy1186 (cdc9-1 + pChVLig-3HA) 
were grown on Sc-His plates for 3 days at the indicated temperatures. Note: The 
expression of Chlorella virus DNA ligase in pChVLig-3HA plasmid is under the CDC9 
promoter.  (b) All strains in a were grown asynchronously to mid-log phase at 25°C.  
Subsequently, cultures were shifted to the restrictive temperature of 35°C for 3 hours.  
PCNA and its ubiquitinated forms, Cdc9 and ChVLig-3HA were detected with anti-
PCNA (S871), anti-Cdc9, and anti-HA antibodies, respectively.  (c) Successive 10-fold 
dilutions of ABy1277 (CDC9 + pRS423gal), ABy1278 (CDC9 + pRS423gal-ChVLig-
3HA), ABy1279 (cdc9-1 + pRS423gal), and ABy1280 (cdc9-1 + pRS423gal-ChVLig-
3HA) were grown on Sc-His plates containing either 2% glucose or 2% galactose for 5 
days at 25°C and 35°C. Note: The expression of Chlorella virus DNA ligase in 
pRS423gal-ChVLig-3HA plasmid is under the GAL10 promoter.  (d) Yeast trains in c 
were grown asynchronously to mid-log phase in medium containing 2% raffinose at 
25°C.  Cultures were split and grown in the presence of either 2% glucose or 2% 
galactose at the restrictive temperature of 35°C for 3 hours. PCNA and its ubiquitinated 
forms, Cdc9 and ChVLig-3HA were detected with anti-PCNA (S871), anti-Cdc9, and 
anti-HA antibodies, respectively.  In b and c, !-tubulin served as a loading control. 
Asterisks indicate non-specific bands. 
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Figure 4.3 
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Figure 4.3 PCNA ubiquitination at K107 is crucial for the S phase arrest in cdc9-1 
mutants.   
(a) Asynchronous cultures of SSL204 (CDC9), ABy685 (CDC9 pol30-K107R), 
SSL612 (cdc9-1), ABy782 (cdc9-1* pol30-K107R) were grown at 25°C and shifted to 
30°C for 1.5h and 3h. (b) Asynchronous cultures of ABy1146 (CDC9 + pEV), ABy1147 
(CDC9 + prad53-KD), ABy1148 (cdc9-1 + pEV), ABy1149 (cdc9-1 + prad53-KD) were 
grown at 25°C and shifted to 35°C for 1.5h and 3h in the presence of 2% galactose.  On 
the right, the same asynchronous ABy1149 culture at 25°C was split and grown in the 
presence of 2% glucose for 1.5h and 3h.  In a and b, DNA was strained with Sytox Green 
and was monitored by flow cytometry.  The vertical line indicates a 2C DNA content. 
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Figure 4.4 
 
Figure 4.4 Differential DNA damage sensitivity and canavanine of various PCNA 
mutants.  
(a) Successive 10-fold dilutions of either wild-type or different PCNA lysine to 
arginine mutants were grown on rich medium plates and treated with different DNA 
damaging agents as indicated.  mec1! sml1! strain was used as a negative control. (b) 
CAN1 forward mutation analysis of two independent isolates of different PCNA mutants 
was analyzed. Briefly, mutation rates from two independent isolates were determined by 
fluctuation analyses twice using the method of the median [Lea and Coulson, 1949].  
Each experiment was performed using 11 cultures and the average value from two 
different clones is reported. 
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Figure 4.5 
 
Figure 4.5 cdc9-1 mutants exhibit enhanced gross chromosomal rearrangements 
(GCR).  
GRC rates of wild-type and cdc9-1 cells were analyzed as described [Chen and 
Kolodner, 1999; Motegi and Myung, 2007].  Briefly, GCR rates from two independent 
isolates were determined by fluctuation analyses twice using the method of the median 
[Lea and Coulson, 1949].  Each experiment was performed using 11 cultures and the 
average value from two different clones is reported. 
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Figure 4.6 
 
Figure 4.6  RAD51/RAD52-mediated homologous recombination is required for 
cdc9-1 survival.   
Diploid strains were dissected and incubated at either 25°C.  All haploid 
genotypes are as indicated. Four independent tetrads (1-4) are laid out horizontally. (a) 
Segregates from CDC9/cdc9-1 rad51!/RAD51 diploid.  (b) Segregates from CDC9/cdc9-
1 rad52!/RAD52 diploid. 
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Figure 4.7 
 
 
Figure 4.7 Genetic interactions of RAD1, RAD10, RAD14, and RAD59 with cdc9-1 
mutants.  
(a) Heatmap indicating strong positive (green) or negative (red) interactions 
between cdc9-1 and rad14!, rad1! or rad59!, respectively. Black indicates no genetic 
interaction. Gray indicates that the interaction could not be scored. Among a collection of 
approximately 1800 SGA queries, only scl1! mutants displayed a genetic interaction 
signature similar to that of cdc9-1 with respect to these three mutants. Other query 
mutants that exhibited similar genetic interactions with two out of the three genes are 
  
 
164 
shown as well as rad27!, which exhibited synthetic sickness with rad59!. PH indicates 
strains received from Phil Hieter. The heatmap was generated based on previously 
published [Costanzo et al., 2010] and new SGA screens in Supplementary Table S1. (b-f) 
Selected diploid strains were dissected and incubated at either 25°C or 30°C. All haploid 
genotypes are as indicated on the right. Four independent tetrads (1-4) are laid out 
horizontally. The diploid strain genotypes are as followed: (b) CDC9/cdc9-1 
rad1!/RAD1, (c) CDC9/cdc9-1 rad14!/RAD14, (d) CDC9/cdc9-1 rad10!/RAD10, (e) 
CDC9/cdc9-1 rad59!/RAD59, (f) CDC9/cdc9-1 slx4!/SLX4. (g) A Venn diagram 
summarizes some of the pertinent genetic interactions with cdc9-1 mutants identified in 
this study. Genes are grouped into their respective repair pathways, homologous 
recombination (HR), HR-mediated single-strand annealing (SSA), and nucleotide 
excision repair (NER). Negative and positive genetic interactions with cdc9-1 mutants 
identified in our SGA screen are illustrated as red and green solid lines, respectively. Red 
dotted lines indicate negative interactions with cdc9-1 mutants that were only observed 
from manual tetrad analysis. No genetic interaction was observed between SLX4 and 
cdc9-1. 
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Figure 4.8 
 
 
Figure 4.8 Deletion of RAD59 in cdc9 mutants does not affect PCNA mono-
ubiquitination.  
(a) Successive 10-fold dilutions of the indicated strains were grown on YP plates 
containing either 2% glucose or 2% galactose at 28°C and 37°C. Cells were also spotted 
on YP + 2% gal plates containing extra copper at 28°C to maintain wild-type Cdc9 
expression in cdc9-td strains. (b) cdc9 rad59! double mutants were grown at the 
permissive temperature and subsequently shifted to the indicated temperatures for 3hr. 
PCNA and its mono-ubiquitinated form were detected with anti-PCNA antibody (S871).  
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Figure 4.9 
 
 
 
Figure 4.9 Deletion of RAD59 in cdc9 mutants displayed an increase in Mrc1 and 
Rad53 phosphorylation. 
 (a) Asynchronous cultures of the indicated strains were grown at 25°C and 
subsequently shifted to 30°C for 90 or 180 min. Unmodified and phosphorylated Rad53 
was detected using an anti-Rad53 antibody. (b and c) Asynchronous cultures were grown 
at 28°C and subsequently shifted to 37°C for the indicated time. Cdc9-td-HA and 
unmodified and phosphorylated 3HA-Mrc1 and Rad53 levels were monitored using an 
anti-HA and anti-Rad53 antibody, respectively. !-tubulin was used as a loading control. 
a 
b 
c 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA.  
Genetic interactions were scored according to [Baryshnikova et al., 2010b] and only those with the epsilon scores either ! < -0.09 or ! 
> 0.09 and p-values < 0.15 were included. Genetic interactions are listed from the smallest to largest !-scores.  
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YKR049C FMP46 -0.6638 3.70E-20 
YDL164C CDC9-1 YOL002C IZH2 -0.5145 2.34E-12 
YDL164C CDC9-1 YMR031W-A YMR031W-A -0.4117 1.45E-02 
YDL164C CDC9-1 YJR100C AIM25 -0.3881 1.38E-04 
YDL164C CDC9-1 YGL235W YGL235W -0.355 6.29E-04 
YDL164C CDC9-1 YJR011C YJR011C -0.3445 2.77E-04 
YDL164C CDC9-1 YDR156W RPA14 -0.3395 9.72E-08 
YDL164C CDC9-1 YLR184W YLR184W -0.3257 7.11E-04 
YDL164C CDC9-1 YMR026C PEX12 -0.3203 1.21E-04 
YDL164C CDC9-1 YBR215W HPC2 -0.311 9.95E-04 
YDL164C CDC9-1 YKL168C KKQ8 -0.286 6.48E-03 
YDL164C CDC9-1 YJL101C GSH1 -0.2726 2.95E-04 
YDL164C CDC9-1 YKL044W YKL044W -0.266 7.95E-03 
YDL164C CDC9-1 YKL171W NNK1 -0.2613 1.93E-03 
YDL164C CDC9-1 YKL188C PXA2 -0.2491 1.85E-02 
YDL164C CDC9-1 YML047C PRM6 -0.2486 4.66E-07 
YDL164C CDC9-1 YIL161W YIL161W -0.2479 5.16E-05 
YDL164C CDC9-1 YLR227C ADY4 -0.2436 1.15E-03 
YDL164C CDC9-1 YMR244C-A YMR244C-A -0.2435 2.49E-03 
YDL164C CDC9-1 YFR040W SAP155 -0.2391 1.97E-03 
YDL164C CDC9-1 YNL013C YNL013C -0.2309 5.50E-03 
YDL164C CDC9-1 YGR270W YTA7 -0.2281 4.79E-04 
YDL164C CDC9-1 YML041C VPS71 -0.2076 1.58E-02 
YDL164C CDC9-1 YHR180W YHR180W -0.2066 0.00E+00 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YKL184W SPE1 -0.2058 1.59E-02 
YDL164C CDC9-1 YMR029C FAR8 -0.2015 1.37E-02 
YDL164C CDC9-1 YPL022W RAD1 -0.1954 1.31E-01 
YDL164C CDC9-1 YML090W YML090W -0.1902 3.34E-03 
YDL164C CDC9-1 YGL045W RIM8 -0.1897 3.27E-02 
YDL164C CDC9-1 YCR102C YCR102C -0.1881 5.83E-32 
YDL164C CDC9-1 YML042W CAT2 -0.1856 2.57E-02 
YDL164C CDC9-1 YIR001C SGN1 -0.1809 5.65E-02 
YDL164C CDC9-1 YLR122C YLR122C -0.1744 1.45E-02 
YDL164C CDC9-1 YLL043W FPS1 -0.1705 7.09E-02 
YDL164C CDC9-1 YMR241W YHM2 -0.1704 2.63E-02 
YDL164C CDC9-1 YGR281W YOR1 -0.169 2.23E-03 
YDL164C CDC9-1 YML051W GAL80 -0.1679 1.92E-02 
YDL164C CDC9-1 YGR231C PHB2 -0.1643 1.30E-02 
YDL164C CDC9-1 YKR035W-A DID2 -0.1598 5.49E-02 
YDL164C CDC9-1 YDL013W HEX3 -0.1593 5.20E-02 
YDL164C CDC9-1 YNL111C CYB5 -0.1582 7.53E-03 
YDL164C CDC9-1 YDR532C KRE28 -0.1573 4.68E-05 
YDL164C CDC9-1 YMR030W RSF1 -0.1548 1.40E-01 
YDL164C CDC9-1 YJL110C GZF3 -0.1545 8.38E-02 
YDL164C CDC9-1 YKL064W MNR2 -0.1545 3.68E-02 
YDL164C CDC9-1 YJR099W YUH1 -0.1527 9.80E-02 
YDL164C CDC9-1 YPR151C SUE1 -0.1476 5.33E-02 
YDL164C CDC9-1 YMR016C SOK2 -0.1469 5.38E-02 
YDL164C CDC9-1 YDR274C YDR274C -0.1451 3.08E-04 
YDL164C CDC9-1 YBR231C SWC5 -0.145 2.69E-05 
YDL164C CDC9-1 YIL168W YIL168W -0.1434 6.00E-02 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YER162C RAD4 -0.1431 1.30E-01 
YDL164C CDC9-1 YLR056W ERG3 -0.1429 6.74E-02 
YDL164C CDC9-1 YHR081W LRP1 -0.1419 9.55E-03 
YDL164C CDC9-1 YBL051C PIN4 -0.1417 2.45E-04 
YDL164C CDC9-1 YJL112W MDV1 -0.1406 1.18E-01 
YDL164C CDC9-1 YAR029W YAR029W -0.1401 8.09E-02 
YDL164C CDC9-1 YJL216C IMA5 -0.1388 6.79E-02 
YDL164C CDC9-1 YIR003W AIM21 -0.1385 1.06E-01 
YDL164C CDC9-1 YJL188C YJL188C -0.1381 1.32E-01 
YDL164C CDC9-1 YAR027W UIP3 -0.138 2.68E-03 
YDL164C CDC9-1 YCL002C YCL002C -0.1358 1.78E-02 
YDL164C CDC9-1 YDR290W YDR290W -0.1342 3.41E-02 
YDL164C CDC9-1 YOL044W PEX15 -0.1313 1.85E-02 
YDL164C CDC9-1 YJL198W PHO90 -0.1305 1.26E-01 
YDL164C CDC9-1 YMR224C MRE11 -0.1301 9.19E-02 
YDL164C CDC9-1 YDR359C VID21 -0.129 1.17E-04 
YDL164C CDC9-1 YKL190W CNB1 -0.129 9.23E-02 
YDL164C CDC9-1 YNL071W LAT1 -0.1287 3.50E-02 
YDL164C CDC9-1 YGL031C RPL24A -0.1286 1.52E-04 
YDL164C CDC9-1 YLR415C YLR415C -0.1281 4.06E-02 
YDL164C CDC9-1 YMR158W-A YMR158W-A -0.1242 9.18E-02 
YDL164C CDC9-1 YLR287C-A RPS30A -0.1236 3.03E-03 
YDL164C CDC9-1 YHR143W DSE2 -0.1224 4.11E-03 
YDL164C CDC9-1 YGR143W SKN1 -0.1223 1.11E-03 
YDL164C CDC9-1 YNL032W SIW14 -0.1202 3.92E-02 
YDL164C CDC9-1 YLR061W RPL22A -0.1191 4.73E-02 
YDL164C CDC9-1 YNL119W NCS2 -0.119 5.17E-02 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YDR395W SXM1 -0.1174 4.52E-02 
YDL164C CDC9-1 YBR103W SIF2 -0.1145 1.09E-04 
YDL164C CDC9-1 YMR048W CSM3 -0.113 6.84E-02 
YDL164C CDC9-1 YGL125W MET13 -0.1127 4.35E-12 
YDL164C CDC9-1 YHR189W PTH1 -0.1126 1.65E-05 
YDL164C CDC9-1 YJL093C TOK1 -0.1117 5.20E-03 
YDL164C CDC9-1 YNL098C RAS2 -0.1112 1.32E-01 
YDL164C CDC9-1 YGL046W YGL046W -0.1101 8.15E-02 
YDL164C CDC9-1 YKL053C-A MDM35 -0.1101 9.67E-02 
YDL164C CDC9-1 YOR196C LIP5 -0.109 1.19E-01 
YDL164C CDC9-1 YOL006C TOP1 -0.1073 1.72E-02 
YDL164C CDC9-1 YPL008W CHL1 -0.1072 3.69E-03 
YDL164C CDC9-1 YMR132C JLP2 -0.1062 6.40E-02 
YDL164C CDC9-1 YCR033W SNT1 -0.1058 2.10E-06 
YDL164C CDC9-1 YPL239W YAR1 -0.1039 2.72E-04 
YDL164C CDC9-1 YLR143W YLR143W -0.1032 1.34E-01 
YDL164C CDC9-1 YDR056C YDR056C -0.1029 1.04E-01 
YDL164C CDC9-1 YPL069C BTS1 -0.1021 1.20E-12 
YDL164C CDC9-1 YDR217C RAD9 -0.1015 9.81E-02 
YDL164C CDC9-1 YNL037C IDH1 -0.1006 9.70E-04 
YDL164C CDC9-1 YOR183W FYV12 -0.1005 2.54E-02 
YDL164C CDC9-1 YOR043W WHI2 -0.1004 1.94E-03 
YDL164C CDC9-1 YPR065W ROX1 -0.1003 6.27E-03 
YDL164C CDC9-1 YMR044W IOC4 -0.0996 8.91E-02 
YDL164C CDC9-1 YDR024W YDR024W -0.0978 1.39E-02 
YDL164C CDC9-1 YPR078C YPR078C -0.0976 1.46E-01 
YDL164C CDC9-1 YMR126C DLT1 -0.0973 4.81E-03 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YPL152W RRD2 -0.096 1.16E-01 
YDL164C CDC9-1 YLR205C HMX1 -0.0958 1.35E-05 
YDL164C CDC9-1 YKL047W YKL047W -0.0957 1.42E-01 
YDL164C CDC9-1 YPR141C KAR3 -0.0948 1.20E-01 
YDL164C CDC9-1 YDR493W MZM1 -0.0947 9.12E-02 
YDL164C CDC9-1 YCL036W GFD2 -0.0946 1.17E-03 
YDL164C CDC9-1 YDL059C RAD59 -0.0939 1.39E-21 
YDL164C CDC9-1 YOR291W YPK9 -0.0938 9.18E-02 
YDL164C CDC9-1 YMR065W KAR5 -0.0931 9.92E-03 
YDL164C CDC9-1 YKR048C NAP1 -0.093 2.74E-02 
YDL164C CDC9-1 YOR221C MCT1 -0.093 7.73E-03 
YDL164C CDC9-1 YNL091W NST1 -0.0909 1.06E-06 
YDL164C CDC9-1 YPR024W YME1 -0.0904 8.07E-02 
YDL164C CDC9-1 YJR040W GEF1 0.0906 1.77E-02 
YDL164C CDC9-1 YGR232W NAS6 0.0909 1.71E-52 
YDL164C CDC9-1 YGL057C GEP7 0.0911 1.25E-01 
YDL164C CDC9-1 YLL002W RTT109 0.0913 9.04E-02 
YDL164C CDC9-1 YLR165C PUS5 0.0916 1.27E-02 
YDL164C CDC9-1 YLR174W IDP2 0.092 3.18E-02 
YDL164C CDC9-1 YLR283W YLR283W 0.0924 1.19E-01 
YDL164C CDC9-1 YDR159W SAC3 0.0925 1.28E-01 
YDL164C CDC9-1 YFR010W UBP6 0.0928 6.54E-02 
YDL164C CDC9-1 YLR239C LIP2 0.0929 5.26E-02 
YDL164C CDC9-1 YER178W PDA1 0.0936 6.75E-02 
YDL164C CDC9-1 YLR332W MID2 0.0937 1.61E-04 
YDL164C CDC9-1 YAL054C ACS1 0.094 3.68E-04 
YDL164C CDC9-1 YDR276C PMP3 0.0945 7.68E-04 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YHR012W VPS29 0.0951 1.17E-01 
YDL164C CDC9-1 YPR018W RLF2 0.0955 1.99E-02 
YDL164C CDC9-1 YGL152C YGL152C 0.0958 5.19E-04 
YDL164C CDC9-1 YLR072W YLR072W 0.096 8.21E-02 
YDL164C CDC9-1 YPL247C YPL247C 0.0983 2.92E-02 
YDL164C CDC9-1 YKL127W PGM1 0.0991 1.44E-03 
YDL164C CDC9-1 YNL147W LSM7 0.1001 1.08E-01 
YDL164C CDC9-1 YFR008W FAR7 0.1003 2.91E-02 
YDL164C CDC9-1 YLR200W YKE2 0.1006 1.28E-01 
YDL164C CDC9-1 YIL122W POG1 0.1007 4.27E-06 
YDL164C CDC9-1 YKL069W YKL069W 0.1008 7.41E-02 
YDL164C CDC9-1 YNR049C MSO1 0.101 9.88E-02 
YDL164C CDC9-1 YGL019W CKB1 0.1011 7.40E-26 
YDL164C CDC9-1 YDR265W PEX10 0.1012 3.81E-02 
YDL164C CDC9-1 YDR447C RPS17B 0.1031 2.29E-03 
YDL164C CDC9-1 YJR014W TMA22 0.1041 8.23E-13 
YDL164C CDC9-1 YGL149W YGL149W 0.1047 7.81E-04 
YDL164C CDC9-1 YHR111W UBA4 0.1084 1.21E-03 
YDL164C CDC9-1 YBR138C YBR138C 0.1089 6.75E-02 
YDL164C CDC9-1 YBR195C MSI1 0.1098 2.76E-54 
YDL164C CDC9-1 YJL120W YJL120W 0.1099 3.14E-02 
YDL164C CDC9-1 YGL153W PEX14 0.1102 7.56E-19 
YDL164C CDC9-1 YMR201C RAD14 0.1123 5.55E-02 
YDL164C CDC9-1 YKR020W VPS51 0.1124 1.24E-02 
YDL164C CDC9-1 YIL036W CST6 0.1129 8.52E-03 
YDL164C CDC9-1 YHL034C SBP1 0.113 1.20E-04 
YDL164C CDC9-1 YGL236C MTO1 0.1143 6.05E-02 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YJR033C RAV1 0.1148 1.29E-01 
YDL164C CDC9-1 YNL097C PHO23 0.1153 1.21E-02 
YDL164C CDC9-1 YGR133W PEX4 0.1156 1.31E-02 
YDL164C CDC9-1 YNL056W OCA2 0.116 2.22E-02 
YDL164C CDC9-1 YOL053W AIM39 0.117 1.01E-01 
YDL164C CDC9-1 YMR015C ERG5 0.1179 4.64E-09 
YDL164C CDC9-1 YKR046C PET10 0.1182 6.46E-02 
YDL164C CDC9-1 YFR049W YMR31 0.1189 2.24E-04 
YDL164C CDC9-1 YHR041C SRB2 0.1189 5.42E-02 
YDL164C CDC9-1 YHR132C ECM14 0.1196 3.54E-03 
YDL164C CDC9-1 YGL180W ATG1 0.1203 1.86E-06 
YDL164C CDC9-1 YLR289W GUF1 0.1205 7.99E-02 
YDL164C CDC9-1 YKL050C YKL050C 0.1248 2.46E-02 
YDL164C CDC9-1 YLR124W YLR124W 0.1251 5.86E-02 
YDL164C CDC9-1 YML033W YML033W 0.128 3.86E-03 
YDL164C CDC9-1 YLR386W VAC14 0.1285 5.19E-02 
YDL164C CDC9-1 YGR200C ELP2 0.1287 2.09E-03 
YDL164C CDC9-1 YBR118W TEF2 0.1292 6.94E-05 
YDL164C CDC9-1 YHR031C RRM3 0.1297 2.20E-04 
YDL164C CDC9-1 YHR067W HTD2 0.1298 2.36E-02 
YDL164C CDC9-1 YGL168W HUR1 0.1302 5.89E-02 
YDL164C CDC9-1 YKL009W MRT4 0.1308 1.20E-02 
YDL164C CDC9-1 YGL056C SDS23 0.1326 6.07E-02 
YDL164C CDC9-1 YNL127W FAR11 0.1367 1.20E-03 
YDL164C CDC9-1 YGL054C ERV14 0.1387 2.59E-02 
YDL164C CDC9-1 YBL104C SEA4 0.139 1.45E-03 
YDL164C CDC9-1 YDR393W SHE9 0.139 1.24E-03 
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Table 4.2  Genetic interactions with cdc9-1 mutants from SGA (continued). 
Query systematic name Query standard name Array systematic name Array standard name Epsilon score p-value 
YDL164C CDC9-1 YIL017C VID28 0.1392 2.28E-10 
YDL164C CDC9-1 YGL237C HAP2 0.1407 2.89E-02 
YDL164C CDC9-1 YGL173C KEM1 0.1417 3.66E-02 
YDL164C CDC9-1 YJL060W BNA3 0.145 2.39E-02 
YDL164C CDC9-1 YDR414C ERD1 0.1479 1.69E-04 
YDL164C CDC9-1 YLR391W YLR391W 0.1488 2.07E-05 
YDL164C CDC9-1 YGL133W ITC1 0.1497 5.07E-04 
YDL164C CDC9-1 YLR190W MMR1 0.1516 3.34E-02 
YDL164C CDC9-1 YKR060W UTP30 0.1552 2.16E-02 
YDL164C CDC9-1 YGL024W YGL024W 0.1559 2.99E-05 
YDL164C CDC9-1 YLR290C YLR290C 0.1602 5.68E-02 
YDL164C CDC9-1 YNR041C COQ2 0.1625 4.44E-03 
YDL164C CDC9-1 YGL043W DST1 0.1642 5.97E-04 
YDL164C CDC9-1 YBR095C RXT2 0.1651 2.29E-03 
YDL164C CDC9-1 YER072W VTC1 0.1707 2.51E-09 
YDL164C CDC9-1 YLR182W SWI6 0.1728 1.20E-01 
YDL164C CDC9-1 YLR410W VIP1 0.1835 9.97E-03 
YDL164C CDC9-1 YBR105C VID24 0.1902 4.79E-03 
YDL164C CDC9-1 YJL177W RPL17B 0.1919 4.11E-02 
YDL164C CDC9-1 YHR193C EGD2 0.1924 1.64E-02 
YDL164C CDC9-1 YAR002W NUP60 0.2052 1.67E-44 
YDL164C CDC9-1 YHR008C SOD2 0.2174 4.11E-15 
YDL164C CDC9-1 YLR191W PEX13 0.221 9.14E-20 
YDL164C CDC9-1 YDR148C KGD2 0.2613 8.11E-28 
YDL164C CDC9-1 YPR066W UBA3 0.2859 1.19E-10 
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CHAPTER 5 
 
Discussion and future studies  
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Discussion 
 
Defects in DNA ligase I trigger the S phase checkpoint. 
The focus of this thesis was to investigate whether cells can sense and deal with 
the accumulation of DNA damage that arises “behind” replication forks.  Here, we 
establish that in the absence of Cdc9, cells do indeed recognize the accumulation of 
nicked DNA and arrest in S phase (Figures 2.3 and 3.1).  The difference between our 
results and the previously described G2 arrest phenotype [Culotti and Hartwell, 1971] is 
likely due to the stringency of cdc9 alleles.  We constructed a cdc9-td strain (Figure 2.2) 
in which DNA ligase I is rapidly degraded by the Ubr1-mediated N-end-rule degradation 
[Sanchez-Diaz et al., 2004].  cdc9-td cells progressed much slower through S phase at the 
restrictive temperature than wild-type cells (Figure 3.1).  Two other cdc9 alleles, cdc9-1 
and cdc9-2, also exhibited a similar S phase delay (Figure 2.3).  Because cdc9-2 mutants 
have higher DNA ligase I levels and are not as temperature sensitive as cdc9-1 alleles, 
they arrested later in S phase (Figures 2.1 and 2.3).  These results support the notion that 
the completion of S phase is dependent on the activity of DNA ligase I.  
The delay in S phase in cdc9 mutants relied on the activation of the S phase 
checkpoint kinase, Rad53, in an Mrc1- and Rad9-dependent manner, indicating the 
presence of both stalled replication forks and DSBs, respectively (Figures 2.4a and b).  
Complete inactivation of Rad53 in cdc9-1 cells by inhibiting both Mrc1 and Rad9 or by 
overexpressing a dominant-negative Rad53 kinase-dead mutant (Rad53-K221A/D339A) 
[Pellicioli et al., 1999; Szyjka et al., 2008] failed to arrest in S phase (Figures 2.4b and 
4.3b).  Altogether, we conclude that cells can sense lesions that arise “behind” the 
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replication fork in the absence of Cdc9 and activate the S phase checkpoint kinase Rad53 
in an Mrc1- and Rad9-dependent manner.      
 
Defects in DNA ligase I activity induce PCNA ubiquitination at K107.  
Besides the S phase checkpoint pathway, we established that nicked replication 
intermediates caused by defects in DNA ligase I trigger PCNA mono- and poly-
ubiquitination at K107 and independently of K164 (Figures 2.6, 2.14, and 4.1).  In 
support of this notion, expression of either S. cerevisiae wild-type Cdc9 or Chlorella 
virus DNA ligase was able to complement cdc9-1 cell viability and revert PCNA 
ubiquitination (Figures 4.1 and 4.2).  A previous study in cdc9 mutants demonstrated that 
Okazaki fragments accumulate as ligatable nicks that can be readily joined upon 
induction of DNA ligase I expression [Bielinsky and Gerbi, 1999]. Moreover, despite the 
failure to ligate Okazaki fragments, replicated DNA is still assembled into nucleosomes 
[Smith and Whitehouse, 2012], and DNA ligase I is active on nucleosomal substrates in 
vitro [Chafin et al., 2000]. This would suggest that cells can recognize both “clean” (3’-
OH and 5’-PO4) and “dirty” (3’-OH and 5’-AMP) nicks in the context of chromatin. It is 
likely that limited amounts of DNA ligase I cause abortive ligation reactions leaving 
behind adenylated nicks. This idea is also consistent with previous reports demonstrating 
the presence of both types of nicks in human 46BR.1G1 DNA ligase I-deficient cells 
[Prigent et al., 1994], raising a possibility that PCNA ubiquitination pathway may be 
present in high eukaryotes. Indeed, we demonstrated that depleting hLIG1 results in 
PCNA ubiquitination in human cells (Figure 2.16). The data presented in this study leads 
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us to propose that both types of nicks trigger PCNA ubiquitination, at least in budding 
yeast. Since this lower eukaryote lacks a homolog of the mammalian nick sensor poly 
(ADP-ribose) polymerase-1 (PARP-1) [Collinge and Althaus, 1994], we further postulate 
that PCNA ubiquitination serves as an integral part of a nick-sensory pathway during 
DNA replication.   
Although PCNA K107 is not present in humans, our results indicate that at least 
the PCNA ubiquitination pathway in response to accumulation of nicks is conserved from 
yeasts to humans.  Thus, future experiments aimed to identify the lysine residue will be 
necessary to understand the significance of PCNA ubiquitination in human DNA ligase I-
deficient cells.  Nevertheless, we conclude that S. cerevisiae can recognize the 
accumulation of unligated Okazaki fragments and trigger PCNA ubiquitination at K107, 
not K164.     
 
PCNA ubiquitination at K107 is dependent on the UBC4/MMS2/RAD5 E2-E3 
ubiquitin complex. 
 Because PCNA is ubiquitinated at K107 in cdc9-1 mutants, we speculated that the 
genetic requirements for PCNA ubiquitination would be different than PCNA 
ubiquitination at K164.  Indeed, we identified a different E2-E3 ubiquitin complex, 
UBC4/MMS2/RAD5, that mono- and poly-ubiquitinates PCNA at K107 in cdc9-1 cells, 
where the poly-ubiquitin chain is linked through K29, instead of K63 (Figure 2.7 and 2.8) 
[Hoege et al., 2002].  The human homolog of Ubc4, UBCH5A, synthesizes K29 linked 
poly-ubiquitin chain in vitro [Mastrandrea et al., 1999], which agrees with our in vivo 
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data.  To date, the in vivo function of K29 poly-ubiquitin chain linkage is not well 
characterized.  In humans, K29-linked poly-ubiquitin chains have been indicated to 
promote protein degradation via the lysosome [Chastagner et al., 2006].  Alternatively, in 
budding yeast, a K29-linked poly-ubiquitin chain was shown to interact with Doa1 
(degradation of alpha 1) [Russell and Wilkinson, 2004].  Doa1 is involved in replenishing 
free ubiquitin pools [Lis and Romesberg, 2006].  Thus, it is unclear whether PCNA K29-
linked poly-ubiquitin signals for protein recruitment or protein degradation.   
Our genetic evidence showing that MMS2 interacts with UBC4 for PCNA 
ubiquitination in cdc9-1 mutants is intriguing because Mms2 is thought to interact only 
with Ubc13, an E2 conjugating enzyme [Hofmann and Pickart, 1999; 2001] (Figure 2.7 
and 2.8).  Since we did not detect any interactions between Ubc4 and Mms2 by co-
immunoprecitipation experiments (data not shown), this raised a question as to whether 
other proteins can interact with Mms2 to promote Ubc4-dependent PCNA ubiquitination 
in cdc9 mutants.  Thus, it is possible that we are still missing components in the complex 
to facilitate PCNA ubiquitination.  Identifying additional components involved in PCNA 
ubiquitination would provide more insight into this novel ubiquitination mechanism.   
Lastly, our laboratory has previously reported that Ubc4 is also important for the 
degradation of Cdc17, the catalytic subunit of pol-! [Haworth et al., 2010], indicating a 
role of Ubc4 during DNA replication that is currently underappreciated.  Dissecting the 
molecular function of Ubc4 during DNA replication and/or replication stress may provide 
an additional layer of regulation linking ubiquitination pathways with other replication 
processes.   
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PCNA ubiquitination at K107 is required for robust Rad53 hyper-phosphorylation. 
From our study, we further established that PCNA mono-ubiquitination at K107 is 
necessary for robust Rad53 hyper-phosphorylation (Figure 2.9b and 2.14e), illustrating a 
novel link between PCNA ubiquitination and the S phase checkpoint.  Because PCNA 
ubiquitination only occurs at stalled forks and not at sites of DSBs [Davies et al., 2008], 
ubiquitination of PCNA at K107 is likely to function in the same pathway as the Mrc1-
mediated Rad53 activation.  In agreement with this notion, we demonstrate that cdc9-1* 
pol30-K107R double mutants fail to arrest in S phase under semi-permissive conditions, a 
similar phenotype as observed in cdc9-1 mrc1AQ mutants (Figure 2.4c and 4.3a).   
How PCNAK107-Ub promotes S phase checkpoint activation is unclear.  Initiating 
the S phase checkpoint cascade requires replication protein A (RPA) coated ssDNA 
(ssDNA-RPA) to recruit Mec1/Ddc2 [Zou and Elledge, 2003]. Thus, some processing of 
the nicks is necessary to generate such ssDNA-RPA structures. It is possible that PCNA 
ubiquitination facilitates this particular step.  The redundant roles of Exo1 and Xrs2, a 
component of the MRX complex (Mre11/Rad50/Xrs2 (X-ray sensitive 2, a yeast 
homolog of human NBS1), have been implicated in the degradation of nascent DNA in 
response to stalled replication forks [Nakada et al., 2004].  Thus, we speculate that they 
may also facilitate processing in the context of PCNA ubiquitination.  Unlike the deletion 
of MRX components, which is lethal in cdc9 mutants (Table 4.2) [Davierwala et al., 
2005], deletion of EXO1 in cdc9-1 cells yielded viable double mutants that displayed a 5-
10 fold increase in temperature sensitivity (Figure 5.1a). This result suggested that Exo1 
plays some role in cdc9-1 cell viability.  However, Exo1 did not appear to be crucial for 
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PCNA ubiquitination nor for Rad53 activation in cdc9-1 mutants (Figures 5.1b and c). At 
this point we consider it highly likely that multiple different exonuclease activities 
contribute to the conversion of nicks into ssDNA-RPA structures, and that Exo1 might be 
one of them (Figure 5.2a).  In an alternative model, which is not mutually exclusive to the 
events proposed above, unligated Okazaki fragments could form flaps, which are 
subsequently bound by RPA, which in turn, recruits Mec1 (Figure 5.2b). Importantly, 
there is recent precedence for such a scenario in dna2 mutants, which accumulate long 
flaps at the 5’-termini of unprocessed Okazaki fragments [Budd et al., 2011]. We 
speculate that PCNAK107-Ub may actively facilitate 5’-flap formation, thereby enabling 
Mec1 phosphorylation (Figure 5.2b). Consistent with this model, mono-ubiquitinated 
PCNA still supports DNA synthesis by pol-!, but prevents Fen1 from accessing 5’-flaps 
in vitro [Zhang et al., 2012]. This would explain why 5’-flaps may have an extended half-
life and could serve as a “docking” platform for Mec1 in cdc9 mutants (Figure 5.2b). 
Moreover, it would provide a rationale for alternative pathways to deal with 5’-flaps in 
the absence of Fen1. We propose here that one such pathway depends on Rad59 for the 
re-annealing of these flaps, which promotes replication fork progression by deactivating 
Mec1 (Figures 5.2b and c).  
 
How do cells cope with accumulated nicks in cdc9 mutants? 
Since Cdc9 is the only ligase that can seal nicks during lagging strand synthesis, it 
is unclear what mechanisms are in place to “resolve” persistent nicks in the presence of 
limited DNA ligase I activity. In cdc9-1 cells, the observation that Mrc1 and Rad9 are 
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crucial for S phase delay suggests the presence of both ssDNA at stalled replication forks 
and DSBs, respectively (Figure 2.4) [Das-Bradoo et al., 2010b].  It is conceivable that 
DSBs are either ligated by Dnl4 or must await Mec1 inactivation to allow repair by HR 
as Mec1 activity inhibits HR-mediated DSBs during S phase [Alabert et al., 2009; 
Barlow and Rothstein, 2009; Irmisch et al., 2009; Lisby et al., 2004].  Rad59 appears to 
have an important role in aiding Mec1 deactivation by suppressing Mrc1 phosphorylation 
(Figure 4.9c).  Mrc1 is phosphorylated at stalled replication forks and the proximity of 
Mec1 to phosphorylated Mrc1 is required for enhancing Mec1 activation [Naylor et al., 
2009].  Therefore, suppression of Mrc1 phosphorylation will counteract this process and 
provides one explanation for how Rad59 promotes cdc9-1 survival (Figures 5.2a and b).  
How Rad59 suppresses Mrc1 phosphorylation on the molecular level and promotes 
replication fork progression is not clear. One clue comes from in vitro studies 
demonstrating that Rad59 is required for the annealing of short oligonucleotides [Davis 
and Symington, 2001; Wu et al., 2006]. If we consider this function in the context of 
impaired Okazaki fragment ligation, it is possible that Rad52-Rad59 dimers simply 
promote the re-annealing of detached flaps that might form at the ends of the nicked 
replication intermediates.  For example, DNA polymerase-! might “invade” a 
downstream Okazaki fragment during the process of displacement synthesis [Jin et al., 
2005; Stith et al., 2008]. As mentioned above, the formation of flaps might be actively 
induced to generate ssDNA and elicit S phase checkpoint activation [Budd et al., 2011]. 
The formation of these flaps would likely interfere with proper nucleosome formation 
behind the fork, which in turn, slows down fork progression [Groth et al., 2007]. This 
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might in fact be beneficial for cdc9 mutants, as it provides the cells with extra time to 
recycle the little DNA ligase I activity that they have at their disposal.  We like this idea 
because the deletion of each of three individual genes, RLF2, MSI1 and ITC1 which 
comprise subunits of the chromosome assembly factor 1 [Kaufman et al., 1997], improve 
cdc9-1 viability (Table 4.2). However, since replication fork slow down generally 
increases the risk of replication fork collapse, the cell likely has means to counterbalance 
this effect. We envision that Rad59 could provide such counterbalance by preserving the 
structure of the ligatable nicks, thereby promoting nucleosome assembly and ultimately 
replication fork progression (Figure 5.2c).  Whereas the Rad1-Rad10 complex plays a 
less prominent role in cdc9-1 survival (Figures 4.7b and c), it could be involved in the 
removal of 3’-flaps, analogous to its role in SSA between direct repeats (Figure 5.2c). 
Our original observation that deletion of RAD14 is beneficial for the survival of cdc9-1 
cells (Figure 4.7d) is consistent with this proposed function for the endonuclease, because 
loss of Rad14 would prevent the use of Rad1-Rad10 in NER, making it available for 
other sites of repair. It is noteworthy that the observed separation of function for RAD1 
and RAD14 that we have described here is rather unique to cdc9-1 mutants. Among a 
collection of approximately 1800 SGA queries, we found only one other strain, scl1 that 
showed a similar pattern (Figure 4.7a).  Scl1 is a subunit of the 20S proteasome and 
whether this finding has any functional significance is currently unclear. 
To date, Rad59’s best-documented role is in SSA. Rad59-dependent, but Rad51-
independent recombination has been implicated in DSB repair between direct repeats [Ira 
and Haber, 2002; Ivanov et al., 1996; Sugawara et al., 2000].  However, we demonstrated 
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that SSA does not play a role in cdc9-1 cell survival because deletion of SLX4, a crucial 
component of SSA-mediated DSB repair [Flott et al., 2007], exhibited no effect on cdc9-
1 (Figure 4.7f).  Based on the finding that deletion of RAD59 exhibited an increase in 
Mrc1 phosphorylation in cdc9 mutants, we favor the view that Rad59 is primarily 
required for suppression of replication fork stalling.  Whether Rad59 functions in the 
same pathway as PCNAK107-Ub is unclear.  We exclude the possibility that Rad59 
promotes Rad53 activation downstream of PCNA ubiquitination. However, it is possible 
that Rad59 is recruited by ubiquitinated PCNA, either directly or indirectly, to help 
alleviate fork arrest.  
It is also worthwhile to note that there is a limited set of only 23 mutants for 
which synthetic sickness/lethality with rad59! has been described [Chanet and Heude, 
2003; Costanzo et al., 2010; Pan et al., 2006] (Supplementary Table S1). Intriguingly, 
among those are four other lagging strand specific mutants, pol3-13, defective in the 
catalytic subunit of the replicative pol-", pol32!, defective in a subunit of pol-", rad27!, 
defective in flap endonuclease, and dna2-1 defective in the endonuclease/helicase 
implicated in flap processing [Budd et al., 2005; Chanet and Heude, 2003; Costanzo et 
al., 2010; Debrauwere et al., 2001; Loeillet et al., 2005; Pan et al., 2006; Symington, 
1998]. This suggests that RAD59 may play a general role at stalled forks in response to 
defects in Okazaki fragment maturation. Thus, the molecular function of RAD59 in pol3-
13, pol32!, rad27! and dna2-1 cells needs to be further investigated in the future.  We 
speculate that Rad59 might have a similar role in dna2-1 mutants as described here for 
DNA ligase I-deficient cells in suppressing Mrc1 activation. 
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DNA repair of dirty nicks in cdc9-1 mutants.   
Another aspect that has not been addressed in this thesis is how cells repair dirty 
nicks.  In cdc9-1 cells, dirty nicks arise from abortive ligation such as in catalytically 
inactive Cdc9-K598A mutants (Figures 4.1b and c).  Because DNA ligase I requires an 
ATP in the first step to catalyze the ligation reaction, the 5’adenylated end of the dirty 
nick needs to be removed prior to ligation.  Hnt3 (histidine triad nucleotide binding 3), a 
yeast homolog of human aprataxin (APTX), was shown to remove the 5’adenylate of 
nicked substrates in vitro [Ahel et al., 2006].  To determine whether Hnt3 may be 
important for cdc9-1 cell survival, we deleted HNT3 in both wild-type and cdc9-1 
mutants.  Indeed, we observed an increase in temperature sensitivity in cdc9-1 hnt3! 
compared to cdc9-1 mutants (Figure 5.3).  However, it is difficult to determine whether 
cells can repair dirty nicks via a different mechanism such as Rad59-mediated 
recombination as shown above, since HR is a predominant repair mechanism in budding 
yeast.  Because mutations in the APTX gene have been linked to axtaxia oculomotor 
apraxia-1 (AOA1) syndrome [Date et al., 2001; Moreira et al., 2001], human cells may 
be more sensitive to the lack of APTX when DNA ligase I is limiting than budding yeast.  
Future experiments addressing the function of APTX in human DNA ligase I-deficient 
cells will have to be performed to determine this question.  
 
PCNA ubiquitination in human DNA ligase I-deficient cells.   
We demonstrated that PCNA ubiquitination in DNA ligase I-deficient cells is 
conserved in humans (Figure 2.16).  Interestingly, human cells have PARP1, a nick 
  
 
186 
sensor protein, that is specialized in repairing SSBs [Caldecott, 2008].  Consistent with 
this notion, BR46.1G1 cells, which have low hLIG1 activity, are hypersensitive to 3-
amino benzamide, an inhibitor of PARP1 [Lonn et al., 1989]. Notably, because no known 
homologs of PARP1 have yet been identified in S. cerevisiae, we hypothesize that the 
PCNA ubiquitination pathway in DNA ligase I-deficient human cells functions either in 
parallel or as a “back-up” pathway to PARP1.  In support of this hypothesis, cells 
depleted of PARP1 did not exhibit a defect in their ability to repair SSBs during S phase. 
However, the cells displayed a significant defect when they were treated with a PARP1 
inhibitor, which locked PARP1 dimers onto DNA, thereby inactivating them and 
masking the nicks [Godon et al., 2008].  These results indicate the presence of an 
additional repair pathway in S phase that is independent of PARP1.  Future studies using 
the same strategy, PARP1 inhibitors versus PARP1-knockdown, which monitor the 
PCNA ubiquitination status in DNA ligase I-deficient should allow us to determine 
whether PCNA ubiquitination functions in the same or parallel pathway to PARP1.   
 
PCNA damage code.   
In this thesis, we established a novel PCNA ubiquitination pathway at K107 in 
cdc9 mutants that is essential for the activation of the S phase checkpoint in response to 
accumulation of nicks during lagging strand synthesis.  This contrasts to the well-known 
PCNA ubiquitination at K164, which functions independently of the S phase checkpoint, 
although both are triggered in response to DNA damage-induced stalled replication forks 
such as UV-irradiation and MMS [Davies et al., 2008; Hoege et al., 2002].  Moreover, a 
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lagging strand mutant, pol32#, which is a subunit of pol-", caused PCNA ubiquitination 
at K164, suggesting that cells may monitor different steps during Okazaki fragment 
processing [Karras and Jentsch, 2010].  Consistent with this result, we also observed 
PCNA ubiquitination in other lagging strand mutants (Nguyen, Becker, and Bielinsky, 
unpublished observations).  Experiments are currently underway to determine whether 
K107, K164 or additional lysine residues on PCNA are important to induce appropriate 
responses.  Besides lagging strand mutants, PCNA is also ubiquitinated independently of 
the RAD6 pathway in an asf1 (anti-silencing function 1) mutant, a nucleosome assembly 
factor [Kats et al., 2009].  Interestingly, in human cells treated with colchicine, a 
microtubule inhibitor, PCNA ubiquitination at K254 was significantly increased [Xu et 
al., 2010], further illustrating that PCNA can be ubiquitinated at different lysine residues.  
Therefore, because PCNA ubiquitination at K107 and K164 are activated in response to 
different types of DNA structures, nicks versus ssDNA, respectively, we propose a 
“PCNA damage code” by which cells can distinguish and categorize different types of 
DNA damage to activate appropriate signaling responses by distinct ubiquitin attachment 
sites and/or different poly-ubiquitin chains on PCNA.   
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Future studies 
 The focus of this thesis was to determine how cells sense and suppress DNA 
damage that arises “behind” the replication fork in order to maintain genomic stability.  
This thesis has noted several interesting and novel observations that open up new avenues 
for future studies.  The main observations from this thesis are as followed: (1) PCNA 
ubiquitination occurs at a novel lysine, K107, when DNA ligase I activity is inhibited; (2) 
the ubiquitination pathway is mediated by the UBC4/MMS2/RAD5 E2-E3 ubiquitin ligase 
complex; (3) PCNA ubiquitination at K107 is required for the activation of the S phase 
checkpoint kinase Rad53, which is dependent on both Mrc1 and Rad9; (4) Rad59-
dependent recombination at stalled forks, either downstream or in a parallel pathway to 
PCNA ubiquitination, is necessary to suppress Mrc1 phosphorylation and promote S 
phase progression when DNA ligase I activity is limited; and lastly, (5) this novel PCNA 
ubiquitination pathway is conserved from yeasts to humans.   
Future studies will aim to characterize the in vivo function of PCNA 
ubiquitination with respect to the S phase checkpoint activation and the Rad59-mediated 
recombination in cdc9 mutants as described in our proposed model (see discussion).  
Secondly, different approaches to investigate the “PCNA damage code” will be outlined.  
Lastly, different strategies will focus on characterizing the PCNA ubiquitination pathway 
in human DNA ligase I-deficient cells.   
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Investigating the role of ubiquitinated PCNA at K107 in S. cerevisiae. 
How does ubiquitinated PCNA at K107 activate the S phase checkpoint?   
We have shown that PCNA ubiquitination at K107 is necessary for the activation 
of the S checkpoint in order to delay cells in S phase (Figure 2.14 and 4.4b).  However, 
the underlying molecular mechanism is unclear.  Additionally, in response to DNA 
damaging agents that induce stalled replication forks such as UV-irradiation or HU, 
Rad53 activation is dependent on the redundant functions of Exo1 and Xrs2 [Nakada et 
al., 2004], generating a ssDNA region on the template DNA by degrading nascent DNA 
in the 5’-3’ direction.  We speculate that Exo1 and Xrs2 may carry out a similar function 
in cdc9 mutants.  Whether PCNA ubiquitination cooperates with Exo1 and Xrs2 to 
activate Rad53 is unclear.  Because inhibition of PCNA ubiquitination was sufficient to 
block Rad53 activation, we propose that Exo1 and/or Xrs2 would function downstream 
of PCNA ubiquitination.  Alternatively, Exo1 and Xrs2 could activate Rad53 in a parallel 
pathway.  We favor the former model because inhibition of PCNA ubiquitination at K107 
was sufficient to suppress the S phase delay phenotype in cdc9 mutants.  Because cdc9 
exo1! double mutants do not exhibit any defect in either PCNA ubiquitination or Rad53 
phosphorylation, we will delete XRS2 in cdc9-1 exo1! strain.  Because deletion of the 
XRS2 in cdc9 mutants is likely to be lethal due to its function in DSB repair, we propose 
to generate the triple mutant in the cdc9-td background and monitor both Mrc1 and 
Rad53 phosphorylation.  If Exo1 and Xrs2 function in parallel to PCNA ubiquitination, it 
would be interesting to test whether overexpression of Exo1 or Xrs2 in cdc9-td pol30-
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K107R double mutants can induce Rad53 phosphorylation to compensate for the loss of 
ubiquitinated PCNA.   
Alternatively, we propose to adapt the newly developed “split PCNA” protein 
expression, to express specifically the ubiquitinated PCNA at K107 in exo1! xrs2! 
mutants and examine whether PCNA ubiquitination can rescue checkpoint activation in 
these cells.  In this approach, PCNA is split and expressed from two different constructs 
so that the ubiquitin is attached immediately upstream of the lysine residue [Freudenthal 
et al., 2010].  Split PCNA at K164 has been shown to be functional in vivo to interact 
with TLS polymerase to promote lesion bypass [Freudenthal et al., 2010].  In our case, 
we will construct an N-terminal half of PCNA1-106 (amino acid 1-106) and C-terminal 
half of PCNA with an ubiquitin attached immediately upstream of K108, linked with two 
Gly residues (Ub-GG-PCNA108-258).  The Gly-Gly linker is thought to mimic the length of 
the lysine side chain. Because ubiquitinated PCNA at K107 induces S phase arrest, we 
will control the split PCNA expression under the control of a galactose promoter.  
Regardless of the outcome, it would be informative to see whether PCNA ubiquitination 
at K107 alone is sufficient to activate the S phase checkpoint. 
 
Identifying proteins that interact with PCNA ubiquitinated at K107.   
To further characterize the molecular mechanism that leads to checkpoint 
activation, we will first utilize a candidate approach by determining whether any of the 
genes identified in our SGA screen interact with ubiquitinated PCNA by co-
immunoprecipitation. Interestingly, we identified a putative PIP-box in Rad59 that 
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potentially mediates interaction with PCNA.  Alternatively, we have access to a 
chemically synthesized form of PCNA that is ubiquitinated at K107 [Chen et al., 2010].  
Briefly, a biotin-tagged version of the ubiquitinated PCNA will be synthesized and used 
in co-immunoprecipitation experiments.  We will first bind ubiquitinated PCNA to a 
streptavidin column prior to incubation with either wild-type or cdc9-1 yeast extracts.  
For a candidate approach, interacting proteins such as Rad59 can be examined by western 
blotting.  Alternatively, the method can be coupled with mass-spectroscopy to identify 
novel candidate interacting proteins.   
 
Determining the binding affinity of ubiquitinated PCNA with replication proteins in vitro.   
Taking advantage of the fact that ubiquitinated PCNA can be chemically 
synthesized, we will also examine how ubiquitinated PCNA affects the binding with 
other known PCNA-interacting proteins, such as pol-" and Cdc9.  In cdc9 mutants, two 
scenarios, not mutually exclusive, could occur with respect to ubiquitinated PCNA.  First, 
ubiquitinated PCNA may reduce the binding affinity of pol-", thereby inhibiting DNA 
synthesis and strand displacement along the lagging strand.  Alternatively, ubiquitinated 
PCNA may “mark” sites of nicks and may have a higher binding affinity to DNA ligase I, 
thereby aiding in the recruiting of DNA ligase I to unligated Okazaki fragments.  
Regardless of the outcome, these in vitro binding studies may provide insight into the in 
vivo function of PCNA that is ubiquitinated at K107.   
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Does accumulation of nicks directly trigger PCNA ubiquitination at K107?   
To experimentally address this question, we have developed a “nicking” assay in 
budding yeast by expressing an I-AniI homing endonuclease mutant (I-AniI-K227M) that 
nicks at a specific 19 bp target sequence (Figure 5.5) [McConnell Smith et al., 2009].  
Briefly, we expressed the I-AniI nickase in yeast under the control of a galactose 
promoter.  We also cloned its target sequence into a high copy number plasmid to 
generate more than a single nick in the cell.  As shown in Figure 5.5, we demonstrated 
that I-AniI nickase, but not the nickase-dead mutant (I-AniI-Q171K/K227M), can 
produce a SSB at its designated target site in yeast.  This approach will allow us to induce 
nicks in different phases of the cell cycle and monitor the PCNA ubiquitination status 
independently of the cdc9 mutation.   
 
“PCNA Damage Code” model. 
Does PCNA ubiquitination occur in other lagging strand mutants?   
We and the Jentsch laboratory showed that PCNA ubiquitination occurred in 
lagging strand specific mutants, cdc9-1 and pol32!, respectively [Das-Bradoo et al., 
2010b; Karras and Jentsch, 2010].  Additionally, these two mutants ubiquitinated PCNA 
at different lysine residues, K107 in cdc9-1 and K164 in pol32! mutants.  These results 
led us to hypothesize that cells can monitor every step during Okazaki fragment 
maturation and ubiquitinate PCNA at different lysine residues.  We have recently tested 
and observed PCNA ubiquitination a rad27! mutant in a different background (Becker 
and Bielinsky unpublished observation).  Therefore, we propose to test other lagging 
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strand mutants (e.g., DNA2 mutations) to determine whether PCNA ubiquitination does 
occur in those strains.  If we observe PCNA ubiquitination, we will determine the site of 
ubiquitination (K107, K164 or a different site) and its in vivo function.  
 
SGA screen with different PCNA mutants.   
Taking advantage of the powerful tool of SGA, we have generated a series of 
PCNA point mutants (lysine to arginine mutations) to mate with the nonessential gene 
deletion array to identify genetic interactions with any of the PCNA mutants 
[Baryshnikova et al., 2010a; Davierwala et al., 2005].  Additionally, these mutants will 
be tested with a collection of temperature sensitive essential mutants, which includes 
genes involved in DNA replication.  Any genetic interaction between the query strains 
and the array mutants will be confirmed by tetrad analysis. Once verified, specific array 
mutants will be tested to determine whether they display any PCNA modification 
(ubiquitination and/or sumoylation). The extensive SGA data base will then be used to 
further understand the genetic profile of specific mutants.  Theoretically, this approach 
could also be utilized to analyze query strains that carry more than one mutation in a 
surface lysine.  
 
PCNA ubiquitination in human DNA ligase I-deficient cells. 
We observed PCNA ubiquitination in human DNA ligase I-deficient cells, 
suggesting that the pathway is conserved.  Genetic requirements in yeast for PCNA 
ubiquitination will be examined in human cells by transient knock-downs using small 
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interfering (si) RNAs against different ubiquitination pathway components.  Additionally, 
because PCNA K107 is not conserved in humans, the site of PCNA ubiquitination in 
human DNA ligase I-deficient cells will also need to be determined.   
An intriguing difference between yeast and humans is that humans have a nick 
sensor protein, PARP1, that binds to nicks and triggers SSB repair [Caldecott, 2008].  
Thus, it will be interesting to determine whether PCNA ubiquitination observed in human 
DNA ligase I-deficient cells functions in the same or parallel pathway to PARP1.  If 
PARP1 and PCNA ubiquitination are in the same pathway, inhibition of PARP1 activity 
either by the use of PARP1 inhibitors or siRNAs in DNA ligase I-deficient cells should 
not induce PCNA ubiquitination.  Alternatively, if they are in separate pathways, 
blocking PARP1 activity by inhibitors will also hinder PCNA ubiquitination due to the 
inaccessibility of the nicks, whereas depletion of PARP1 by siRNA will expose nicks that 
can activate the PCNA ubiquitination pathway.  Because PARP1 inhibitors are currently 
in clinical trials, these studies will be valuable for cancer research regardless of their 
outcome.  Better understanding of PCNA ubiquitination pathway would be advantageous 
to design more specific target inhibitors against components of the PCNA ubiquitination 
pathway, since this could potentially inhibit S phase checkpoint activation, similar to 
yeast. Thus, a combination of inhibitors that target PARP1 to block DNA repair, and 
components of the PCNA ubiquitination pathway to block the S phase checkpoint, would 
increase cancer cell sensitivity to cancer therapy drugs.   
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Figure 5.1 
 
 
 
Figure 5.1  Deletion of EXO1 does not alter PCNA mono-ubiquitination and Rad53 
phosphorylation in cdc9-1 mutants.  
(a) Successive 10-fold dilutions of indicated strains were spotted on YPD plates 
and incubated for 3 days at the indicated temperatures. (b, c) Strains in (a) were grown 
asynchronously to mid-log phase at 25°C and subsequently shifted to 30°C for 1.5 and 
3h. In b, only 3h time point samples were used for PCNA blot. PCNA and its 
ubiquitinated forms, Cdc9, and Rad53 were detected with anti-PCNA (S871), anti-Cdc9, 
and anti-Rad53 antibodies, respectively. !-tubulin served as a loading control. An 
asterisk indicates a non-specific band.   
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Figure 5.2 
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Figure 5.2  Alternative models to explain how Rad53 might be regulated at 
PCNAK107-Ub-flagged replication forks. (a) In the absence of Cdc9 activity, we suggest 
that PCNA ubiquitination, in conjunction with Exo1, promotes the generation of ssDNA 
on the lagging strand template (left).  ssDNA regions recruit Mec1 to the stalled 
replication fork. Mec1 then phosphorylates Mrc1 at the fork, which leads to Rad53 
hyper-phosphorylation to delay cells in S phase (right).  Rad53, in turn, has been shown 
to phosphorylate Exo1 to inhibit further nascent strand degradation [Morin et al., 2008]. 
(b) Alternatively, pol-" may displace the downstream Okazaki fragment, generating a 5’-
flap (left). The 5’-flap may bind to RPA (not shown), thereby recruiting Mec1 to 
chromatin in order to phosphorylate Mrc1 at the fork. In both a and b, Rad59 acts to 
suppress Mrc1 phosphorylation at the fork. Because we observed synthetic sickness 
between cdc9-1 with the rad1! and rad10!, we speculate that Rad1 and Rad10 may also 
function to suppress Mrc1 phosphorylation. (c) A model for Rad59 in the suppression of 
flap formation at unligated Okazaki fragments. In the absence of Cdc9 activity, pol-" 
might promote strand displacement synthesis to generate a 5’-flap (1). Pol-" 3’-5’ 
exonuclease activity can degrade the 3’-end of the Okazaki fragment (2), leaving a short 
ssDNA region for Rad59 to re-anneal the 5’-flap to the template DNA to maintain the 
ligatable nick (3). Alternatively, if the 3’-end of the Okazaki fragment is separated from 
the template DNA (2a), Rad1/10 endonuclease can cleave the 3’-tail (2b), which creates 
a ssDNA gap for Rad59-mediated strand re-annealing (3). Finally, cells seal the nick with 
DNA ligase I (4). 
  
 
198 
Figure 5.3 
 
 
Figure 5.3  Deletion of HNT3 results in increase temperature sensitivity in cdc9-1 
mutants.   
Successive 10-fold dilutions of CDC9, CDC9 hnt3!, cdc9-1, and cdc9-1 hnt3! 
cells were grown on rich medium plates and incubated at the indicated temperatures.   
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Figure 5.4 
 
 
 
Figure 5.4  Generation of nicked DNA by expressing I-AniI-K227M nickase enzyme 
in budding yeast.   
Left, the I-AniI-K227M nickase target site was cloned into pRS424 vector, 
flanked by two non-encoding genes, VirD2 from Agrobacterium tumefaciens and GFP to 
yield “pTarget site” plasmid. Asterisks indicate a 5’-biotinylated primer that anneals to 
the bottom strand of VirD2 region. Right, cells were grown asynchronously at 25°C to 
mid-log phase and subsequently switched to medium containing 2% galactose to 
overexpress either the I-AniI-K227M nickase or the enzyme dead mutant I-AniI-
Q171K/K227M, which are under the control of a galactose promoter. The 5’-biotinylated 
primer was used for primer extension. Purified pTarget site plasmid from E. coli 
linearized with either NcoI or XhoI were used as a positive control for primer extension 
reactions to produce the indicated ssDNA fragments. A primer extension reaction with no 
DNA added was used as a negative control.  
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